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Abstract 
The effect of the sympathetic nervous system (SNS) on blood flow distribution within 
skeletal muscle microvasculature is conditional upon regional activation of SNS receptors. 
Due to a lack of appropriate experimental models and techniques, no study has systematically 
evaluated the effect of SNS receptor activation in continuously branching skeletal muscle 
arteriolar trees. In line with previous work, we hypothesize that there will be a spatially-
dependent distribution of sympathetic receptor activation along the arteriolar tree. 
Specifically, we anticipate a progressive decrease of adrenergic activation and a progressive 
increase of peptidergic and purinergic activation with increasing arteriolar order. We 
developed a novel rat gluteus maximus (GM) muscle preparation which provided access to a 
large vascular network, from which we developed an experimental method for collecting cell 
velocity profiles in fast-flowing arterioles. Using these data, we derived an empirical 
relationship between velocity ratio (VMax/VMean) and arteriolar diameter, collected novel data 
on cell free layer width and estimated wall shear rates, and derived a wall shear rate equation 
from experimental data that can be used for calculating wall shear rates in skeletal muscle 
microvasculature. We evaluated SNS receptor activation (α1R, α2R, NPY1R, and P2X1R) in 
continuously branching arteriolar trees in the rat GM, as a function of network topology. A 
computational flow model estimated the total flow, resistance, and red blood cell flow 
heterogeneity. For the first time, we highlight effects of SNS receptor activation on network 
hemodynamics, where proximal arterioles responded most to adrenergic activation, while 
distal arterioles responded most to Y1R and P2X1R activation. Our data highlight the 
functional consequences of topologically-dependent SNS receptor activation. The tools 
developed in this thesis are beneficial for computing hemodynamic parameters from in vivo 
data, as well as providing input variables to and validation of computational flow models. 
 iii 
 
Keywords 
Sympathetic nervous system, skeletal muscle, arterioles, blood flow, hemodynamics, 
microcirculation, norepinephrine, neuropeptide Y, ATP, computational modelling, 
fluorescent red cells, velocity profiles, wall shear rate.  
 iv 
 
List of Abbreviations and Symbols 
?̅?𝑅𝐵𝐶 𝐸𝐷𝐺𝐸: mean of edge velocities of the velocity profile 
𝐴𝑉𝑒𝑠𝑠𝑒𝑙: vessel cross-sectional area 
𝑉𝐶𝑒𝑛𝑡𝑒𝑟: centerline velocity 
𝑉𝐸𝑑𝑔𝑒 𝐹𝑎𝑐𝑡𝑜𝑟: conversion factor for calculating experimental edge velocities 
𝑉𝐸𝑑𝑔𝑒: velocity value at the edge of the velocity profile 
𝑉𝐸𝑥𝑝𝑡 𝑅𝐵𝐶 𝐸𝑑𝑔𝑒: experimentally-acquired velocity value at the edge of the velocity profile 
𝑉𝑀𝑎𝑥: maximum velocity 
𝑉𝑀𝑒𝑎𝑛: mean velocity 
𝑉𝑅𝐵𝐶: red blood cell velocity 
𝑉𝑅𝑎𝑡𝑖𝑜: velocity ratio, index of velocity profile bluntness 
𝑊𝑖𝑑𝑡ℎ𝐶𝐹𝐿: red blood cell free layer width 
𝑑𝑃
𝑑𝑥
: partial pressure gradient along a vessel segment 
∆𝑃: change in pressure in a vessel segment 
µ: blood viscosity in a vessel segment 
µpl: plasma viscosity in a vessel segment 
µrel: relative blood viscosity in a vessel segment 
ANOVA: analysis of variance 
ATP: adenosine triphosphate 
cAMP: cyclic adenosine monophosphate 
CCD: charged-couple device 
COX: cyclooxygenase 
D: arteriolar diameter 
EDHF: endothelial derived hyperpolarizing factor 
EDL: extensor digitorum longus 
 v 
 
EMax: absolute maximum constriction response 
FITC: fluorescein isothiocyanate 
GM: gluteus maximus muscle 
GPC: G-protein coupled receptor 
Hct: hematocrit 
HD: discharge hematocrit 
Hz: hertz 
IVVM: intravital video microscopy 
L: vessel length  
LogEC50: concentration of agonist which elicits half of the maximum constriction response 
NA: numerical aperture 
NE: norepinephrine 
NO: nitric oxide 
NPY: neuropeptide Y 
P2X1R: purinergic receptor subunit type 1 receptor 
PE: phenylephrine 
PRU: peripheral resistance units 
PSS: physiological salt solution 
r: vessel radius 
r2: coefficient of determination 
RBC: red blood cell 
RC: radius of the red blood column 
RS: radius of vessel at the centroid of the edge streak 
RWall, RL: radius of vessel lumen 
S.E.M.: standard error of the mean 
SD: standard deviation 
 vi 
 
sec: second (unit of time) 
SNP: sodium nitroprusside 
SNS: sympathetic nervous system 
TH: tyrosine hydroxylase 
TPR: total peripheral resistance 
Y1R: neuropeptide Y Y1 receptor 
α1R: α1 adrenergic receptor 
α2R: α2 adrenergic receptor 
𝐷: oxygen diffusion constant 
𝑄,?̇?: blood flow 
𝑅: resistance in a vessel segment 
𝑘: oxygen’s solubility in a given medium 
 
 
 
 
 
 
 
 
 
 
 
 vii 
 
Co-Authorship Statement 
The work (conception, design, experimentation, data analyses, and preparation of 
manuscript) contained in this dissertation was performed by the author (BKA), under the 
supervision of Dr. Dwayne N. Jackson and Dr. Daniel Goldman, with the advice of Dr. 
Christopher G. Ellis.  
In Chapter 2, Dr. Nicole M. Novielli assisted with surgical training, and Dr. Philip J. 
Medeiros collected flow cytometry data. In Appendix C, Dr. Philip J. Medeiros conducted 
cell migration assays and assisted with writing the methods section of the manuscript, and 
Dr. Nicole M. Novielli provided manual measurements to serve as a gold standard in 
analysis. 
 
 
 
 
 
 
 
 
 
 viii 
 
Dedication 
It is with great honor that I dedicate this thesis, my greatest academic achievement thus far, 
to my family, my husband, and my 9 month old daughter Emilene. 
To my father with the captivating smile, Karim Al-Khazraji, although you left this world too 
early, you have provided eternal enrichment to my life from my childhood memories alone. I 
not only dedicate this thesis to you, but I dedicate all of my academic work to you. We will 
continue to publish together, side by side, as Baraa Karim Al-Khazraji. 
To my sweet, and most generous mother, Hanan, you independently raised 4 children while 
holding down a job to provide for us. You never let me see myself as anything short from 
spectacular. It is when I think of you, and how you see me, that I keep myself in check and 
always seem to do what is best.  
To my siblings, Hajar, Sayf and Adam, if I can do this, you three can do anything. Always 
remember that no one has the connection that we have. Our roots are intertwined, no matter 
how far apart we are from each other. I see you as my older sister and brothers. I am in awe 
watching you grow to become your own individual selves. You continually inspire me. 
To the man I am blessed to call my husband, Asoomy, we have squeezed in an enormous 
amount of “living” in the time that we have known each other. Thank you for *always* being 
here, right here beside me, right where I wanted you. You are the ideal teammate for me, and 
were integral to this entire process. You provided me with the mental clarity that was 
required for me to see this to its end. Thank you as a wife, and as a mother. 
To the most precious creature I have ever come to know, my baby Emilene. Mama is so 
proud and excited that she can even be in a position to write about you in her dissertation! 
You were a complete gem throughout the entire process, and I have learned a lot about 
myself from you. Throughout this entire rollercoaster of a PhD, everything turned out better 
than you or I could have imagined. You make Mama and Baba’s life feel very full and rich.  
 ix 
 
Acknowledgements 
Throughout the course of my PhD, I learned more about myself, the scientist and person, 
than I did about sympathetic receptors and hemodynamics. I have several people to thank and 
acknowledge for taking part in this journey with me. 
My supervisors Dr. Dwayne Jackson and Dr. Daniel Goldman, I owe you many thanks for 
your patience, guidance, and continuous support. Thank you for always providing me with 
opportunities to grow as a young scientist, and as an individual thinker. Thank you for 
guiding me in such a way where I was able to harness my strengths, and work on my 
weaknesses. To Dr. Christopher G. Ellis, you have been more than a member of my PhD 
advisory committee. Your words of advice transcend the confines of my PhD. I am forever 
grateful to you for imparting your wisdom to me. 
Thank you to my thesis examiners (Drs. Steve Segal, Peter Canham, Ian MacDonald, and 
Jamie Melling) for extensively going through my thesis, providing many beneficial 
comments and making several edits. You made the defense a very enjoyable experience 
(surprisingly!). Thank you Dr. Roland Pittman (VCU) for all of your effort and involvement 
in promoting the success of my career. 
My labmates that turned into the dearest of friends, Nicole, Phil, and Nate, thank you for 
being genuine, for always caring, for belly aching laughs and most importantly, thank you for 
letting us pick up where we left off. 
The many good people (students, professors – special thanks to Dr. Peter Canham, Dr. Jerry 
Battista, Dr. Grace Parraga – and administration – special thanks to Wendy Hough for 
looking out for me for nearly a decade!) of MBP that I run into at seminars or in the hallway, 
and have more of a positive impact on me than they know. You have provided the perfect 
atmosphere for learning by making the department feel more like a community. I have likely 
thanked you in person far too many times, so you very well know who you are! 
My decade (and then some) life-long friends, my Windsor girls, my undergraduate Perth 
girls, and my graduate-school-turned-into-long-term friends. What haven’t we seen each 
other go through? Thanks for the soul food. 
My family who were my foundation, and my focus of a horizon when I felt as though I lost 
sight of things. Mama, Hajar, Sayf, and Adam, your words of encouragement kept me going. 
Thank you Baba, your spirit accompanied me the entire way, and you helped me persevere.  
Most of all thank you to my teammate of a husband, you pulled more than your weight, 
especially near the end, so I could finish my degree. My daughter, Emilene, you gave new 
meaning to this PhD. Thank you both for using your smiles to remind me that at the end of 
the day, I have a home in your hearts. 
 x 
 
Table of Contents 
Abstract ............................................................................................................................... ii 
List of Abbreviations and Symbols.................................................................................... iv 
Co-Authorship Statement.................................................................................................. vii 
Dedication ........................................................................................................................ viii 
Acknowledgements ............................................................................................................ ix 
Table of Contents ................................................................................................................ x 
List of Tables .................................................................................................................... xv 
List of Figures .................................................................................................................. xvi 
List of Appendices ......................................................................................................... xviii 
 : General introduction......................................................................................... 1 
 What is the microcirculation? ................................................................................. 2 
 What is unique to skeletal muscle microcirculation? ............................................. 4 
 How is skeletal muscle microcirculation regulated? .............................................. 5 
 Sympathetic nervous system-mediated arteriolar vasoconstriction ........................ 7 
 Importance of the SNS in microvascular control .................................................... 9 
 The overlooked non-adrenergic control of skeletal muscle microcirculation ...... 10 
 Importance of network topology in microvascular regulation .............................. 16 
 Where has skeletal muscle microvasculature classically been studied? ............... 18 
 How has skeletal muscle microcirculation classically been imaged? ................... 24 
 Purpose of thesis dissertation ................................................................................ 30 
 References ............................................................................................................. 31 
 : A simple “streak length method” for quantifying and characterizing red blood 
cell velocity profiles and blood flow in rat skeletal muscle arterioles ......................... 39 
 Introduction ........................................................................................................... 40 
 Materials and methods .......................................................................................... 42 
 xi 
 
 Preparations and protocols ........................................................................ 42 
 Intravital video microscopy ...................................................................... 44 
 RBC streaks, velocity profiles and flow calculations ............................... 45 
 Statistical analyses and data presentation ................................................. 51 
 Results ................................................................................................................... 53 
 Systemic measures and arteriolar responses to O2 .................................... 53 
 Streak length method validation ............................................................... 53 
 In vivo velocity profiles, experimental blood flow calculations, and 
velocity ratios ............................................................................................ 53 
 Discussion ............................................................................................................. 56 
 Measuring VRBC in skeletal muscle arterioles ........................................... 56 
 Arteriolar RBC velocity profiles ............................................................... 58 
 Relationship between blood flow and arteriolar diameter ........................ 59 
 Conclusion ............................................................................................................ 60 
 References ............................................................................................................. 61 
 : Taking the “stress” out of shear rate calculations: An experimentally-derived 
shear rate equation for use in skeletal muscle microvasculature ................................. 64 
 Introduction ........................................................................................................... 65 
 Materials and methods .......................................................................................... 67 
 Data source................................................................................................ 67 
 Data analysis: Wall shear rate estimation ................................................. 67 
 Data analysis: Development of an experimentally derived and 
straightforward wall shear rate equation ................................................... 68 
 Data analysis: Comparison to other wall shear rate calculation methods . 70 
 Statistical analysis ..................................................................................... 71 
 Results ................................................................................................................... 71 
 Wall shear rate estimation from in vivo velocity profiles ......................... 71 
 xii 
 
 Development of an experimentally-derived and straightforward wall shear 
rate equation .............................................................................................. 78 
 Comparison of wall shear rate calculation methodologies ....................... 83 
 Discussion ............................................................................................................. 85 
 Wall shear rate estimation ......................................................................... 85 
 Development of an experimentally derived and straightforward wall shear 
rate equation .............................................................................................. 86 
 Comparison of wall shear rate calculation methodologies ....................... 88 
 Conclusion ............................................................................................................ 89 
 References ............................................................................................................. 90 
 : From one generation to the next: A comprehensive account of sympathetic 
receptor control in branching arteriolar trees ............................................................... 93 
 Introduction ........................................................................................................... 94 
 Materials and methods .......................................................................................... 96 
 Animal care and use .................................................................................. 96 
 Anesthesia and skeletal muscle preparation ............................................. 96 
 Intravital video microscopy (IVVM) ........................................................ 97 
 Experimental protocols ............................................................................. 98 
 Selection of agonist concentrations .......................................................... 99 
 Experimental data collection................................................................... 100 
 Tissue viability and inclusion criteria ..................................................... 101 
 Arteriolar order classification ................................................................. 101 
 Computational modelling........................................................................ 102 
 Data presentation and statistical analyses ............................................... 105 
 Results ................................................................................................................. 108 
 Phenylephrine data .................................................................................. 108 
 UK 14,304 data ....................................................................................... 110 
 xiii 
 
 Neuropeptide Y data ............................................................................... 110 
 ATP data ................................................................................................. 113 
 α,β-methylene ATP data ......................................................................... 113 
 Computational analysis: Calculating hemodynamic consequences from 
spatially-dependent SNS receptor activation .......................................... 117 
 Discussion ........................................................................................................... 125 
 Experimental findings: Topologically-dependent sympathetic control 
along arteriolar trees ............................................................................... 125 
 Computational findings: Total network resistance and flow changes as a 
result of a differential distribution of receptors for sympathetic 
neurotransmitters..................................................................................... 133 
 Conclusion .......................................................................................................... 135 
 References ........................................................................................................... 136 
 : General discussion ....................................................................................... 142 
 Development of the gluteus maximus skeletal muscle preparation .................... 143 
 Development of a method for calculating blood flow in fast-flowing arterioles 144 
 Use of in vivo red blood cell velocity profiles for estimating wall shear stress.. 148 
 Recent use of “streak length” method in skeletal muscle microvascular studies 151 
 Use of “streak length” method for the validation of an in-house computational 
flow model .......................................................................................................... 153 
 Use of the rat GM for investigating SNS receptor functionality in branching 
arteriolar trees ..................................................................................................... 155 
 Topologically-dependent SNS receptor activation and ligand contribution ....... 157 
 Importance of collecting data from microvascular networks ............................. 158 
 Future Studies ..................................................................................................... 159 
 Experimental values of hematocrit ......................................................... 159 
 Sympathetic nervous system co-transmission of neurotransmitters ....... 161 
 Other topics of interest ............................................................................ 162 
 References ........................................................................................................... 163 
 xiv 
 
Appendices ...................................................................................................................... 166 
Appendix A: Copyright license agreement for Chapter 2 .............................................. 166 
Appendix B: Animal use protocol approval ................................................................... 167 
Appendix C: An automated cell-counting algorithm for fluorescently-stained cells in 
migration assays ......................................................................................................... 168 
Appendix D: Cell counting algorithm............................................................................. 182 
Curriculum Vitae ............................................................................................................ 184 
 xv 
 
List of Tables 
Table 4.1: Summary values for 5 arteriolar orders. .............................................................. 107 
 
 xvi 
 
List of Figures 
Figure 1.1: Topologically-dependent SNS receptor functionality. ......................................... 15 
Figure 2.1: Schematic of streak length method technique. ..................................................... 46 
Figure 2.2: Velocity profiles from binned diameters of arteriolar segments. ......................... 47 
Figure 2.3: Relationship between experimental blood flow and arteriolar diameter. ............. 52 
Figure 2.4: Relationship between velocity ratio and arteriolar diameter. ............................... 55 
Figure 3.1: Relationship between experimentally acquired wall shear rate and arteriolar 
diameter................................................................................................................................... 73 
Figure 3.2: Relationship between cell free layer width and arteriolar diameter. .................... 74 
Figure 3.3: Normalized cell free layer as a function of arteriolar diameter. ........................... 75 
Figure 3.4: Relationship between profile edge velocity and arteriolar diameter. ................... 76 
Figure 3.5: Relationship between centerline velocity and arteriolar diameter. ...................... 77 
Figure 3.6: Relationship between change in cell free layer width and centerline velocity. ... 79 
Figure 3.7: Comparison of experimental and calculated wall shear rates. ............................. 82 
Figure 3.8: Comparison of wall shear rates (WSR) using different velocity ratios. ............... 84 
Figure 4.1: Arteriolar responses to α1R activation at 5 arteriolar orders. ............................ 109 
Figure 4.2: Arteriolar responses to α2R activation at 5 arteriolar orders. ............................ 111 
Figure 4.3: Arteriolar responses to Y1R activation at 5 arteriolar orders. ............................ 112 
Figure 4.4: Arteriolar responses to ATP application at 5 arteriolar orders. .......................... 114 
Figure 4.5: Arteriolar responses to ATP application with P2X1R blockade at 5 arteriolar 
orders..................................................................................................................................... 115 
 xvii 
 
Figure 4.6: Arteriolar responses to αβ-meATP application at 5 arteriolar orders. ............... 116 
Figure 4.7: Computational network reconstruction schematic. ............................................ 118 
Figure 4.8: Validation of computational flow data with experimental flow data. ................ 119 
Figure 4.9: Calculated total network flow during baseline, and sympathetic receptor 
activation. .............................................................................................................................. 121 
Figure 4.10: Calculated total network resistance during baseline, and sympathetic receptor 
activation. .............................................................................................................................. 122 
Figure 4.11: Change in RBC flow heterogeneity at 2A to 5A during sympathetic receptor 
activation. .............................................................................................................................. 124 
 
  
 xviii 
 
List of Appendices 
Appendix A: Copyright license agreement for Chapter 2 .................................................... 166 
Appendix B: Animal use protocol approval ......................................................................... 167 
Appendix C: An automated cell-counting algorithm for fluorescently-stained cells in 
migration assays .................................................................................................................... 168 
Appendix D: Cell counting algorithm................................................................................... 182 
 
 
1 
 
 
 
 
 
 
 
 
: 
General introduction 
 
 
 
 
 
 
 
The chapter was solely written by BKA. Excerpts of this chapter have been modified to 
assist in the preparation of the following manuscript: 
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 What is the microcirculation? 
The microcirculation is comprised of the smallest vessels in the body, namely the 
arterioles, capillary networks and the venules. The microcirculation is embedded within a 
tissue or organ, allowing there to be an intimate interaction between these vessels and the 
surrounding parenchyma. This anatomical set-up provides immediate exchange of gasses, 
metabolites and nutrients both to and from the microcirculation and the proximate tissue. 
One of the unique features of the microcirculation is that it does not scale with species, in 
that capillary and red blood cell sizes are similar from mouse to large mammals (West et 
al., 1997). This feature allows for cross-examination of hemodynamic responses between 
species, where conclusions drawn from microcirculatory studies likely carry relevance 
across a wide range of animal species.  
Progressing from the larger conduit vessels (e.g., aorta and arteries) into the 
microcirculation, there is a large decrease in vascular inner diameter. Feed arterioles 
entering a tissue can be up to 200 μm in diameter, followed by an intermediate branching 
arteriolar network that leads to an interconnected parallel network of capillaries with 4-8 
μm inner lumenal diameter, and exiting venules. At the arteriolar level, this decrease in 
diameter is met with a large increase in vascular resistance as well as the greatest 
pressure drop in the circulatory system (Fronek & Zweifach, 1975). Poiseuille’s flow 
equation (Equation 1.1) coupled with a variation on Ohm’s law (Equation 1.2), describes 
the relationship between pressure, resistance, flow, and geometry in microvascular beds. 
Poiseuille’s equation (Equation 1.1) is useful when modelling a vessel segment as a 
straight smooth bore tube with a constant radius, which contains steady laminar flow with 
Newtonian (i.e., constant) viscosity. 
3 
 
Equation 1.1 
∆𝑷 =
𝟖𝝁𝑳𝑸
𝝅𝒓𝟒
 
Equation 1.2 
∆𝑷 = 𝑸𝑹 
Where ΔP is change in pressure along a vessel segment (Equation 1.1) or across any two 
points in the circulatory system (Equation 1.2), μ is blood viscosity, L is length of vessel 
segment, 𝑄 is blood volume flow through a vessel segment (Equation 1.1) or across any 
two points in the circulatory system, r is the radius of a vessel segment. Equation 1.1 and 
1.2 can be combined to solve for 𝑅, or resistance, for a given vessel,  
Equation 1.3 
𝑹 =
𝟖𝝁𝑳
𝝅𝒓𝟒
 
It is through modification of these hemodynamic parameters that resistance (𝑅) in the 
microcirculation is controlled, and blood flow is regulated in a tissue. Therefore, in 
addition to metabolite exchange within the tissue and regulation of systemic arterial 
pressure via changes in total peripheral resistance, the microcirculation serves to regulate 
blood flow distribution both to and within tissues.  
Blood is a suspension of formed elements in plasma (primarily made up of water, and 
contains dissolved proteins, electrolytes, sugars, clotting factors) and consists of a red 
blood cell (RBCs; 42-45%), white blood cells (1/600 of total cell volume), and platelets 
(1/800 of total cell volume). Blood flowing through a vessel segment generally follows a 
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two-phase model, where RBCs aggregate towards the center resulting in axial 
accumulation, and a plasma annulus is left near the inner wall of the vessel (Popel & 
Johnson, 2005). Poiseuille's equation (Equation 1.1) leads to a parabolic velocity profile, 
but blunted velocity profiles can be explained by radial variations in viscosity produced 
by variations in RBC density when blood flow is modelled as a two-phase model. 
 What is unique to skeletal muscle microcirculation? 
Skeletal muscle comprises a large proportion of the body’s weight [~40% of total body 
mass (Janssen et al., 2000)]. This large active tissue is fed with highly regulated vascular 
networks which allows skeletal muscle to increase its blood flow supply by up to 100-
fold (Andersen & Saltin, 1985). The largest volume of resistance arterioles resides within 
skeletal muscle, and is also where the greatest contribution to total peripheral resistance 
occurs.  
Each muscle fiber exhibits its own resting metabolic demand, which is primarily 
governed by its fiber type (Mackie & Terjung, 1983). This unique level of demand is 
precisely met by adequate blood flow, which is finely titrated by concurrent neurally-
mediated vasoconstriction (supplied by the SNS) and metabolically mediated 
vasodilation. Thus, this myofiber-centric blood flow supply results in heterogenous levels 
of blood flow distribution across a single muscle tissue (Koga et al., 2014). As well, 
blood flow heterogeneity across striated muscle tissue may result from time-dependent 
variability in blood flow distribution, thereby illustrating that skeletal muscle is subject to 
both spatially- and temporally-dependent changes in blood flow heterogeneity (Iversen & 
Nicolaysen, 1989). 
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To summarize, the uniqueness of skeletal muscle microvasculature is a result of the 
following: 1) the majority of total peripheral resistance is controlled and maintained 
within skeletal muscle microvasculature, 2) the ability of skeletal muscle to increase its 
blood supply by up to 100-fold, 3) heterogeneous blood flow distribution within a single 
muscle, and 4) its microvasculature is fine-tuned to precisely match the metabolic 
demands of muscle fibers on a moment-by-moment basis. Furthermore, skeletal muscle is 
responsible for adjustments to posture and voluntary movement, both of which require 
instantaneous coordinated changes in blood flow supply. 
To this end, investigating microvascular hemodynamics in skeletal muscle models 
provides the opportunity to characterize the behaviour of the microcirculation over a wide 
range of metabolic conditions (e.g., resting heterogeneous blood flow distribution to near 
instantaneous 100-fold increases in blood flow supply during muscular contraction). 
Experiments utilizing skeletal muscle preparations for the study of blood flow provide 
insight to the vast capacity of control elicited by the microcirculation’s innate regulatory 
mechanisms, and how these mechanisms may adapt or become disrupted during 
abnormal tissue conditions. 
 How is skeletal muscle microcirculation regulated?  
The essence of microvascular regulation lies in maintaining the balance between oxygen 
supply in the microvessels, and the oxygen demand of the surrounding tissue. Regulation 
of skeletal muscle microvasculature involves fulfilling regional metabolic demands of 
single muscle fibers, as well as integrating local blood flow responses to ensure overall 
adequate blood supply to the whole tissue. Fick’s law of diffusion, given by Equation 1.4, 
best describes the assimilated responses to oxygen extraction in microvascular networks.   
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Equation 1.4 
𝑭 = −𝑫𝒌𝑨 (
𝒅𝑷
𝒅𝒙
) 
In the context of oxygen transfer, Fick’s law states that oxygen flux (𝐹) occurs down a 
partial pressure gradient (
𝒅𝑷
𝒅𝒙
), is proportional to the surface area of the membrane (𝐴), and 
is inversely proportional to the thickness of the membrane through which oxygen must 
travel (𝑥). 𝐷 refers to oxygen diffusion constant, and 𝑘 is oxygen’s solubility in a given 
medium. To facilitate the exchange of oxygen in the microcirculation, oxygen transfer 
occurs in the arterioles as well as in the capillaries where the thinnest vascular walls 
reside (i.e., one endothelial cell thick), and the flow is significantly slower in order to 
provide enough time for oxygen extraction. As well, the greatest surface area throughout 
the vascular network occurs at the capillaries (Poole et al., 2013), further optimizing 
oxygen extraction from RBCs.  
As described, the topological features of the capillary bed facilitate oxygen extraction 
into the surrounding parenchyma. Capillaries are not directly regulated by the SNS, and 
must rely on the received blood volume flow in order to determine the hematocrit (or 
percentage of RBCs in whole blood) and RBC supply rate, and the ensuing oxygen 
available for extraction. The arterioles directly feed into the capillary network, which 
then immediately feed into the venular network. Microvascular regulation, and therefore 
coordinated blood flow delivery to and from the capillaries, occurs in both the arteriolar 
and the venular components of the microvascular system. 
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Skeletal muscle microvascular regulation is governed by a net effect of multiple 
vasostimulatory actions (Segal, 2005) including vasoconstriction, vasodilation, and the 
consequent “network” effect on responses as illustrated by the effects of upstream and/or 
downstream resistance. For a given site, local microvascular regulation is executed either 
through constriction or dilation at a given vessel. The degree to which constriction or 
dilation occurs depends on the integration of supply-demand relationships across an 
entire network. That is, resistance vessels may instantaneously dilate (allow for more 
blood flow when metabolic demands are high) (Naik et al., 1999) or constrict (conserve 
blood flow when demands are low) in order to meet metabolic demands of the tissue on a 
moment-by-moment basis; however, in order to maintain perfusion throughout the whole 
tissue, constriction/dilation occurs within the confines of assimilating vasoregulation 
across multiple branch orders of a network. Thus, the underpinnings of microvascular 
regulation must reside in a network’s topology, where any investigation of regulation at 
this level ought to consider both the geometry (i.e., diameter) and the topology (i.e., 
length, branch order) of the network.  
 Sympathetic nervous system-mediated arteriolar 
vasoconstriction 
The sympathetic nervous system (SNS) is the autonomic regulator of microvascular flow 
in skeletal muscle. Numerous locally derived/released endothelial factors evoke ongoing 
vasodilation [notably nitric oxide (NO), ATP (adenosine triphosphate), cyclooxygenase 
(COX), endothelial derived hyperpolarizing factor (EDHF), adenosine from 5’-
nucleotidase (5’NUC)]. For the purposes of this thesis, only the SNS and its contributions 
to vascular resistance will be discussed.  
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The sympathetic nervous system innervates the adventitiomedial layer of arterioles, 
coming in direct contact with vascular smooth muscle cells. These nerves elicit tonic 
vasoconstriction of arterioles through the release of norepinephrine (NE), neuropeptide Y 
(NPY), and ATP acting on their associated receptors (α1R and α2R, Y1R, and P2X1R) 
located on smooth muscle cells. Independent of the SNS, vasomotor tone is set by the 
integration of myogenic contraction of smooth muscle and the vasodilator influence of 
the endothelium.  
There are four vascular smooth muscle cell sympathetic receptors that are responsible for 
arteriolar vasoconstriction: α1 adrenergic receptor, α2 adrenergic receptor, NPY Y1 
receptor, and P2X1 receptor. The two adrenergic receptors (O'Connell et al., 2014) and 
the NPY Y1R receptor (Hirsch & Zukowska, 2012) are classified under the metabotropic 
G-protein coupled receptor (GPCR) family of receptors; whereas the purinergic receptor 
subunit type 1 receptor (P2X1R) is part of the ligand-gated ion channel family of 
receptors (specifically, an ATP-gated cation channel) (Surprenant & North, 2009). 
The α1 adrenergic receptor (α1R) belongs to the Gq/11 family of heterotrimeric G 
proteins. Briefly, upon α1R activation via norepinephrine or epinephrine binding, β-
isoforms of phospholipase C are stimulated and generate IP3 which then causes a release 
of calcium (Ca2+) from intracellular stores and activation of protein kinase C (PKC; to 
phosphorylate and activate downstream cascade of protein signaling) via DAG (Exton, 
1996). This release of Ca2+ binds onto calmodulin, which activates myosin light chain 
kinase to phosphorylate myosin heads, increasing myosin ATPase activity. Myosin cross-
bridges are created causing actin to slide over using myosin power strokes (sliding 
filament theory) to contract the smooth muscle, resulting in overall vasoconstriction. 
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Both the NPY Y1R (Brothers & Wahlestedt, 2010) and the α2 adrenergic receptor (α2R) 
(Bylund, 1992) belong to the Gi family of the heterotrimeric G proteins. Upon ligand 
binding, this receptor acts through adenylyl cyclase inhibition, ultimately attenuating 
cyclic adenosine monophosphate (cAMP) production from ATP. The drop in cAMP 
increases the activity of myosin light chain kinase, thereby phosphorylating myosin light 
chain and resulting in overall vasoconstriction. 
In contrast to the above metabotropic receptors, the P2X1 receptor is an ionotropic 
receptor and a member of the ligand-gated ion channel P2X receptor family (Valera et 
al., 1994). Upon binding of ATP to an allosteric binding site, the P2X1 receptor changes 
conformation and allows for Ca2+ and Na2+ into the cell, depolarizing smooth muscle 
cells and resulting in overall vasoconstriction in the arteriole. 
 Importance of the SNS in microvascular control 
Activation of the SNS receptors in the periphery largely contributes to the maintenance of 
total peripheral resistance (TPR) in the control of systemic blood pressure. To illustrate, 
the mere act of a person moving from a supine to a standing position, requires activation 
of the SNS in order to maintain mean arterial pressure when cardiac output falls in order 
to prevent neurally-mediated syncope (Fu & Levine, 2014). As well, SNS-mediated 
maintenance of blood pressure, via control of TPR, is achieved in the face of cardiac 
output distribution to various tissues and organs, as well as blood flow redistribution 
within tissues, based on local regional metabolic needs.  
The SNS and its actions are graded with the level of exercise; in the case of high intensity 
exercise, cardiac output is redirected from the splanchnic circulation to the active limbs 
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(Rowell et al., 1964). These regulatory mechanisms speak to the various degrees of 
control (peripherally) the SNS exerts on the cardiovascular system: from maintenance of 
blood pressure to fine-tuned distribution of blood flow fractions within microvascular 
networks, which will be further discussed in sections below. 
 The overlooked non-adrenergic control of skeletal 
muscle microcirculation 
The majority of studies characterizing sympathetic neuronal density expression in 
skeletal muscle microvasculature have utilized data collected from adrenergic neuronal 
staining. One of the earliest reports of adrenergic nerve fiber density in a skeletal muscle 
vascular bed was from the cat gastrocnemius and tibialis anterior muscles, where 
adrenergic fibers uniformly innervated the microcirculation (Fuxe & Sedvall, 1965). 
Similarly, immunohistochemical analysis performed in the rat cremaster (Fleming et al., 
1989) and later in the hindlimb of the guinea pig (Anderson et al., 1996) and in the 
hamster retractor muscle (Grasby et al., 1999) resolved spatially-dependent co-localized 
tyrosine hydroxylase (TH; rate-limiting enzyme in the synthesis of norepinephrine) and 
NPY-containing axons, where these neurons uniformly innervated proximal to distal 
arterioles, but not veins or venules. As well, in the case of the hamster retractor and cheek 
pouch study, these NPY and TH co-localized adrenergic neurons were only present on 
the skeletal muscle region (retractor) and were absent on the epithelial (cheek pouch) 
portion of the preparation (Grasby et al., 1999). 
There are a limited number of studies investigating sympathetic neuronal density as a 
function of arteriolar network topology. The adrenergic plexus spatial density (via 
catecholaminergic neuronal staining with glyoxylic acid) has been shown to be 
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topologically-dependent within the arteriolar network, where there is a progressive 
increase in adrenergic nerve density when transitioning from the arcade to transverse 
arterioles in the rat spinotrapezius, and is absent in terminal arterioles (Saltzman et al., 
1992). As well, NPY-containing sympathetic axons profusely innervate resistance vessels 
(i.e., arterioles) and become progressively more dense with increasing arteriolar order 
(Sundler et al., 1993). Evidence for a differential neuronal density distribution at the 
microanatomical level provides indication of topologically-dependent heterogeneous 
sympathetic control in skeletal muscle microvasculature. 
One of the first detailed accounts of heterogeneous arteriolar responses to sympathetic 
stimulation in skeletal muscle was provided by Marshall’s work on the microvascular bed 
of the rat spinotrapezius (Marshall, 1982). In congruence with aforementioned findings 
on spatially-dependent sympathetic innervation in skeletal muscle microvasculature, 
Marshall reported order-dependent differences in arteriolar responses, where 1st and 2nd 
order arterioles exhibited a gradual on-set in large vasoconstrictor responses to 
paravascular nerve stimulation at 8-10 Hz (up to an 85% decrease in diameter), which 
was in contrast to the rapid on-set of short-lived constriction responses exhibited by 
terminal arterioles.  
Similarly, during sympathetic nerve stimulation, maximum constriction occurred in 4th 
order vessels, and there was a progressively greater “sympathetic escape” (i.e., secondary 
fall in vascular resistance) with increasing arteriolar orders of the cat sartorius 
(Boegehold & Johnson, 1988). Furthermore, in 1st to 6th order arterioles of the 
exteriorized cat sartorius muscle, 3rd order arterioles have the greatest levels of responses 
during concurrent sympathetic nerve stimulation at 8 Hz (Dodd & Johnson, 1991).  
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In complementary experiments, sympathetic neuronal stimulation in the rat cremaster 
elicited vasoconstriction along the arteriolar network; yet, responses were abolished in 
proximal vessels with the concurrent addition of prazosin (1R antagonist), and were 
also abolished in distal vessels with the addition of rauwolscine (2R antagonist). This 
study also suggested that sympathetic nerve stimulation at low frequencies 
(corresponding to basal neurogenic vascular tone) of 0.2-2 Hz results in preferential 
constriction of small arterioles via 2-adrenergic receptor activation, and would largely 
contribute to changes in neurogenic resistance. At higher neuronal firing frequencies in 
the rat cremaster, proximal arterioles would be more responsive via 1 adrenergic 
receptor activation and would be the predominant determinant of neurogenic tone 
(Ohyanagi et al., 1991). These varying constrictor patterns could reflect variations in 
sympathetic neurotransmitter release patterns, post-junctional receptor sensitivity and/or 
post-receptor contractile properties of vascular smooth muscle.  
In the rat hindlimb, sympathetic stimulation elicited blood flow responses during muscle 
contraction that were dependent on contraction intensity and muscle fiber type (i.e., high 
oxidative rat soleus did not exhibit functional sympatholysis (inhibition of SNS mediated 
vasoconstriction during skeletal muscle contraction) during maximal contractions, 
compared to absence of functional sympatholysis in the highly-glycolytic rat 
gastrocnemius-plantaris muscles during low-intensity contractions) (Thomas et al., 
1994). Despite these differences, application of specific adrenergic agonists elicited 
similar arteriolar vasoconstrictor responses between both the mouse fast-twitch extensor 
digitorum longus muscle and the slow-twitch soleus muscle, highlighting that vascular 
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responses to adrenergic receptor activation are independent from skeletal muscle type 
(Lambert & Thomas, 2005). 
Interestingly, despite the existence of three different SNS neurotransmitters acting on 
their respective receptors, both the roles of NPY and ATP in skeletal muscle blood flow 
regulation remain to be characterized. The view, more recently considered as 
oversimplified, that sympathetic vascular control is dominated by the adrenergic system 
was primarily justified by a) baseline NE concentration and an increase in NE 
concentration during stress (Zukowska-Grojec et al., 1988); and b) decrease in vascular 
resistance, and blood pressure, during prazosin administration (α1R adrenergic blockade) 
(Oates et al., 1976). 
However, despite having negligible effects on blood pressure, NPY itself elicits 
vasoconstriction at interstitial concentrations that are nearly 1000× lower than NE 
(Hirsch & Zukowska, 2012; Mortensen et al., 2012). In fact, NPY was shown to play an 
important role in microvascular flow regulation through its effects on Y1R in distal 
arterioles (Jackson et al., 2004). As previously mentioned, the density of NPY-containing 
axons progressively increases with decreasing resistance vessel diameter (Sundler et al., 
1993). Therefore, despite higher interstitial concentrations of NE, the above highlights 
that NE and NPY possess spatially-dependent heterogeneous functions in the vasculature 
(i.e., proximal versus distal locations of action). This is further supported by work on cat 
microcirculatory beds showing that both NPY (Ekelund & Erlinge, 1997) and ATP 
studies in the rat (Gitterman & Evans, 2000) exert diameter-dependent vasoconstrictor 
responses, with peak responses occurring at the distal arterioles. Taken together, the 
classically accepted adrenergic view of vascular control may have evolved from a 
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shortage in comprehensive evaluations of SNS-mediated vasoconstrictor effects at 
multiple microvascular branch orders. 
To further investigate the spatially- or topologically-dependent heterogeneous response to 
receptor activation, α-adrenoreceptor (i.e., α1R and α2R) arteriolar control of the rat 
cremaster (Faber, 1988; Ohyanagi et al., 1991) and mouse gluteus maximus muscle 
(Moore et al., 2010) were investigated. However, these studies were limited to 
adrenoreceptor control in partial networks (i.e., 1st to 3rd order arterioles), and primarily 
focused on acquiring functional bio-assay data on ligand sensitivity, leaving any 
consequent hemodynamic changes to speculation. Thus, our working hypothesis is that 
there may be an emerging relationship between network topology and ligand-receptor 
activation, suggesting there may be a heterogeneous vaso-active response to all 4 
sympathetic receptors progressing from the proximal (feed artery) to the distal (pre-
capillary terminal arterioles) arterioles. 
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Summary of SNS receptor functionality as a function of network topology. Based on 
previous literature, it is hypothesized that there is a progressively decreasing sensitivity to 
adrenergic (α1R and α2R) receptor activation with increasing branch order (towards 
distal, pre-terminal arterioles that branch into the capillary bed), and a progressively 
decreasing sensitivity to purinergic and peptidergic receptor activation with decreasing 
branch order (towards proximal, inlet arterioles). 
 
 
Figure 1.1: Topologically-dependent SNS receptor functionality. 
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Since arteriolar network geometry (i.e., topology) plays a considerable role in setting 
network resistance, it necessarily follows that acute control of arteriolar diameter must 
coordinate with topology in order to regulate microvascular blood flow and RBC 
distribution efficiently. Currently, the impact of microvascular topology on 
sympathetically-mediated arteriolar control is unknown. The importance of assessing 
microvascular network hemodynamics has been either overlooked or not experimentally 
feasible.  
 Importance of network topology in microvascular 
regulation 
Blood flow to capillary beds is affected by upstream vasoregulation (e.g., upstream 
dilation/constriction) (Segal et al., 1989), topology, morphology, and hemodynamic 
parameters (Zweifach, 1974; Pries et al., 1986; Duling & Damon, 1987; Pries et al., 
1995). Skeletal muscle microvascular data are predominantly collected from single 
microvessels within a network (VanTeeffelen & Segal, 2006; Moore et al., 2010; Frisbee 
et al., 2011), and the remaining network data are extrapolated from the experimentally 
collected data (Duling et al., 1982). However, with the existence of blood flow 
heterogeneity in skeletal muscle microvasculature (Duling & Damon, 1987), it becomes 
necessary to collect data from more complete networks (Pries et al., 1986; Pries et al., 
1995) as opposed to single sites of observation. 
Blood can be described as a two-phase fluid, comprised of both red blood cell and plasma 
components. When blood meets a bifurcation, there may be uneven distribution of the red 
blood cell fraction (i.e., hematocrit) between the two daughter vessels, which contributes 
to the heterogeneous level of red blood cell distribution within a vascular network. 
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Therefore, even within a single bifurcation there may be differences in hematocrit in 
individual segments that will ultimately affect hematocrit at the level of the capillaries 
(Pries et al., 1996).  
Blood flow supplied to the microvasculature is also affected by the architecture of the 
supplied downstream network. As microvascular networks are more than an 
interconnected set of isolated vessels, changes in demand at the capillary end can be 
communicated to the preceding branches in order to receive the required level of 
adequate blood flow supply. As summarized by Bearden, signals are sent from the 
downstream vessels along the length of a vessel upstream, and are categorized as 
intercellular, mechanical, or countercurrent forms of communication (Bearden, 2006). 
Intercellular communication occurs when a segment of a vessel is exposed to a 
vasomotor stimuli, and sends a vasomotor signal upstream to a part of the network that is 
not experiencing the same stimulus to cause remote changes in vasodilation upstream 
(Segal & Duling, 1987). Mechanical communication is illustrated when downstream 
dilation causes an increase in shear stress upstream. Countercurrent communication 
describes the communication between a venule and an arteriole, through which the tissue 
can send a signal (via release of a vasoactive substance) to cause a dilation in upstream 
arterioles. As illustrated, the inherent network connectivity present in microvascular 
networks precludes complete acquisition of hemodynamic data from single sites of 
observation. Therefore, to more thoroughly investigate hemodynamic parameters within a 
network, it is pertinent to incorporate downstream and upstream changes in parameters, 
as well as network geometry and morphology.  
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Although experimental data on skeletal muscle microvascular hemodynamics are limited, 
the tenacious efforts of Pries, Secomb and their collaborators have greatly contributed to 
network hemodynamic analysis via decades of seminal work on microvascular networks 
from the rat mesentery. As it is experimentally difficult to acquire data from all segments 
within a network, Pries et al. have mastered the photomontage technique and collected 
experimental data that are complemented by computational simulations to assess full 
network hemodynamics (Pries et al., 1986; Pries et al., 1990; Pries et al., 1994). This 
approach has been very useful in simulating network structural adaptations to elevated 
pressure (Pries et al., 2001b), angio-adaptation in tumor microvascular networks 
(Secomb et al., 2012), and general adaptations of the terminal network to changes in 
tissue demands (Pries et al., 2001a). Much of the advances made in microvascular 
network flow simulations can be accredited to their work. With the development of more 
network-accessible skeletal muscle preparations, the experimentally collected and 
computationally simulated approach to data collection would serve as a powerful 
technique in calculating valuable hemodynamic data in skeletal muscle microvascular 
networks.  
 Where has skeletal muscle microvasculature classically 
been studied? 
The first description of a systemic circulation was given by William Harvey in the early 
1600s. In 1661, nearly 4 years after Harvey’s death, Marcello Malpighi observed blood 
flowing through small tubes (nowadays known as capillaries) in the frog. He was the first 
to assert that capillaries were the connection between arteries and veins, thereby 
completing the systemic circuitry that was first laid out by Harvey (Pearce, 2007). 
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The majority of our understanding on microvascular regulation in skeletal muscle tissues 
comes from experiments conducted on in vivo preparations, all notably described in the 
1973 5th Volume of the Microvascular Research journal. These preparations [namely the 
rat cremaster (Baez, 1973), hamster cheek pouch (Duling, 1973), rat spinotrapezius 
(Gray, 1973), and cat sartorius (Burton, 1973)] revolutionized microvascular research and 
pushed past the previous limits of in vivo research, launching a new realm of in-depth 
microvascular regulation studies.  
The definitive objective of an in vivo skeletal muscle microvascular preparation is to best 
recreate the endogenous environment, while providing an opportunity to manipulate and 
observe the regulation of control systems within microvascular networks. The 
development of a functional, in vivo skeletal muscle preparation for intravital video 
microscopy is a difficult feat. Each step in the procedure must be executed with great 
care: from animal handling, to finely exposing the tissue with minimal surgical trauma 
and maintaining both the preparation and animal under stable conditions throughout the 
course of the experiment.  
In 1961, the cremaster muscle was described as a valuable model for microvascular 
observation (Grant, 1964). This method of cremaster preparation was limited as there 
were three key characteristics which constrained the view of the microcirculatory 
network: a) curvature of the testes was left in situ thus creating a smaller field of view; b) 
the preparation oscillated with respiration; and c) the vessels found in the tunica 
albuginea lining of the cremaster provided a poor background of contrast for the 
cremaster vessels. As a means to evade the anatomical obstructions, a white enamel 
spatula was introduced through an abdominal incision to prevent curvature of the 
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preparation (thereby increasing its field of view), to better secure the muscle in situ 
(therefore preventing respiratory artifacts in imaging), and to provide a white background 
for imaging cremaster microcirculation (an improvement from the low-contrast 
vascularized tunica albuginea background) (Majno et al., 1967). While introduction of 
the white enamel spatula improved the imaging quality of the cremaster microcirculation, 
it, along with the original method proposed by Grant et al., depended on incident light 
illumination for microvascular imaging. This type of imaging can only be carried out 
under low magnification conditions, thereby preventing imaging at the resolution 
necessary for identifying a clear boundary between the lumen and the wall of the vessel.  
To circumvent aforementioned obstructions to imaging, a detailed method was described 
in 1973 that involved fully opening and exposing the cremaster muscle, as well as 
implementing transillumination in lieu of incident light illumination (Baez, 1973). Fully 
opening up the cremaster along with the use of transillumination proved to be a powerful 
combination as this allowed, for the first time since the conception of utilizing the 
cremaster for microcirculatory observations, data collection from a large field of view as 
well as clearly defined borders between the lumen and vessel wall in the cremaster 
muscle. 
The hamster cheek pouch was first described as a preparation for observing 
microcirculation in the late 1940’s and early 1950’s (Fulton et al., 1947; Lutz & Fulton, 
1954). In 1973, the hamster cheek pouch preparation for acute experimentation, its 
anatomical characteristics, and functional responses (to acetylcholine and oxygen) were 
described in full detail. This preparation has been praised for: 1) its dual nature in cell 
types (its anatomy involves a cheek skin pouch that is retained by a thin retractor muscle 
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(Grasby et al., 1999), thereby possessing both striated muscle and cutaneous circulatory 
beds) providing the ability to conduct comparative studies, 2) being a thin tissue which is 
ideal for tissue transillumination and improving clarity of microvessel observations, and 
3) providing visual access to multiple consecutive branch orders. While this preparation 
has lent its utility to the study of blood flow regulation in skeletal muscle, there exist 
important anatomical differences between the retractor muscle and true locomotor 
muscles and therefore may limit its generalisability to non-locomotor muscles (Loeb et 
al., 1987; Williams & Segal, 1993; Welsh & Segal, 1997). 
The spinotrapezius skeletal muscle preparation was introduced by Zweifach and Metz in 
1955 (Zweifach & Metz, 1955), and its preparation was first described in detail by 
Hyman and Paldino who used the spinotrapezius to study local temperature regulation 
(Hyman & Paldino, 1962). Since then, the preparation was refined and modified (Gray, 
1973), and has been used in recent work (Chen et al., 2013). Due to the thickness of this 
muscle, the spinotrapezius has been used to measure capillary hemodynamics during 
muscle contractions (Bailey et al., 2000; Richardson et al., 2003). This locomotor muscle 
has been difficult to study during exercise paradigms as rodent treadmill experiment 
paradigms (the conventional training program used during exercise experimentation) do 
not activate the spinotrapezius, and in fact reduce blood flow within the muscle (Musch 
& Poole, 1996). It has been shown that the spinotrapezius is activated during downhill 
running; an eccentric movement that has been shown to elicit powerful muscle 
contractions (Meyer et al., 2003) and induces muscle adaptation (Clarkson et al., 1992) 
despite the potential muscle damage that may be accompanied with such exercise (Kano 
et al., 2004a; Kano et al., 2004b). 
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The cat sartorius muscle preparation was developed for microcirculatory studies as it 
exhibits two ideal characteristics necessary for improved visualization of the 
microvessels: thinness for optimized transillumination, and a parallel muscle fiber layout. 
Another key benefit to utilizing the cat sartorius muscle was that its blood supply 
(primarily, lateral circumflex femoral artery and vein; secondarily, femoral artery and 
vein) can be cannulated (Burton & Johnson, 1972; Burton, 1973), which is the ideal 
method for acquiring total flow to a tissue during hemodynamic experiments where data 
can then be used as inputs for experimental modelling. Of particular importance, the frog 
sartorius was extensively used by Tyml et al. to provide some of the first evidence 
showing the capillary as a medium of communication in the microvasculature (Dietrich & 
Tyml, 1992), as well as for highlighting the importance of capillary recruitment and 
blood flow heterogeneity within capillaries (Tyml, 1986). Although the sartorius muscle 
is simple to exteriorize, at its thinnest region, it may have up to 15 muscle fibers with 
capillaries exhibiting countercurrent flow near adjacent muscle fibers (Sullivan & 
Pittman, 1982). 
In most preparations, thick fascia tissue hinders microvascular visibility, which limits the 
age range to younger subjects as they have less fascia tissue; however, this prevents the 
conduction of aging studies. The rat extensor digitorum longus (EDL) preparation was 
developed with the incentive that it would be an in vivo skeletal muscle preparation that 
provides good microvascular visibility independent of animal age or size (Tyml & 
Budreau, 1991). As the EDL is a tubular muscle, deep in the hindlimb muscles, where 
capillary beds and their small venules are easily observed at the surface of the muscle. A 
coverslip is placed on the muscle and is used to a) prevent air exposure to the muscle, 
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thus bypassing the use of superfusion (as employed by other studies), b) stabilizes 
preparation from breathing artifacts, and c) enables good visualization for use in epi-
illumination. With this set-up and the microvascular anatomy of the preparation itself, 
live imaging of red blood cell velocity and perfused capillary density is possible. The 
major benefits of this preparation are a) it is a true locomotive skeletal muscle, b) the 
preparation can be used independent of animal age or size, c) does not depend on use of 
superfusion for stability, and d) can be used with a coverslip to maximize the field of 
view size (Tyml & Budreau, 1991). Despite the many benefits of the EDL preparation, its 
primary utility lies in the investigation of capillary beds, as its tubular anatomy does not 
allow access to a microvascular network. That is, the feed arteriole/exiting venule are 
embedded closer to the middle; subsequent vessels then bifurcate towards the surface of 
the muscle, where only capillaries are visible. As well, another drawback to the use of the 
coverslip is it does not allow for hemodynamic investigation of drug perturbations, which 
would otherwise have been easily dissolved in a superfusate solution flowing over the 
muscle. 
These described preparations have been integral in providing a window into the 
microcirculation, a once ambitious experimental feat to have overcome. In addition, it is 
noteworthy to mention non-skeletal muscle preparations such as the rat mesenteric bed 
(McGregor, 1965), rabbit ear (Ahern et al., 1949), and bat wing (Nicoll & Webb, 1946) 
that have also greatly contributed to the knowledge base of microvascular regulation. 
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 How has skeletal muscle microcirculation classically 
been imaged? 
The establishment of many viable models for visualizing the microcirculation was 
conveniently conducted in tandem with the development of techniques for quantifying 
red blood cell velocity and flow hemodynamics in microvessels. The different techniques 
were developed under various experimental conditions and are dependent upon many 
contributing factors (i.e., type/method of illumination, size of vessel, magnification, and 
cell velocity). Initially, observation of the microcirculation utilized a visual method 
approach, which was then followed by photographic methods; however, the majority of 
today’s techniques either include to some capacity or directly evolve from electro-optical 
methods. 
A complete, yet brief, history of red blood cell velocity quantification is described by 
Wiedeman et al., (Wiedeman et al., 1981) where they state the first attempt at visually 
determining the velocity of a red cell was made in the late 17th century by Anton Van 
Leewenhoek when he observed how far a red cell would travel in the time it took for him 
to recite four syllables. He concluded that the velocity of a red cell was 2 mm·sec-1, 
which is remarkably similar to what is measured today. There was a single criterion that 
had to have been met in order for Leewenhoek to determine the red cell velocity with 
such accuracy: he would have needed to observe and track either one cell or a small 
group of cells at a time in order to allow him to confidently obtain velocity 
measurements. The visual methods that followed Leewenhoek’s measurement technique 
also pursued a similar timed-interval-of-travel course of action, although velocity 
measurements were limited to values of 2 mm·sec-1. This was accepted as a limitation in 
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microcirculatory observation up until the 1960’s, when Monro developed a novel streak-
image technique that measured up to 16 mm·sec-1 velocities by taking advantage of the 
human retina’s ability to accurately measure the angle at which streaks of light (remains 
of fast moving objects) would pass in front of it (Wiedeman et al., 1981).  
Photographic, unlike visual, methods have the advantage of allowing measurements to be 
made off-line, and by multiple observers. These methods, however, also come with 
criteria which must be met prior to their use: a) the same target or cell must be in two 
consecutive image frames for a set interval of time between frames, and b) there must be 
high enough resolution to distinguish the target or cell in a given frame. In order to 
ensure that the first criterion is met, only one target must have passed in a pair of 
subsequent frames collected over a finite period of time, thereby necessitating use of high 
enough frame rates that would ensure the object has not passed by the time the second 
frame is captured.  
By ensuring that the target is not in a state of transit during frame acquisition, the second 
criterion is met; the target must not be moving faster than the shutter speed, or the rate at 
which the image was taken. In this context, one is left with the issue of balancing shutter 
speed and frame rate. Too low of an exposure time does not allow enough light to enter 
the shutter leaving the potential for lower contrast in imaging. High exposure times 
improve contrast, however this is achieved at the expense of catching the target in 
transition (i.e., not still) as well as slowing down frame rate. Cinephotography was the 
preferred method of data acquisition for the photographic approach to measuring 
velocities. Although, high frame rates are required, this technique would require 
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unfeasibly large amounts of film in order to store the images for off-line analysis 
(Wiedeman et al., 1981).  
Both the visual and photographic methods rely on high contrast visibility of the target. 
The single red blood cell against the plasma provides high contrast for imaging. Thus, the 
eye recognizes the red cell itself as it exhibits a different light intensity compared to the 
formed plasma gaps found between each red cell. This visual algorithm can be 
implemented electronically by using electro-optical techniques, where a sensor is used to 
differentiate between the varying light intensities of the red cell and the plasma gaps. The 
sensor converts the light information into a signal with amplitude corresponding to the 
light intensity. If this sensor is fixed in a single position on a vessel, then it can detect red 
blood cell flow patterns as a function of time. Taking it one step further, if two sensors 
are placed at two different locations in a vessel, with the same cell flowing past each of 
the two sensors, then fixed distance between the two sensors must be traveled in the time 
it took for the single cell to pass from the first to the second sensor.  
According to Wiedeman et al., Müller was the first to execute an electro-optical 
technique in microcirculatory imaging in the early 1960’s (Wiedeman et al., 1981), and 
Wayland and Johnson later refined the method in the late 1960s. Wayland and Johnson 
used a photomultiplier tube as a sensor for detecting light (to increase the range of light 
that can be detected), and added two sensors instead of just one, which allowed them to 
account for the time of travel between the two sensors that were fixed in position. These 
adjustments (Wayland & Johnson, 1967) were pivotal in changing microvascular 
imaging, and the theories behind the two-slit photometric imaging technique remain to be 
one of the most widely used techniques in microvascular hemodynamic quantification. 
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The utility of the two-slit photometric method is accompanied by specific assumptions; 
namely, the red blood cell flow pattern (distance of the plasma gap occupied by two red 
cells) is assumed to remain constant in length as it travels between the upstream and 
downstream photo sensors. With regards to practicality, there are a number of limitations 
(Sapuppo et al., 2004) associated to the original technique: 1) system parameters (e.g., 
system’s clock frequency) must first be manually modified to give information about 
velocity, leaving room for operator bias; 2) correlated velocity peaks only give one 
velocity measurement resulting in non-reproducible values; 3) data cannot be saved in 
digital format; 4) although the system collects data in real-time, it does not cross-correlate 
peaks between the two sensors automatically, which does not allow the system to follow 
the time changes of velocity, thereby only providing average velocity values. In a recent 
study (Roman et al., 2012), the dual-slit technique was replaced by two regions of 
interest in a simulation involving computer-generated image sequences of red blood cells 
flowing through a tube. This allowed for the control of hematocrit and velocity profile; 
two factors known to influence the outcome of dual-sensor measurements conducted on 
vessels that are larger than capillaries (i.e., non-single file flow vessels) (Pittman & 
Ellsworth, 1986; Roman et al., 2012). 
Laser Doppler velocimetry is a method which takes advantage of coherent light 
scattering, and infers changes in particle velocities based on the Doppler shift in laser 
light. When a laser light strikes biological tissue, a portion of the light will reflect back 
from static tissue with the same incident frequency. The other portion of light will reflect 
from moving particles (specifically, red blood cells), and experience a shift in frequency 
as a result of the Doppler shift (Nilsson et al., 1980). However, due to Doppler 
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velocimetry’s dependence on incident angle of the light, an issue arises with imaging 
microvascular beds as the directionality of blood flow is found in random orientations. To 
resolve this, a technique was developed which incorporated use of a uni-dimensional 
fringe pattern formation atop the region of interest (kept at an angle normal to the blood 
stream), and as blood particles passes the bands of the fringe pattern, reflections in the 
light bands are picked up by a photodetector (Le-Cong & Zweifach, 1979). These 
reflections are interpreted by the Doppler shift principle, are directly related to the 
number of red cells, and quantified as velocity measurements. The advantages of this 
technique are that it is non-invasive, does not require tracers or particle labeling, and 
allows for longitudinal tissue perfusion monitoring without influencing blood flow 
regulation in the tissue. This technique is limited by the lack of standardized 
interpretation available for the measured signals, use of arbitrary units, and its inability to 
be calibrated to units relevant to perfusion. 
More recently, technological advances in ultra high-speed cameras and imaging 
microscopy have launched the acquisition of whole velocity fields in microvessels 
through the development of particle image velocimetry (PIV). This technique is used to 
reconstruct velocity profiles by measuring the instantaneous two- or three-dimensional 
velocity vector fields of particles seeded in flow. In microcirculation, PIV has been 
subjected to difficulties with optimal resolving power and out-of-focus effects of the 
microscopy system. Macro-PIV, or application of PIV to large-scale flows (e.g., such as 
in mechanical engineering practices) acquires velocity field vector data by illuminating a 
single 2-dimensional plane with lasers, and correlating wavelengths emitted by seeded 
particles with directional flow. Micro-PIV (µ-PIV), or application of PIV to small-scale 
29 
 
flows (e.g., micro-channels and microvasculature), requires illumination of the entire 
channel. This provides great loss of accuracy in vector field information as velocities are 
simultaneously collected from multiple stacked fields within the channel or microvessel 
and averaged in the orthogonal or z-direction.  
To circumvent axial averaging errors, µ-PIV has been implemented with use of confocal 
microscopy to acquire single planes of velocity vector field data. Although coupling of 
confocal microscopy with µ-PIV is an advancement, the issue remains that use of a RBC 
as a particle tracker in µ-PIV may not provide high enough resolution for near-wall 
interactions due to the existence of the cell-free layer in microvessels (Popel & Johnson, 
2005). 
The optical section thickness for velocity data acquisition is largely dependent on the 
numerical aperture (NA) of the objective, where higher (compared to lower) NA values 
resolve thinner volume measurements and is commonly specified by the depth-of-field 
for a given microscope system. It is often the case that depth-of-field is mistaken for the 
absolute thickness of tissue under microscopic observation. In fact, this thickness, 
predicted using a Gaussian intensity distribution, is called depth-of-correlation and is 
largely dependent on the size of the tracer particle (Poelma et al., 2012). Depth-of-
correlation indicates a particle’s contribution to the averaging of cross-correlated particle 
tracer velocities. Due to this depth-of-correlation parameter, both artificial and naturally 
occurring particle tracers (RBCs) provide identical blood flow measurements at low 
magnifications (Poelma et al., 2012).  
30 
 
 Purpose of thesis dissertation 
The SNS has a vital role in maintaining microvascular network resistance in skeletal 
muscle microcirculation. Previous findings confirm that the SNS has differential control 
over the span of a microvascular network, and that the varying levels of control may be 
attributed to heterogeneous functional distribution of the SNS receptors within the 
network (Fig. 1.1). Despite the evidence for a relationship between the functionality of 
each SNS receptor and vascular diameter, there remains to be a comprehensive 
evaluation of receptor activation in a skeletal muscle microvascular network. These 
shortcomings are partly due to the absence of a single skeletal muscle microvascular 
preparation that provides access to a complete network for evaluation of SNS receptor 
activation along the network.  
Moreover, the prominent role of the SNS in microvascular control presents a strong case 
for the SNS having an intimate role in skeletal muscle hemodynamics. However, the 
current set of blood flow measurement techniques is not conducive to assessing the role 
of the SNS in skeletal muscle microvascular hemodynamics (e.g., RBC velocity, flow, 
wall shear rate). Some of the limitations presented by the previously mentioned blood 
flow techniques are: 1) spatial averaging which poses the risk of over- or under-
estimating blood flow calculations within a vessel segment, 2) difficulty in acquiring 
measures from fast-flowing arterioles, 3) use of non-native tracers (i.e., not naturally 
found in blood), and 4) in-depth post-experiment computation preventing fast data 
acquisition. 
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To this end, the objectives of the thesis herein are to: 1) develop a viable in vivo skeletal 
muscle preparation for use with intravital video microscopy that provides access to a 
complete microvascular network, 2) develop a blood flow measurement technique for 
acquisition and calculation of in vivo hemodynamic parameters (i.e., RBC velocity, flow, 
and shear rate), 3) characterize SNS receptor functional distribution along the network, 
and 4) assess how SNS receptor activation along the network affects skeletal muscle 
microvascular hemodynamics within various levels of the network. We hypothesize a 
topologically-dependent SNS receptor functionality, with adrenergic receptor activation 
primarily governing the proximal vessels and peptidergic and purinergic receptor 
activation primarily governing the distal vessels (Fig. 1.1). 
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 Introduction 
The function of skeletal muscle, which is essential for locomotion and shares many basic 
features with other metabolically active tissues, relies on microvascular resistance 
networks that are directly involved in blood flow and pressure regulation (Popel & 
Johnson, 2005). The unique structure of the microvascular units (i.e., a terminal arteriole 
and the subsequent capillaries it supplies) within skeletal muscle are arranged to 
maximize diffusion and exchange. Arteriolar resistance is modulated by intrinsic systems 
(e.g., myogenic control and endothelium derived factors) and extrinsic systems (e.g., 
sympathetic nerves) that tightly match blood flow (oxygen delivery) to metabolic 
demand. Thus, for decades, physiologists have been interested in the characteristics of 
skeletal muscle blood flow, with an emphasis on measuring and understanding red blood 
cell velocity (VRBC). 
Blood flow through a vessel segment is generally calculated as a product of mean red 
blood cell flow velocity (VMean) and vessel cross sectional area (AVessel). Centerline VRBC 
(VCenter) is commonly measured using Doppler velocimetry (VanTeeffelen & Segal, 
2006; Jackson et al., 2010) or the dual-slit/sensor technique (Sato & Ohshima, 1988; Lee 
& Duling, 1989) and is converted to VMean through use of the Baker and Wayland 
velocity ratio conversion factor (VRatio; an index of profile bluntness and transition layer) 
of 1.6 (Baker & Wayland, 1974). Use of this conversion factor, however, disregards 
diameter- and hematocrit-dependent changes in luminal VRBC profiles and depending on 
the size and location of the vessel of interest tends to erroneously estimate blood flow 
(Pittman & Ellsworth, 1986).  
41 
 
At present, evaluation of microvascular VRBC profiles is limited to experiments 
investigating arterioles and/or venules in the mesentery (Tangelder et al., 1985; 
Tangelder et al., 1986; Tangelder et al., 1988; Nakano et al., 2003) and omentum 
(Schmid-Schoenbein & Zweifach, 1975), or skeletal muscle venules (Bishop et al., 2004; 
Das et al., 2007). However, due to experimental and technical limitations, these past 
studies have been constrained to a small range of arteriolar diameters (approximately 17-
40 m), limiting current knowledge of VRBC profiles to this range.  
Arteriolar networks in many tissues have a broad range of diameters; for example, 
skeletal muscle arterioles range from ~15 m to ~100 m. Thus, there remains a need for 
a feasible in vivo experimental model enabling concurrent measurement of VRBC profiles 
at multiple levels within microvascular networks. Having a means to acquire VRBC 
profiles for a broad range of arteriolar diameters would provide accurate and detailed data 
necessary to derive VRatio. Such data would facilitate accurate blood flow calculations for 
a broad range of arteriolar diameters in studies limited to centreline VRBC measurements 
that require VRatio to calculate VMean.   
In the current study we used the rat gluteus maximus (GM) muscle preparation and 
intravital video microscopy to meet the following objectives: 1) develop a method 
(“streak length method”) for VRBC detection, improved characterization of in vivo VRBC 
profiles and blood flow for a broad range of diameters in continuously branching 
arterioles and 2) obtain a best fit regression line describing the relationship between VRatio 
and arteriolar diameter. 
42 
 
 Materials and methods 
 Preparations and protocols 
 Animal care and use  
The Council on Animal Care at the University of Western Ontario approved the 
experimental protocol. Experiments were performed using 6 male Sprague Dawley rats 
(6-7 weeks old; mass: 168.5  9 grams, mean  SD), purchased from Charles River 
Laboratories (Saint-Constant, Quebec, Canada) and housed on site for at least 1 week 
prior to study. Rats were housed in animal care facilities of the University of Western 
Ontario, at ∼24°C on a 12 h–12 h light–dark cycle with access to food and water ad 
libitum. Upon completion of experimental procedures each day, the anesthetised rat was 
euthanized with an overdose of α-chloralose and urethane cocktail mix (intraperitoneal 
injection), and cervical dislocation. 
 Anesthesia and skeletal muscle preparation  
Using intraperitoneal injection, the rat was anesthetised with a cocktail of α-chloralose 
(80 mgkg-1) and urethane (500 mgkg-1). A mid-neck incision was made and a tracheal 
cannula (PE-205) was introduced to facilitate spontaneous respiration. The right jugular 
vein was cannulated (PE-50 tubing) to maintain a constant infusion of anesthetic to the 
animal (-chloralose: 8-16 mgkg-1hr-1, urethane: 50-100 mgkg-1hr-1) and a T-connector 
was used to inject fluorescent RBCs. The left carotid artery was cannulated (PE-50 
tubing) to allow for recording of arterial blood pressure via the amplified signal of a 
pressure transducer using a PowerLab system (model ML118 PowerLab Quad Bridge 
Amplifier; model MLT0699 BP Transducer, AD Instruments, Colorado Springs, CO, 
USA). The rat was placed prone on a custom-fabricated animal platform using conducted 
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heat with animal temperature feedback to maintain rectal temperature at 37°C. With the 
animal shaved and skin prepared, under microscopic guidance the GM muscle was cut 
from its origin along the spine and along its rostral and caudal borders [adapted from the 
mouse preparation (Bearden et al., 2004)]. With great care taken to preserve its 
neurovascular supply, the muscle flap was gently reflected away from the rat, spread 
evenly onto a transparent Sylgard® (Sylgard 184; Dow Corning, Midland, MI, USA) 
pedestal to approximate in situ dimensions and pinned to secure edges. The exposed 
tissue was superfused continuously (4-5 mlmin-1) with bicarbonate-buffered 
physiological salt solution (PSS; 35C at tissue, pH 7.4) of the following composition 
(mM): NaCl 137, KCl 4.7, MgSO4 1.2, CaCl2 2, NaHCO3 18 and equilibrated with 5% 
CO2 / 95% N2.  
 Fluorescent labelling of red blood cells  
One day prior to experimentation, blood was drawn from a donor animal via cardiac 
puncture into a vial containing heparin. Sample was centrifuged at 1300g for 5 minutes, 
and the plasma layer and buffy coat were discarded. RBCs were then washed in Tris-
buffered Ringer's solution (room temperature, pH = 7.4), and incubated in a freshly 
prepared FITC (fluorescein isothiocyanate, [0.4 mgml-1], Cat# 4014f, Research Organics 
Inc., Cleveland, OH, USA) dye solution (FITC mixed into dimethyl sulfoxide and Tris-
buffered Ringer’s albumin (biotechnology grade bovine albumin, [0.005 gml-1], 
Bioshop Canada Inc.) solution, room temperature, pH = 7.4) for 2 hours. Cells were 
washed in Tris-buffered Ringer's albumin solution and stored overnight at 4C. On day of 
experiment, excess dye was removed by washing cells in Tris-buffered Ringer's albumin 
solution, and hematocrit (Hct) was adjusted to ~30-35% with buffer. Prior to injection, 
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fluorescent RBCs were imaged on a microscope and qualitatively evaluated for 
fluorescence signal and cellular integrity. Prior to intravital video microscopy (IVVM), 
cells were injected (1% of total animal blood volume, blood volume estimated to be 6 
ml(100 g)-1 rat) into the animal via the jugular vein (PE-50 tubing for cannula) and the 
line was flushed with heparinized saline. To confirm labelled cell fraction, post-
experiment systemic blood samples were acquired and analysed using flow cytometry. In 
a separate set of experiments, the hang test (i.e., RBCs are free to fall on their edge in an 
oil suspension where their geometry can be observed) was conducted to derive sphericity 
factors, an indicator of RBC deformability (Canham & Burton, 1968), for both 
fluorescent and unstained RBCs. There was no significant difference in sphericity index 
between groups. Additionally, it has been previously shown that FITC labelled fresh 
blood (1 day or less) did not exhibit adherent or undeformable characteristics in the 
circulation (Chin-Yee et al., 2009). In our experiments, no plugging of capillaries with 
FITC labelled cells was observed in the muscle preparation. 
 Intravital video microscopy 
Upon completion of microsurgical procedures, the preparation was transferred to the 
stage of the intravital microscope (Olympus BX51). The preparation was equilibrated for 
~30 minutes, during which time the arteriolar network was observed and a diagram was 
made to identify sites for data collection (vasomotion was not observed). Microvessels 
were observed under Kohler illumination using a long working distance condenser (NA = 
0.80) and a long working distance water immersion objective (Olympus LUMPLFL: 10 
NA = 0.30; depth of field ~9µm) with illumination from a 100-Watt halogen light source. 
To enhance contrast of the RBC column, a 450 nm/20 nm band-pass filter (450BP20, 
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Omega Optical, Brattleboro, VT, USA) was placed in the light path. In an effort to assess 
microvascular VRBC, fluorescent RBCs were epi-illuminated using a 120-Watt Mercury 
Vapor Short Arc light source (EXFO, X-Cite 120PC Q) in line with a FITC (450-490 nm) 
filter. The optical image was coupled to a front-illuminated interline CCD camera 
(Qimaging EXi Blue) and viewed/stored to a hard drive using specialised imaging 
software (MetaMorph® 7.6). Following equilibration, baseline internal vessel lumen 
diameter was recorded and arterioles were tested for oxygen sensitivity by elevating 
superfusate O2 from 0 to 21% (5% CO2, balance N2) for 10 minutes, and recording 
arteriolar diameter. Equilibration with 5% CO2–95% N2 was restored for the duration of 
experimental procedures. Video (.tiff) images were collected (15 fps) under epi-
illumination for off-line analysis of VRBC, and blood flow. Corresponding bright-field 
video (.tiff) images were collected (15 fps) under Kohler bright-field illumination for off-
line analysis of RBC column (and luminal) diameters. 
 RBC streaks, velocity profiles and flow calculations  
Fluorescent images were collected (15 fps) at 5-20 millisecond (msec) exposure times 
(lower exposure times for faster flow in larger arterioles, and higher exposure times for 
slower flow in smaller arterioles), causing fluorescing RBCs to form streaks in images 
(Fig. 2.1). Arteriolar lumens were divided into “lanes” (lane width was maintained from 
vessel to vessel) based on the number of RBCs spanning the lumen. Multiple streak 
measurements (manual; ImageJ 1.43u, National Institute of Health, USA) were made 
across the vessel lumen within each lane, and average VRBC (n = 5-12 velocity 
measurements in each lane) for each lane were plotted to create VRBC distribution profiles 
for each vessel segment (Fig. 2.2, Panel A).  
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Figure 2.1: Schematic of streak length method technique. 
Epi-fluorescent image of an arteriolar (A) and a venular (V) bifurcation in the rat gluteus 
maximus muscle (red and blue↓: direction of flow); exposure time: 10 msec; 15 fps at 
10. Arteriolar lumen was divided into “lanes” based on number of RBCs spanning the 
RBC column, with RBC width represented by streak width. 
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Figure 2.2: Velocity profiles from binned diameters of arteriolar segments. 
Top to bottom binned diameter ranges: 83+ m, 66-82 m, 50-65 m, 36-49 m, 20-35 
m. Red dashed lines indicate extrapolated data from RS to RC. Blue dashed lines indicate 
extrapolated data from RC to vessel wall (RL). Panel A column: Absolute VRBC 
distributions across normalized arteriolar lumens (-RL to RL, including transition layer). 
Panel B column: Data normalized to VMax across normalized RBC column (-RL to RL, 
including transition layer). Panel C column: Data normalized to VMax with across 
normalized RBC column (-RS to RS). Data represent mean ± SD of repeated VRBC 
measurements (n=5-12 streaks) at each radial (“lane”) placement in lumen. 
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Velocity measurements were taken from fluorescent streaks that satisfied the following 
inclusion criteria: 
1) Streaks must begin and end within the field of view of a single frame.  
2) To ensure velocity measures were from the equatorial plane of the vessel at any given 
radial position (or “lane”): i) prior to epi-illumination, the equatorial plane (center) of 
the vessel was in the plane of focus under bright-field illumination, and ii) only streaks 
with the longest and lowest level of pixel intensity were measured. This excluded 
streaks that may have been travelling closer to the vessel wall, but still in the center 
lane (as indicated by short, bright streaks).  
3) To ensure data were not collected from overlapping fluorescent red cells travelling 
behind one another, only streaks with similar light intensity across the length of the 
streak were included.  
Single VRBC values were calculated by using Equation 2.1. 
Equation 2.1   
𝑽𝑹𝑩𝑪 =
𝑹𝑩𝑪 𝑺𝒕𝒓𝒆𝒂𝒌 𝑳𝒆𝒏𝒈𝒕𝒉 − 𝑹𝑩𝑪 𝑳𝒆𝒏𝒈𝒕𝒉
𝑬𝒙𝒑𝒐𝒔𝒖𝒓𝒆 𝑻𝒊𝒎𝒆
 
With the assumption that the biconcave characteristic of the RBC was preserved [RBC 
thickness was approximated as constant (Canham et al., 1984)] during flow through any 
arteriole, the RBC was modelled as an elliptical cross section (AlMomani et al., 2008). 
RBC width was set to the width of each individual streak and RBC length was calculated 
using Equation 2.2, where ARBC (calculated from average rat red blood cell diameter of 
7.18 m, i.e., 𝐴𝑅𝐵𝐶 = 𝜋𝑟
2) is the coronal cross sectional area of the RBC. 
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𝑨𝑹𝑩𝑪 = 𝝅 (
𝑹𝑩𝑪 𝑾𝒊𝒅𝒕𝒉
𝟐
) (
𝑹𝑩𝑪 𝑳𝒆𝒏𝒈𝒕𝒉
𝟐
) 
 
Equation 2.2 
𝑹𝑩𝑪 𝑳𝒆𝒏𝒈𝒕𝒉 =  
𝟒𝑨𝑹𝑩𝑪
𝝅(𝑹𝑩𝑪 𝑾𝒊𝒅𝒕𝒉)
 
    
At the outermost edge of the RBC column (RC), velocity was extrapolated from the 
middle of the outermost streak (RS, centroid of the outermost RBC) to the edge RC (for 
both left and right sides of the profile; Equation 2.3. Indicated in red dashed lines on Fig. 
2.2, Panels A and B). Using experimentally acquired velocity distribution profile plots, 
velocity curves (Equation 2.3) were fit to both left and right side of each profile to 
determine the power “a”, which is also an indicator of profile bluntness within the RBC 
column.   
Equation 2.3   
𝑽(𝒓) = 𝑽𝑪𝒆𝒏𝒕𝒆𝒓 − (𝑽𝑪𝒆𝒏𝒕𝒆𝒓 − 𝑽𝑹𝑺) (
𝒓
𝑹𝑺
)
𝒂
, 𝟎 < 𝒓 < 𝑹𝑪 
Using Matlab® (R2010a, The MathworksTM, Inc.), the sum of integration (trapezoidal 
approximation) for each profile was performed to calculate flow (

Q

RBC) over the RBC 
column (Equation 2.4). Plasma flow through the cell-free layer (

Q

CFL) was calculated by 
integrating over an assumed linear velocity gradient (between RC and RWall) which also 
satisfied the no-slip condition at vessel wall (V(RWall) = 0) and is indicated by blue 
dashed lines in Fig. 2.2, Panels A and B. Total blood flow through vessel cross section 
was taken as a sum of 

Q

RBC and 

Q

CFL. 
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Equation 2.4 
?̇? = 𝟐𝝅 ∫ 𝑽(𝒓)𝒓𝒅𝒓
𝑹𝑾𝒂𝒍𝒍
𝟎
= 𝟐𝝅 ∫ 𝑽(𝒓)𝒓𝒅𝒓
𝑹𝑪
𝟎
+ 𝟐𝝅 ∫ 𝑽(𝒓)𝒓𝒅𝒓
𝑹𝑾𝒂𝒍𝒍
𝑹𝑪
 
= 𝟐𝝅 ∑ 𝑽(𝒓𝒊)𝒓𝒊∆𝒓
𝒓𝒊=𝑹𝑪
𝒓𝒊=𝟎
+ 𝟐𝝅 ∫ 𝑽(𝑹𝑪)
(𝑹𝑾𝒂𝒍𝒍 − 𝒓)
(𝑹𝑾𝒂𝒍𝒍 − 𝑹𝑪)
𝒓𝒅𝒓
𝑹𝑾𝒂𝒍𝒍
𝑹𝑪
 
= ?̇?𝑹𝑩𝑪 + ?̇?𝑪𝑭𝑳 
To calculate VMean, calculated blood flow values were divided by vessel cross sectional 
area (AVessel), and corresponding velocity ratios (VRatio) were calculated by dividing VMax 
by VMean.     
𝑨𝑽𝒆𝒔𝒔𝒆𝒍 = 𝝅(𝑹𝑾𝒂𝒍𝒍)
𝟐 
𝑽𝑴𝒆𝒂𝒏 =
?̇?
𝑨𝑽𝒆𝒔𝒔𝒆𝒍
 
𝑽𝑹𝒂𝒕𝒊𝒐 =
𝑽𝑴𝒂𝒙
𝑽𝑴𝒆𝒂𝒏
 
 Streak length method validation 
To test the reliability of flow calculations acquired through streak length method, 
mass balance error calculations were performed at bifurcations where theoretically:  
?̇?𝑷𝒂𝒓𝒆𝒏𝒕 = ?̇?𝑫𝒂𝒖𝒈𝒉𝒕𝒆𝒓𝟏 + ?̇?𝑫𝒂𝒖𝒈𝒉𝒕𝒆𝒓𝟐 
𝑴𝒂𝒔𝒔 𝑩𝒂𝒍𝒂𝒏𝒄𝒆 𝑬𝒓𝒓𝒐𝒓 =
|(?̇?𝑫𝒂𝒖𝒈𝒉𝒕𝒆𝒓𝟏 + ?̇?𝑫𝒂𝒖𝒈𝒉𝒕𝒆𝒓𝟐) − ?̇?𝑷𝒂𝒓𝒆𝒏𝒕|
?̇?𝑷𝒂𝒓𝒆𝒏𝒕
× 𝟏𝟎𝟎% 
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 Statistical analyses and data presentation 
Systemic measures are presented as mean  SD, unless otherwise stated. Data were 
analyzed using Prism® software (version 4.0a, GraphPad Software Inc., La Jolla, CA, 
USA) and differences were accepted as significantly different at P < 0.05. In an effort to 
discriminate the degree of bluntness in VRBC profiles (specifically for Fig. 2.2), it was 
necessary to discretely bin arterioles into specific ranges of diameters. VRBC profiles 
within each binned diameter range of arterioles were fit to a 2nd order polynomial (Y = 
C2x
2 + C1x + C0), and an F-test was performed for all parameters of the polynomial to 
test whether profiles of a given bin were significantly different from one another 
(performed on profiles from Fig. 2.2, Panel C). Linear regression was performed to 
evaluate the correlation between VRatio and arteriolar diameter for each animal (Fig. 2.4). 
To test bilateral (left and right) symmetry of individual velocity profiles, left and right 
“a” values (see Equation 2.3) were compared using a paired t-test (n = 37 vessels). Linear 
regression was performed to evaluate the correlation between calculated blood flow and 
arteriolar diameter for experimental flow calculations (Fig. 2.3). An experimental power 
law relationship of blood flow as a function of diameter was derived from a linear 
equation (not shown) fit to a log-log plot.  
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Figure 2.3: Relationship between experimental blood flow and arteriolar diameter. 
Log-log plot of pooled experimental blood flow (nL⋅sec-1; calculated from profiles) 
versus diameter (μm) for 37 vessel segments (n = 6 animals); slope of linear regression 
line = 2.63; r2 = 0.96, P < 0.0001.  
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 Results 
 Systemic measures and arteriolar responses to O2 
Animals were normotensive (mean arterial pressure = 94  8 mmHg), and had normal 
systemic Hct levels (42  4%) within and across experiments. In all experiments, 
arterioles were viable as tested by their reactivity to elevated (21%) O2, which resulted in 
a 9  2 m diameter decrease in vessels ranging from 21 to 76 m in diameter.   
 Streak length method validation 
There was 0.6  3.2% error (mean ± SEM., n = 5 bifurcations) in mass balances 
calculated at bifurcations. Post-experiment flow cytometry on systemic blood samples 
confirmed total percentage of labelled cells did not exceed 1%, with total number of 
counted cells (>200,000 RBCs) providing less than 5% coefficient of variation in 
determining exact percentage of labelled cells (Sarelius & McKinlay, 1985). 
Additionally, post-experiment blood samples imaged on a hemocytometer confirmed 
maintenance of fluorescence signal and cellular integrity of labelled cells. 
  In vivo velocity profiles, experimental blood flow 
calculations, and velocity ratios 
A total of 37 profiles were generated from continuous branching arteriolar trees (n = 5-10 
arterioles per network; diameter range: 21-115 m; n = 6 animals). There were no 
significant differences between left and right curve fit values of “a”, indicating symmetry 
across all 37 profiles (with significant effective pairing of left and right values, P < 
0.0001). Profiles within a bin were plotted (n = 37 individual vessels; Fig. 2.2, Panel A), 
and illustrated congruency in VRBC profile shape (in the experimentally measured portion 
of RBC column; -Rs to Rs) among arterioles within the binned diameter range (fit to a 2nd 
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order polynomial; Fig. 2.2, Panel C). Velocity profiles became progressively more blunt 
with decreasing diameter with the quadratic coefficient (C2 from the 2
nd order polynomial 
fit) becoming less negative moving from largest (83+ m) to smaller (20-35 m) 
diameters (C2 = -0.42 to -0.27, respectively; Fig. 2.2, Panel C). 
Experimental blood flow values ranged from 1.3 nLsec-1 to 106 nLsec-1 (diameters: 21-
115 m, respectively), and were correlated with diameter in the log-log plot (Fig. 2.3; r2 
= 0.96, P < 0.0001). Experimental blood flow data, as a function of arteriolar diameter (in 
µm), are described by the power equation: Blood Flow = 10-3.43  Diameter2.63.  
There was a positive linear correlation between VRatio and arteriolar diameter. From this, 
the least-squares linear regression of VRatio on arteriolar diameter (D; in m) yielded  
Equation 2.5 
𝑽𝑹𝒂𝒕𝒊𝒐 = 𝟎. 𝟎𝟎𝟕𝟏 × (𝑫) + 𝟏. 𝟏𝟓 
with an r2 of 0.90 (Fig. 2.4, P < 0.0001). VRatio values ranged from 1.35 to 1.98 (obtained 
from diameters ranging from 21-115 m), indicating that profiles across the rat gluteal 
arteriolar network exhibit a wide range of bluntness, and become approximately parabolic 
(VRatio = 2) at diameters 115 m.  
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Figure 2.4: Relationship between velocity ratio and arteriolar diameter. 
Velocity ratios for arterioles with diameters ranging from 21 to 115 μm (5-10 arterioles 
per animal; n = 6 animals). Within all animals, there was a positive correlation between 
diameter and VRatio (r
2 = 0.90; P < 0.0001). For all data, the velocity ratio, as a function of 
arteriolar diameter (in μm), is described by the experimentally-derived equation shown 
below the graph.  
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 Discussion 
In the current study we successfully developed and validated a novel in vivo method for 
characterizing VRBC profiles, VRatio, and blood flow in arterioles with a broad range of 
diameters from microvascular networks in rat skeletal muscle. Furthermore, we derived a 
linear relationship between VRatio and arteriolar diameters (from 21-115 m). From this 
relationship we have derived an equation that may be used in other studies to calculate 
blood flow based on the arteriolar diameter of interest.  
 Measuring VRBC in skeletal muscle arterioles 
In the present study, in vivo velocity profiles across continuously branching skeletal 
muscle arterioles were determined using fluorescent-labelled RBCs and a novel video 
method for determining VRBC. Previously described microscopic video methods for single 
VRBC detection use video playback on conventional video systems and analyses that 
require single RBC tracking from frame to frame. As discussed by Parthasarathi et al. 
these conventional video methods, that generally use cameras with frame rates of 25-30 
Hz, are capable of resolving VRBC of only 2 mmsec-1 or less (Parthasarathi et al., 1999).  
In an effort to overcome this limitation and resolve single particle velocities, specialized 
methods capable of resolving high VRBC (~15-40 mmsec-1) have been presented; 
however, they require specialized strobe illumination (Tangelder et al., 1986), 
asynchronous flash illumination (Pries et al., 1994), or high speed synchronized 
shuttering (Parthasarathi et al., 1999). More recently, Nakano et al. described a technique 
called particle image velocimetry (PIV), which uses an intravital microscope and 
transillumination coupled to an ultra-high speed digital camera (1000 fps) (Nakano et al., 
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2003). Although this method is capable of high-resolution instantaneous VRBC detection, 
it is limited to velocities of 6 mm·sec-1. Furthermore, due to the necessary use of high 
magnification objectives all of these past methods are limited due to a shallow depth of 
focus and thus have an upper limit on the arteriolar diameter (< 50 m) that can be 
studied.  
For the first time, we have measured VRBC in continuously branching arterioles in a broad 
range of diameters from single frame captures using conventional IVVM. With our streak 
length method, we investigated arterioles with diameters ranging from 21 to 115 m and 
were able to measure VRBC greater than 20 mmsec-1 with a maximum detectable VRBC of 
approximately 100 mmsec-1. Using our streak length method VRBC is measured based on 
the exposure time of a single frame, thus eliminating the need for specialised illumination 
or high camera frame rates. It is important to note that our method is limited by the 
sensitivity of the camera to resolve streaks under low exposure times.  
In contrast to other methods, we can effectively resolve VRBC using a low power (10) 
objective. Thus, data can be collected from larger fields of view (facilitating simultaneous 
VRBC measurements at bifurcations) with greater depth of focus (necessary for data 
collection from the equatorial plane in large arterioles). Based on the above, it is implicit 
that our streak length method is capable of measuring VRBC in all vessels (independent of 
diameter), so long as they can be brought into the focal plane. Finally, capturing VRBC 
within single frames enables measurement of rapid changes in VRBC, which may be useful 
for future microvascular studies involving muscle stimulation and/or the administration 
of vasoactive drugs, where blood flow changes occur rapidly.  
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  Arteriolar RBC velocity profiles 
This is the first study to evaluate velocity ratios from in vivo VRBC profiles in skeletal 
muscle for continuously branching arterioles encompassing a large range of diameters 
(21-115 μm). Arterioles within this range represent the major resistance pathways 
responsible for the redistribution of blood flow within tissues (Zweifach et al., 1981). 
Arteriolar velocity profiles demonstrated bilateral symmetry at all levels of the network 
and, as expected, velocity profiles became blunter in descending diameters of arterioles; 
where larger arterioles exhibited a more parabolic profile, and as diameter decreased 
there was a trend towards plug flow (VMean and VMax are equal). In support, velocity 
ratios positively correlated with arteriolar diameter (Fig. 2.4). In accordance with work in 
rabbit mesenteric networks (Tangelder et al., 1986), profiles in a given arteriolar diameter 
range were similar regardless of differing centerline velocities, as indicated by 
normalized velocity distributions (Fig. 2.2, Panels B and C).   
Baker & Wayland first proposed a VRatio of 1.6 for arterioles (Baker & Wayland, 1974), 
which represents a correction made for the instrumental artefacts due to vertical 
averaging of velocity profiles. This correction factor is commonly used for blood flow 
calculations and has been confirmed by other studies (Seki & Lipowsky, 1989; 
Koutsiaris, 2009). Our VRatio values describe the true shape of the velocity profiles that 
were acquired from the equatorial plane of the vessels. Thus, we propose that using the 
generalized VRatio of 1.6 underestimates or overestimates flow calculations by up to 20% 
in arterioles smaller or larger than ~65 m respectively (Fig. 2.4). Even when accounting 
for a maximum systematic error of 3.8% (calculated from mass balance at bifurcations), 
there remains over 16.2% of unresolved error using a VRatio of 1.6.  
59 
 
In an effort to account for diameter-dependent differences in VRatio and reduce errors in 
blood flow calculations, we propose a linear equation derived from the relationship 
between velocity ratio and arteriolar diameter (21-115 μm) as measured in vivo (Fig. 2.4). 
Tangelder et al. derived a linear equation describing this relationship for rabbit mesentery 
arterioles; however, due to experimental constraints, their equation is limited to diameters 
in the range of 17 to 32 m (Tangelder et al., 1986). The rat GM preparation represents 
true locomotive striated skeletal muscle and offers several advantages for investigating 
hemodynamics.  
First, arteriolar networks are anatomically arranged such that concurrent evaluation of 
multiple arteriolar levels (from 1st order to terminal arterioles) is conveniently achieved 
within the same focal plane. Second, the vascular anatomy is maintained across animals, 
as has been shown in mice (Bearden et al., 2004) and confirmed in the rat (qualitative 
observations), enabling investigation of the same sets of vessels from experiment to 
experiment. We have outlined the advantages of our streak length method above (see: 
Measuring VRBC in skeletal muscle arterioles), which facilitate the calculation of blood 
flow from the large range of arteriolar diameters that can be observed using the GM 
preparation.  
 Relationship between blood flow and arteriolar diameter 
In the current study we derived the following equation to describe the relationship 
between experimentally derived blood flow and arteriolar diameter: Blood Flow = 10-3.43 
 Diameter2.63, where the exponent associated with diameter (2.63) describes the slope of 
the log-log linear relationship. The slope of 2.63 is in close agreement with blood flow 
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data taken from rat cremaster muscle where power law regression yielded an exponent of 
2.73 (House & Lipowsky, 1987). Additionally, the power law exponent of 2.63 is in 
agreement with Murray’s law (Murray, 1926) and other similar studies where 
experimentally-derived exponents from power laws ranged from approximately 2 in 
larger arteries (Zamir et al., 1992) to 3 in arterioles (Mayrovitz & Roy, 1983). 
In conclusion, using the rat GM model we have developed a new method for VRBC 
detection in skeletal muscle arterioles that is compatible with conventional microscopes 
and video systems. Our streak length method eliminates the need for frame-to-frame cell 
tracking that requires specialized illumination, video shuttering, or high-speed cameras. 
By simply altering exposure time, our method is capable of resolving a large range of 
VRBC up to ~100 mmsec-1. From the data generated herein, we have provided a linear 
equation for calculating velocity ratios for arterioles (in skeletal muscle and other tissues) 
ranging from 21 to 115 m in diameter.  
 Conclusion 
We have described a relatively simple means for acquiring VRBC from a broad range of 
arteriolar diameters (from 21-115 µm). Furthermore, a linear relationship was derived 
between VRatio and arteriolar diameter. From which, we present an equation that may be 
used in future studies to more accurately calculate blood flow based on the arteriolar 
diameter. This work provides significant insight to the field of blood flow and single 
RBC dynamics in complete microvascular networks. 
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 Introduction 
Transmural pressure gives rise to forces exerted on the vessel wall, such as 
circumferential and longitudinal stress. Shear stress, a tangential force, is due to the 
viscous friction of RBC laminae brushing past one another, and when blood flows along 
the vessel wall, the friction results in wall shear stress. Shear stress experienced at the 
endothelium, or wall shear stress, is involved in modulating vasoregulatory mechanisms 
such as endothelial-derived nitric oxide release (Kuchan et al., 1994). Shear-mediated 
nitric oxide release in skeletal muscle microcirculation is involved in healthy vascular 
regulation (Koller & Kaley, 1991; Davies, 1995; Boegehold, 1996), and is altered in 
vascular dysfunction conditions associated with peripheral vascular disease, as seen in 
spontaneously hypertensive rats (Koller & Huang, 1995).  
In the skeletal muscle microcirculation, a wall shear rate (or radial velocity gradient) 
exists in the plasma (i.e., cell free layer or CFL)-endothelium interface. Since shear rate is 
dependent on blood flow velocity profiles through vessel segments, the wall shear rate 
can be most accurately described by the slope of blood flow velocity profile evaluated 
over the width of the CFL. Experimentally, under the assumption of steady plasma flow 
and a linear slope in the velocity gradient in the CFL (Namgung et al., 2011), the wall 
shear rate equation is defined as the edge velocity of the red blood cell column over the 
CFL width: 𝛾𝐸 =
𝑉𝐸𝐷𝐺𝐸
𝑊𝑖𝑑𝑡ℎ𝐶𝐹𝐿
. 
Obtaining the necessary data for computing experimental wall shear rate is difficult and 
time consuming. Thus, many groups have commonly quantified shear rate from 
experimentally-derived mean blood velocity and arteriolar diameter (Hester & Duling, 
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1988; Kurjiaka & Segal, 1995; Welsh & Segal, 1996) using the equation: 𝛾𝑊𝑎𝑙𝑙 =
8𝑉𝑀𝑒𝑎𝑛
𝐷
. 
Mean blood velocity is calculated as: 𝑉𝑀𝑒𝑎𝑛= 
𝑉𝑀𝑎𝑥
1.6
, where a fixed velocity profile along 
the microvascular network is assumed, as indicated by using a constant velocity ratio for 
all diameters [Baker Wayland ratio of 1.6 (Baker & Wayland, 1974)]. However, our 
group has shown that velocity profile in the gluteus maximus muscle microcirculation is 
dependent on the arteriolar diameter [Chapter 2 (Al-Khazraji et al., 2012)] and, as a 
result, previous calculations in skeletal muscle microvascular networks may be subject to 
over- or under-estimation (depending on diameter) of wall shear rate and wall shear 
stress.  
Although a few past studies have calculated shear rate values from velocity profiles, their 
data were limited to narrow ranges of diameters from the mesenteric microcirculation 
(Tangelder et al., 1988) or skeletal muscle arterioles (Ortiz et al., 2014), or estimated 
from computational simulations (Sriram et al., 2014). To date, wall shear rate values 
from experimentally derived velocity profiles in complete, continuously branching, 
skeletal muscle arteriolar trees have not been calculated. Using the rat gluteus maximus 
preparation [GM, adapted from the mouse (Bearden et al., 2004)] and our “streak length” 
method from Chapter 2 (Al-Khazraji et al., 2012) for assessing red blood cell (RBC) 
velocity profiles, the current study was carried out with the following objectives:  
1) Calculate wall shear rate from in vivo RBC velocity profiles in gluteus maximus 
arterioles for a wide range of diameters.  
2) Provide an experimentally-derived and straightforward wall shear rate estimation 
function for use in skeletal muscle microvascular studies (and possibly in other tissues).  
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3) Compare our calculated wall shear rate values to those from conventional wall shear 
rate calculation methods.  
 Materials and methods 
 Data source 
In vivo data were utilized from analysis of previous work involving the assessment of 
RBC velocity profiles for a total of 39 arterioles in the gluteus maximus muscle 
preparation from 6 Sprague Dawley rats, using fluorescently-labeled red blood cells (Al-
Khazraji et al., 2012). Arteriolar lumenal diameters ranged from 0.021 to 0.115 mm, and 
mean velocities were calculated from flow values determined by integrating in vivo 
velocity profiles using trapezoidal rule. In particular, this analysis provided values for the 
thickness of the red blood cell-free layer near the vessel wall and the axial flow velocity 
at the outer edge of the RBC column. This analysis also provided centerline RBC 
velocity and its relation to mean blood velocity. 
 Data analysis: Wall shear rate estimation 
We first estimated experimental wall shear rate, 𝛾𝐸, using experimental edge RBC 
velocities taken from our in vivo red blood cell velocity profiles and assumed a linear 
velocity profile across the cell free layer width, with a boundary condition of zero 
velocity at the wall, 
Equation 3.1 
𝜸𝑬 =
𝑽𝑹𝑩𝑪 𝑬𝑫𝑮𝑬
𝑾𝒊𝒅𝒕𝒉𝑪𝑭𝑳
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where 𝑉𝑅𝐵𝐶 𝐸𝐷𝐺𝐸 is a mean of the most left and right red blood cell velocity values in the 
velocity profile. 𝑊𝑖𝑑𝑡ℎ𝐶𝐹𝐿 is the width of the red blood cell free layer (CFL), determined 
by the difference between the position of the edge red blood cell, and the internal vessel 
lumenal wall, and averaged between both left and right sides of the profile. 𝛾𝐸 was then 
plotted as a function of diameter. 
 Data analysis: Development of an experimentally derived 
and straightforward wall shear rate equation 
In an effort to develop an accurate equation from experimentally acquired velocity 
profiles for use in microcirculatory studies such that minimal experimental input is 
required (i.e. arteriolar diameter and centerline velocity), we first determined 𝑊𝑖𝑑𝑡ℎ𝐶𝐹𝐿, 
𝑉𝑅𝐵𝐶 𝐸𝐷𝐺𝐸 (average velocities of edge red blood cells) and 𝑉𝑀𝑎𝑥 (centerline red blood cell 
velocity) as linear functions of arteriolar diameter. As well, 𝑊𝑖𝑑𝑡ℎ𝐶𝐹𝐿 was normalized to 
arteriolar radius and fitted to a power law equation to obtain a power law relationship 
with arteriolar inner diameter.  
Velocity-diameter relationships were used to determine a conversion factor, which we 
denote 𝑉𝐸𝑑𝑔𝑒 𝐹𝑎𝑐𝑡𝑜𝑟, relating experimental 𝑉𝑀𝑎𝑥 to 𝑉𝑅𝐵𝐶 𝐸𝐷𝐺𝐸.  𝑉𝐸𝑑𝑔𝑒 𝐹𝑎𝑐𝑡𝑜𝑟 should be of 
benefit in experiments that acquire centerline RBC velocity, where it may be difficult to 
acquire edge velocities. 
Equation 3.2 
𝑽𝑬𝒅𝒈𝒆 𝑭𝒂𝒄𝒕𝒐𝒓 =
𝑽𝑹𝑩𝑪 𝑬𝑫𝑮𝑬(𝑫)
𝑽𝑴𝒂𝒙(𝑫)
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Edge velocities, 𝑉𝐸𝑥𝑝𝑡 𝑅𝐵𝐶 𝐸𝑑𝑔𝑒, can then be estimated from experimentally acquired 
centerline velocities, 𝑉𝐸𝑥𝑝𝑡 𝑀𝑎𝑥, using the velocity conversion factor, 𝑉𝐸𝑑𝑔𝑒 𝐹𝑎𝑐𝑡𝑜𝑟, 
Equation 3.3 
𝑽𝑬𝒙𝒑𝒕 𝑹𝑩𝑪 𝑬𝒅𝒈𝒆 = 𝑽𝑬𝒅𝒈𝒆 𝑭𝒂𝒄𝒕𝒐𝒓 × 𝑽𝑬𝒙𝒑𝒕 𝑴𝒂𝒙 
As well, after plotting 𝑊𝑖𝑑𝑡ℎ𝐶𝐹𝐿 as a function of diameter, we tested whether 𝑊𝑖𝑑𝑡ℎ𝐶𝐹𝐿 
values were independent of changes in 𝑉𝑀𝑎𝑥 by plotting the slope of 𝑊𝑖𝑑𝑡ℎ𝐶𝐹𝐿(𝐷) 
against 𝑉𝑀𝑎𝑥. The slope of 𝑊𝑖𝑑𝑡ℎ𝐶𝐹𝐿(𝐷) was determined by evaluating 
Equation 3.4 
𝑺𝒍𝒐𝒑𝒆 𝒐𝒇 𝑾𝒊𝒅𝒕𝒉𝑪𝑭𝑳 =
𝑾𝒊𝒅𝒕𝒉𝑪𝑭𝑳 − 𝒃
𝑫
 
Where 𝑏 is equal to the intercept from the regression fit of 𝑊𝑖𝑑𝑡ℎ𝐶𝐹𝐿(𝐷) plotted as a 
function of arteriolar diameter.  
Therefore Equation 3.1 can be modified to require experimentally acquired arteriolar 
diameter, and in vivo experimental centerline velocity as input variables for estimating 
experimental wall shear rate, 𝛾𝐸𝑥𝑝𝑡 𝑊𝑎𝑙𝑙, in microvascular studies 
Equation 3.5 
𝜸𝑬𝒙𝒑𝒕 𝑾𝒂𝒍𝒍 =
𝑽𝑬𝒙𝒑𝒕 𝑹𝑩𝑪 𝑬𝒅𝒈𝒆
𝑾𝒊𝒅𝒕𝒉𝑪𝑭𝑳(𝑫)
 
Finally, in order to test the experimentally-derived wall shear rate equation, we calculated 
wall shear rate using the derived equation and compared it to the experimentally-acquired 
wall shear rates. 
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 Data analysis: Comparison to other wall shear rate 
calculation methods 
In an effort to compare conventional wall shear rate calculation methods (Hester & 
Duling, 1988) to the wall shear rates estimated from experimentally acquired velocity 
profiles (Equation 3.1), we calculated wall shear rate under the assumption of  a parabolic 
velocity profile with Poiseuille flow characteristics, 
Equation 3.6 
𝜸𝑾𝒂𝒍𝒍 =
𝟖𝑽𝑴𝒆𝒂𝒏
𝑫
 
where 𝐷 is arteriolar diameter, and 𝑉𝑀𝑒𝑎𝑛 is calculated by adjusting centerline velocity 
using an assumed static velocity ratio (𝑉𝑅𝑎𝑡𝑖𝑜). For true parabolic flow 𝑉𝑅𝑎𝑡𝑖𝑜 is 2, where 
𝑉𝑀𝑎𝑥 is two-fold greater than 𝑉𝑀𝑒𝑎𝑛. However, investigators commonly set 𝑉𝑅𝑎𝑡𝑖𝑜 to 1.6  
as a global correction factor for velocity profile blunting [Baker Wayland ratio (Baker & 
Wayland, 1974)].  
Equation 3.7 
𝜸𝑾𝒂𝒍𝒍 =
𝟖𝑽𝑴𝒂𝒙
𝑽𝑹𝒂𝒕𝒊𝒐 × 𝑫
 
However, we have recently shown that 𝑉𝑅𝑎𝑡𝑖𝑜 is dependent on arteriolar diameter [in µm; 
(Al-Khazraji et al., 2012)] where:  
𝑽𝑹𝒂𝒕𝒊𝒐(𝑫) = 𝟎. 𝟎𝟎𝟕𝟏 × (𝑫) + 𝟏. 𝟏𝟓 
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Thus, using Equation 3.7, wall shear rate was calculated for three cases: 1) 𝑉𝑅𝑎𝑡𝑖𝑜 = 1.6, 
2) 𝑉𝑅𝑎𝑡𝑖𝑜 = 2, and 3) 𝑉𝑅𝑎𝑡𝑖𝑜(𝐷) = 0.0071 × (𝐷) + 1.15 [for arteriolar diameters in µm 
(Al-Khazraji et al., 2012)]. 
Our experimentally acquired wall shear rates, 𝛾𝐸, was then compared to the wall shear 
rates calculated for the three cases.  
 Statistical analysis 
To test for differences between the three cases for calculating wall shear rate, a linear 
regression statistical comparison for slope and y-intercepts was conducted. Comparisons 
were made using a linear regression statistical comparison for differences in slope and y-
intercept values. For all linear regression fitting, the dependent variable (y) was 
considered to be linearly related to the independent variable (x) when the slope was 
significantly different from zero. Differences between the various calculation methods 
were accepted when P value was less than α level of significance of 0.05. All data were 
plotted and analyzed using Graphpad Prism (V. 4.0a, La Jolla, CA, USA). 
 Results 
 Wall shear rate estimation from in vivo velocity profiles 
Experimentally acquired wall shear rates, 𝛾𝐸, ranged from 1317 to 3684 sec
-1, for 
arteriolar diameters ranging from 0.021 to 0.115 mm, and there was no relationship 
between 𝛾𝐸 and arteriolar diameter (Fig. 3.1). There was a positive linear relationship 
between 𝑊𝑖𝑑𝑡ℎ𝐶𝐹𝐿 and diameter (Fig. 3.2; P<0.05; r
2=0.64), for arteriolar diameters 
ranging from 0.021 to 0.115 mm, described by 
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Equation 3.8 
𝑾𝒊𝒅𝒕𝒉𝑪𝑭𝑳(𝑫) = 𝟎. 𝟎𝟐𝟐 × (𝑫) + 𝟎. 𝟎𝟎𝟎𝟕𝟒 
Average cell free layer width (left and right wall lumenal measurements) ranged from 
0.001 to 0.0043 mm, and the mean cell free layer width for the 39 arterioles was 0.00198 
± 0.0007 mm. There was a negative power law relationship between normalized 
𝑊𝑖𝑑𝑡ℎ𝐶𝐹𝐿values and arteriolar diameter, highlighting the importance of the cell free layer 
with decreasing diameter (Fig. 3.3, r2=0.74).   
RBC velocities at the edge of the velocity profile, 𝑉𝑅𝐵𝐶 𝐸𝐷𝐺𝐸, were positively linearly 
correlated with arteriolar diameter (Fig. 3.4; r2 = 0.44; P<0.05), and are described by  
Equation 3.9 
𝑽𝑹𝑩𝑪 𝑬𝑫𝑮𝑬(𝑫) = 𝟒𝟒 × (𝑫) + 𝟏. 𝟗𝟗 
Centerline RBC velocities, 𝑉𝑀𝑎𝑥, were positively linearly correlated with arteriolar 
diameter (Fig. 3.5; r2 = 0.71; P<0.05) and are described by 
Equation 3.10 
𝑽𝑴𝒂𝒙(𝑫) = 𝟏𝟔𝟔 × (𝑫) + 𝟎. 𝟑𝟗 
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Figure 3.1: Relationship between experimentally acquired wall shear rate and 
arteriolar diameter. 
Calculated wall shear rate values (using edge velocities) as a function of diameter. 
Calculated experimental wall shear rate (𝛾𝐸) were independent of arteriolar diameter. 𝛾𝐸 
values ranged from 1317 to 3684 sec-1, for arteriolar diameters ranging from 0.021 to 
0.115 mm. 
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Figure 3.2: Relationship between cell free layer width and arteriolar diameter. 
Arteriolar diameter ranging from 0.021 to 0.115 mm; r2=0.64; and P<0.05, relationship 
described by 𝑊𝑖𝑑𝑡ℎ𝐶𝐹𝐿(𝐷) = 0.022 × (𝐷) + 0.00074. 
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Figure 3.3: Normalized cell free layer as a function of arteriolar diameter. 
Arteriolar diameter ranging from 0.021 to 0.115 mm (r2=0.74), power relationship 
described by 𝑊𝑖𝑑𝑡ℎ𝐶𝐹𝐿/𝑅𝑎𝑑𝑖𝑢𝑠 = 6.3 × (𝐷)
2.3 + 0.003 × (𝐷)−1.04 
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Figure 3.4: Relationship between profile edge velocity and arteriolar diameter. 
Arteriolar diameter ranging from 0.021 to 0.115 mm, r2=0.44; P<0.05, relationship 
described by 𝑉𝐸𝑑𝑔𝑒 = 44 × (𝐷) + 1.99 
 
 
 
 
77 
 
 
Figure 3.5: Relationship between centerline velocity and arteriolar diameter. 
Arteriolar diameter ranging from 0.021 to 0.115 mm, r2=0.71; P<0.05, relationship 
described by 𝑉𝑀𝑎𝑥 = 166 × (𝐷) + 0.39 
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 Development of an experimentally-derived and 
straightforward wall shear rate equation 
As both 𝑉𝑅𝐵𝐶 𝐸𝐷𝐺𝐸 and 𝑉𝑀𝑎𝑥 expressed a relationship with arteriolar diameter (P<0.05), 
then the functions can be used to describe 𝑉𝐸𝑑𝑔𝑒 𝐹𝑎𝑐𝑡𝑜𝑟, the conversion factor for 
calculating experimental edge velocities from experimentally-acquired centerline 
velocities. 
𝑽𝑬𝒅𝒈𝒆 𝑭𝒂𝒄𝒕𝒐𝒓 =
𝑽𝑹𝑩𝑪 𝑬𝑫𝑮𝑬(𝑫)
𝑽𝑴𝒂𝒙(𝑫)
=
𝟒𝟒 × (𝑫) + 𝟏. 𝟗𝟗
𝟏𝟔𝟔 × (𝑫) + 𝟎. 𝟑𝟗
 
Finally, in order to ensure that 𝑊𝑖𝑑𝑡ℎ𝐶𝐹𝐿 independent of changes with 𝑉𝑀𝑎𝑥, the slope of 
𝑊𝑖𝑑𝑡ℎ𝐶𝐹𝐿(𝐷), Equation 3.4 (using y-intercept from Equation 3.8, the regression fit of 
Fig. 3.2; P<0.05) was plotted against 𝑉𝑀𝑎𝑥. 
From Equation 3.8, the 𝑏 term is 0.00074; therefore, the slope of 𝑊𝑖𝑑𝑡ℎ𝐶𝐹𝐿 is 
Equation 3.11 
𝑺𝒍𝒐𝒑𝒆 𝒐𝒇 𝑾𝒊𝒅𝒕𝒉𝑪𝑭𝑳 =
𝑾𝒊𝒅𝒕𝒉𝑪𝑭𝑳 − 𝟎. 𝟎𝟎𝟎𝟕𝟒
𝑫
 
Experimental 𝑊𝑖𝑑𝑡ℎ𝐶𝐹𝐿, and 𝐷 values were used as inputs to determine 
𝑆𝑙𝑜𝑝𝑒 𝑜𝑓 𝑊𝑖𝑑𝑡ℎ𝐶𝐹𝐿. There was no relationship between 𝑆𝑙𝑜𝑝𝑒 𝑜𝑓 𝑊𝑖𝑑𝑡ℎ𝐶𝐹𝐿 and 𝑉𝑀𝑎𝑥 
(Fig. 3.6), indicating that 𝑊𝑖𝑑𝑡ℎ𝐶𝐹𝐿  is independent of changes in 𝑉𝑀𝑎𝑥. 
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Figure 3.6: Relationship between change in cell free layer width and centerline 
velocity. 
Plot of centerline RBC velocity, VMax and 𝑆𝑙𝑜𝑝𝑒 𝑜𝑓 𝑊𝑖𝑑𝑡ℎ𝐶𝐹𝐿 (r
2=0.008), where there 
was no relationship. 
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As CFL width exhibited a linear relationship with arteriolar diameter (Fig. 3.2; P<0.05), 
then the linear relationship 𝑊𝑖𝑑𝑡ℎ𝐶𝐹𝐿(𝐷) = 0.022 × (𝐷) + 0.00074 can be used as an 
input function in Equation 3.5 for calculating experimental wall shear rate, 𝛾𝐸𝑥𝑝𝑡 𝑊𝑎𝑙𝑙, 
using centerline velocities (in mm·sec-1) and arteriolar diameters (in mm) as inputs. 
Recall, Equation 3.1 as a function of arteriolar diameter, 𝐷, and centerline velocity, 𝑉𝑀𝑎𝑥, 
can be modified to Equation 3.5 
𝜸𝑬𝒙𝒑𝒕 𝑾𝒂𝒍𝒍 =
𝑽𝑬𝒙𝒑𝒕 𝑹𝑩𝑪 𝑬𝒅𝒈𝒆
𝑾𝒊𝒅𝒕𝒉𝑪𝑭𝑳(𝑫)
 
As previously described, experimental centerline velocity can be converted to edge 
velocity using the following equation 
𝑽𝑬𝒙𝒑𝒕 𝑹𝑩𝑪 𝑬𝒅𝒈𝒆 = 𝑽𝑬𝒅𝒈𝒆 𝑭𝒂𝒄𝒕𝒐𝒓 × 𝑽𝑬𝒙𝒑𝒕 𝑴𝒂𝒙 
𝑽𝑬𝒅𝒈𝒆 𝑭𝒂𝒄𝒕𝒐𝒓 =
𝟒𝟒 × (𝑫) + 𝟏. 𝟗𝟗
𝟏𝟔𝟔 × (𝑫) + 𝟎. 𝟑𝟗
 
𝜸𝑬𝒙𝒑𝒕 𝑾𝒂𝒍𝒍 =
𝑽𝑬𝒅𝒈𝒆 𝑭𝒂𝒄𝒕𝒐𝒓 × 𝑽𝑬𝒙𝒑𝒕 𝑴𝒂𝒙
𝟎. 𝟎𝟐𝟐 × (𝐃) +  𝟎. 𝟎𝟎𝟎𝟕𝟒
 
Equation 3.12 
∴ 𝜸𝑬𝒙𝒑𝒕 𝑾𝒂𝒍𝒍 =
(
𝟒𝟒 × (𝑫) + 𝟏. 𝟗𝟗
𝟏𝟔𝟔 × (𝑫) + 𝟎. 𝟑𝟗
) × 𝑽𝑬𝒙𝒑𝒕 𝑴𝒂𝒙
𝟎. 𝟎𝟐𝟐 × (𝐃) +  𝟎. 𝟎𝟎𝟎𝟕𝟒
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Equation 3.12 can be used in microvascular skeletal muscle experiments, requiring only 
arteriolar diameter (in mm) and centerline velocity (in mm·sec-1), to calculate wall shear 
rate without the assumption of parabolic velocity profiles, and without requiring the use 
of a constant velocity ratio (e.g., commonly used Baker Wayland ratio of 1.6). 
As previously mentioned, there was no relationship between wall shear rate calculated 
using Equation 3.1 and arteriolar diameter (Fig. 3.1). As well, there were no differences 
in slopes and y-intercept values for the regression lines of both values calculated (Fig. 
3.7) using the experimentally-derived wall shear rate equation (Equation 3.12) and our 
experimentally-acquired wall shear rates (Equation 3.1). 
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Figure 3.7: Comparison of experimental and calculated wall shear rates. 
Comparison of estimated wall shear rates from experimentally-derived velocity profiles, 
𝛾𝐸 (using Equation 3.1), versus calculated wall shear rates from the experimentally-
derived equation, 𝛾𝐸𝑥𝑝𝑡−𝑑𝑒𝑟𝑖𝑣𝑒𝑑 (using Equation 3.12). There were no differences 
between the slopes or y-intercepts of the two lines, and each set of wall shear rate values 
had no relationship with diameter. r2 for 𝛾𝐸 is 0.0005; r
2 for 𝛾𝐸𝑥𝑝𝑡−𝑑𝑒𝑟𝑖𝑣𝑒𝑑 is 0.04. 
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 Comparison of wall shear rate calculation methodologies 
There was no relationship between wall shear rate and arteriolar diameter (calculated 
using Equation 3.6) for 𝑉𝑅𝑎𝑡𝑖𝑜 = 1.6 and 𝑉𝑅𝑎𝑡𝑖𝑜 = 2 (Fig. 3.8). However, there was a 
relationship between wall shear rate and arteriolar diameter when 𝑉𝑅𝑎𝑡𝑖𝑜(𝐷) = 0.0071 ×
(𝐷) + 1.15, which is described by 𝛾𝑊𝑎𝑙𝑙 = −5579 × (𝐷) + 1235 (Fig. 3.8; r
2 = 0.24; 
P<0.05). There was no significant difference between the slopes of the linear regressions 
for the three cases; however, there was a significant difference in y-intercept values 
(P<0.05). 
Upon comparison of each of the three cases with our experimental wall shear rates (from 
Equation 3.1; Fig. 3.8), experimental wall shear rate values were different from wall 
shear rate calculated from any one of the three cases for velocity ratio. Upon comparing 
values (percent change) evaluated at 0.021 mm and 0.115 mm using the fitted regression 
lines between wall shear rates when 𝑉𝑅𝑎𝑡𝑖𝑜(𝐷) and when 𝑉𝑅𝑎𝑡𝑖𝑜 = 1.6 (Equation 3.6), 
there was a 20% and 25% over- and under-estimation, respectively. 
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Figure 3.8: Comparison of wall shear rates (WSR) using different velocity ratios. 
Wall shear rate as a function of arteriolar diameter for 1) experimental wall shear rate, 𝛾𝐸, 
(black closed circles; no relationship with diameter), 2) 𝑉𝑅𝑎𝑡𝑖𝑜 = 1.6 (red open squares 
with red regression line; no relationship with diameter), 3) 𝑉𝑅𝑎𝑡𝑖𝑜= 2 (black triangles with 
black regression line; no relationship with diameter), and 4) 𝑉𝑅𝑎𝑡𝑖𝑜(𝐷) = 0.0071 ×
(𝐷) + 1.15 (black open circles with blue regression line; positive linear relationship 
described by 𝑊𝑆𝑅(𝐷) = −5579 × (𝐷) + 1235; r2 = 0.24; P<0.05). Y-intercepts are 
significantly different between the three linear regressions. 𝛾𝐸 values were greater than 
the other three cases with varying 𝑉𝑅𝑎𝑡𝑖𝑜 values (P<0.05).  
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 Discussion 
The salient findings of the study herein are: 1) estimated wall shear rate calculated from 
experimentally-acquired velocity profiles does not have a relationship with arteriolar 
diameter (Fig. 3.1), 2) a straightforward wall shear rate equation has been derived from 
the relationship of experimental hemodynamic parameters with arteriolar diameter 
(Equation 3.12), and this equation yields wall shear rate calculations that are the same as 
our experimental values (Equation 3.1; Fig. 3.7), 3) our estimated wall shear rate (Fig. 
3.1), 𝛾𝐸, was significantly greater than wall shear rate values evaluated under Poiseuille 
parabolic flow assumption, regardless of the velocity ratio value (Fig. 3.8).  
 Wall shear rate estimation 
Experimental data on the width of the microvascular cell free layer are limited; with 
conflicting findings showing both diameter-independent cell free layer width values as 
reported in cat cerebral microvessels (Yamaguchi et al., 1992), as well as diameter-
dependent cell free layer width values as seen in the human red blood cell perfused rabbit 
mesentery (Soutani et al., 1995). In the study herein, using our estimated shear rate 
equation (Equation 3.1), we show that shear rate/stress is diameter independent (Fig. 3.1). 
This finding is in accordance with an extension on Murray’s law (Murray, 1926), where it 
was shown that shear stress is independent of vessel diameter (Zamir, 1977). This process 
of maintaining constant shear stress would involve adjustments to diameter; that is, if 
blood flow changes within a vessel, the vessel diameter would respond accordingly to the 
increases in shear, and the shear stress is returned to normal baseline levels (Reneman et 
al., 2006). 
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We provide novel evidence on the cell free layer-arteriolar diameter relationship for a 
wide range of arteriolar diameters (0.021 to 0.115 mm; Fig. 3.2) in an in vivo skeletal 
muscle preparation. The mean cell free layer width for the 39 arterioles was 0.00198 ± 
0.0007 mm, and was in agreement with previous reported values of 0.0016 ± 0.0013 mm 
in the rat mesentery (Pries et al., 1989), and  0.0008 to 0.0029 mm in the rat cremaster 
muscle (Kim et al., 2007). As well, normalized CFL width values (Fig. 3.3) were in 
accordance with both experimental and theoretical values, as summarized by Sriram et al. 
(Sriram et al., 2014).  
The majority of in vivo data on cell free layer width and shear rate/stress have been 
collected from the rat cremaster muscle preparation (Kim et al., 2007; Ong et al., 2010; 
Ong et al., 2011). To our knowledge, the study herein is the first to report these 
hemodynamic parameters from a microvascular network in true locomotive skeletal 
muscle. 
 Development of an experimentally derived and 
straightforward wall shear rate equation 
We have also provided an equation which can be used to calculate wall shear rate using 
experimental inputs of arteriolar diameter and 𝑉𝑀𝑎𝑥 (Equation 3.12), both of which are 
parameters that are easily acquired from in vivo skeletal muscle microvascular studies.  
This equation can also be used to calculate wall shear stress, as the gradient of the 
velocity profile is evaluated over the width of the CFL, thereby only requiring plasma 
viscosity for wall shear stress calculations. Using these profiles, we have provided 
equations describing relationships between edge and maximum velocities as functions of 
diameter (Figs. 3.4 and 3.5, respectively), which can be used as a conversion factor when 
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using experimental 𝑉𝑀𝑎𝑥 values for shear rate calculations. Additionally, experimental 
arteriolar diameter values can be used as inputs to calculate CFL, when it is not 
experimentally feasible to collect such data.  
Recently, a wall shear stress correction factor has been described which corrects the 
conventional widely-used wall shear stress calculation which relies on Poiseuille’s law, 
and only requires the additional input of discharge hematocrit, 𝑉𝑀𝑎𝑥, and vessel radius 
(Sriram et al., 2014). While this correction factor adjusts for important parameters that 
would certainly influence wall shear rate calculations, its utility is limited by 1) the 
assumption of parabolic Poiseuille flow profiles, and 2) the difficulty in acquiring in vivo 
discharge hematocrit measurements.  
In the equation we propose for wall shear rate (Equation 3.12), there is no assumption of 
velocity profile shape as only the edge velocities were used to develop the equation, 
which would indirectly imply a diameter dependent velocity profile shape (Al-Khazraji et 
al., 2012) as edge velocities are linearly correlated with arteriolar diameters (Fig. 3.4). As 
our wall shear rate equation depends on edge velocities and the cell free layer width, then 
our shear rate values can easily be converted to wall shear stress by multiplying the 
computed shear rate values by plasma viscosity. As plasma viscosity remains relatively 
constant throughout the microvasculature, as it is primarily affected by plasma protein 
content (Kesmarky et al., 2008), our wall shear rates are a direct indication of wall shear 
stress for the full range of arteriolar diameters.  
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 Comparison of wall shear rate calculation methodologies 
We have shown in our previous study (Al-Khazraji et al., 2012) that velocity ratios are 
diameter-dependent. Upon computing wall shear rates using our diameter-dependent 
velocity ratio, there was an over- and under-estimation of wall shear rate calculation 
compared to shear rates calculated using a fixed velocity ratio of 1.6. As well, upon 
comparison of our experimental wall shear rates (using Equation 3.1) against the wall 
shear rates computed using Poiseuille based wall shear rate equations under the three 
cases of velocity ratio, our experimental data were greater than all of the three cases. 
Despite utilizing a diameter-dependent velocity ratio in Poiseuille based wall shear rate 
equations, the computed wall shear rates did not adjust for computational error as data 
remained significantly less than our experimental wall shear rates.  
Pseudoshear rate, or mean shear across a vessel lumen, is defined as: 
𝑉𝑀𝑒𝑎𝑛
𝐷
, and is 
directly proportional to Poiseuille based calculations of wall shear rate (Equation 3.6). 
Thus, previous accounts of wall shear rate in microvascular studies that have utilized 
Equation 3.6 were greatly underestimating wall shear rate values and were indirectly 
reporting values proportional to mean shear rates, rather than the intended wall shear 
rates.  
Shear rate is lowest (approximately zero) in the center of the vessel, and highest near the 
inner wall; thus, our method of computing shear rate that only involves shear rate 
evaluation over the thickness of the CFL provides a better estimate of wall shear rate than 
values that are computed over the entire lumen diameter. While data on CFL width, and 
RBC column edge velocities are difficult to obtain, we provide a straightforward equation 
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that can be adapted to other studies, and is derived from in vivo velocity profile data. In 
support, shear rate values calculated from in vivo velocity profiles in the rabbit mesentery 
were approximately 2 times higher than the values that would have been estimated under 
the assumption of a parabolic flow profile (Tangelder et al., 1988).  
It has been shown that wall shear stress is dependent on vascular diameter in the rat (Pries 
et al., 1995a) and cat mesentery (Lipowsky et al., 1978) and the rat cremaster (Koller & 
Kaley, 1991). Under the assumption of a fixed plasma viscosity (i.e., wall shear rate 
values are in direct proportion to wall shear stress), the relationship between our 
experimental wall shear rates and arteriolar diameter is in accordance with the above 
previous studies, where there is minimal dependence of shear stress values on arteriolar 
diameter for arterioles greater than 15 µm. Finally, Zamir concluded that while the 
“constant shear” arising from acceptance of Murray’s law is invalid across the entire 
circulatory system, it may certainly hold validity in groups of vessels (i.e., capillaries, 
arterioles, etc.), in which the major determinant regulating blood vessel radii is attributed 
to shear forces acting on the endothelium (Zamir, 1977). These concepts, presented 4 
decades ago, now have some experimental support from our work on arteriolar diameters 
and calculated wall shear stress. 
 Conclusion 
The acquisition of in vivo velocity profiles in fast-flowing arterioles using our 
fluorescently-labeled red blood cell velocity measurement technique has provided the 
ability to estimate wall shear rate without the assumption of fixed velocity profile shape. 
The optimized wall shear rate equation provided in the study herein can easily be adapted 
to use in several studies investigating wall shear rate. The equations provided in the study 
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herein are easily adaptable to use with other velocity measurement techniques in order to 
collect wall shear rate and (in cases where plasma viscosity is known) stress from skeletal 
muscle preparations for a wide range of arterioles.  
 References 
Al-Khazraji BK, Novielli NM, Goldman D, Medeiros PJ & Jackson DN. (2012). A 
simple "streak length method" for quantifying and characterizing red blood cell 
velocity profiles and blood flow in rat skeletal muscle arterioles. Microcirculation 
19, 327-335. 
 
Baker M & Wayland H. (1974). On-line volume flow rate and velocity profile 
measurement for blood in microvessels. Microvasc Res 7, 131-143. 
 
Bearden SE, Payne GW, Chisty A & Segal SS. (2004). Arteriolar network architecture 
and vasomotor function with ageing in mouse gluteus maximus muscle. J Physiol 
561, 535-545. 
 
Boegehold MA. (1996). Shear-dependent release of venular nitric oxide: effect on 
arteriolar tone in rat striated muscle. Am J Physiol 271, H387-395. 
 
Davies PF. (1995). Flow-mediated endothelial mechanotransduction. Physiol Rev 75, 
519-560. 
 
Hester RL & Duling BR. (1988). Red cell velocity during functional hyperemia: 
implications for rheology and oxygen transport. Am J Physiol 255, H236-244. 
 
Kesmarky G, Kenyeres P, Rabai M & Toth K. (2008). Plasma viscosity: a forgotten 
variable. Clin Hemorheol Microcirc 39, 243-246. 
 
Kim S, Kong RL, Popel AS, Intaglietta M & Johnson PC. (2007). Temporal and spatial 
variations of cell-free layer width in arterioles. Am J Physiol Heart Circ Physiol 
293, H1526-1535. 
 
Koller A & Huang A. (1995). Shear stress-induced dilation is attenuated in skeletal 
muscle arterioles of hypertensive rats. Hypertension 25, 758-763. 
 
Koller A & Kaley G. (1991). Endothelial regulation of wall shear stress and blood flow in 
skeletal muscle microcirculation. Am J Physiol 260, H862-868. 
 
Kuchan MJ, Jo H & Frangos JA. (1994). Role of G proteins in shear stress-mediated 
nitric oxide production by endothelial cells. Am J Physiol 267, C753-758. 
 
91 
 
Kurjiaka DT & Segal SS. (1995). Conducted vasodilation elevates flow in arteriole 
networks of hamster striated muscle. Am J Physiol 269, H1723-1728. 
 
Lipowsky HH, Kovalcheck S & Zweifach BW. (1978). The distribution of blood 
rheological parameters in the microvasculature of cat mesentery. Circ Res 43, 
738-749. 
 
Murray CD. (1926). The Physiological Principle of Minimum Work: I. The Vascular 
System and the Cost of Blood Volume. Proc Natl Acad Sci U S A 12, 207-214. 
 
Namgung B, Ong PK, Johnson PC & Kim S. (2011). Effect of cell-free layer variation on 
arteriolar wall shear stress. Ann Biomed Eng 39, 359-366. 
 
Ong PK, Jain S, Namgung B, Woo YI & Kim S. (2011). Cell-free layer formation in 
small arterioles at pathological levels of erythrocyte aggregation. 
Microcirculation 18, 541-551. 
 
Ong PK, Namgung B, Johnson PC & Kim S. (2010). Effect of erythrocyte aggregation 
and flow rate on cell-free layer formation in arterioles. Am J Physiol Heart Circ 
Physiol 298, H1870-1878. 
 
Ortiz D, Briceno JC & Cabrales P. (2014). Microhemodynamic parameters quantification 
from intravital microscopy videos. Physiol Meas 35, 351-367. 
 
Pries AR, Ley K, Claassen M & Gaehtgens P. (1989). Red cell distribution at 
microvascular bifurcations. Microvasc Res 38, 81-101. 
 
Pries AR, Secomb TW & Gaehtgens P. (1995). Design principles of vascular beds. Circ 
Res 77, 1017-1023. 
 
Reneman RS, Arts T & Hoeks AP. (2006). Wall shear stress--an important determinant of 
endothelial cell function and structure--in the arterial system in vivo. 
Discrepancies with theory. J Vasc Res 43, 251-269. 
 
Soutani M, Suzuki Y, Tateishi N & Maeda N. (1995). Quantitative evaluation of flow 
dynamics of erythrocytes in microvessels: influence of erythrocyte aggregation. 
Am J Physiol 268, H1959-1965. 
 
Sriram K, Intaglietta M & Tartakovsky DM. (2014). Non-Newtonian flow of blood in 
arterioles: consequences for wall shear stress measurements. Microcirculation 21, 
628-639. 
 
Tangelder GJ, Slaaf DW, Arts T & Reneman RS. (1988). Wall shear rate in arterioles in 
vivo: least estimates from platelet velocity profiles. Am J Physiol 254, H1059-
1064. 
 
92 
 
Welsh DG & Segal SS. (1996). Muscle length directs sympathetic nerve activity and 
vasomotor tone in resistance vessels of hamster retractor. Circ Res 79, 551-559. 
 
Yamaguchi S, Yamakawa T & Niimi H. (1992). Cell-free plasma layer in cerebral 
microvessels. Biorheology 29, 251-260. 
 
Zamir M. (1977). Shear forces and blood vessel radii in the cardiovascular system. J Gen 
Physiol 69, 449-461. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
93 
 
  
 
 
 
 
 
 
: 
From one generation to the next: A comprehensive 
account of sympathetic receptor control in branching 
arteriolar trees 
 
 
 
 
 
 
 
A form of this manuscript has been accepted for publication: 
Al-Khazraji BK, Saleem A, Goldman D, Jackson DN. (2015). From one generation to the 
next: A comprehensive account of sympathetic receptor control in branching arteriolar 
trees. J Physiol (in press; April 2015). 
94 
 
 Introduction 
The sympathetic nervous system (SNS) promotes tonic vasoconstriction in skeletal 
muscle microvascular beds (Clifford & Hellsten, 2004; Segal, 2005) via neuronal release 
of norepinephrine (NE), neuropeptide Y (NPY), and adenosine-5'-triphosphate (ATP), 
which act on their respective receptors (i.e., α1R and α2R, Y1R, and P2X1R) located 
extraluminally on arteriolar vascular smooth muscle cells (Kiowski et al., 1983; Ruffolo 
et al., 1991; Malmstrom et al., 1997; Burnstock, 2007). Vasoconstriction to SNS 
stimulation varies among arterioles due to arteriolar size and branch order (Marshall, 
1982; Boegehold & Johnson, 1988; Dodd & Johnson, 1991). Arteriolar network geometry 
(i.e., topology) is a primary determinant of baseline network resistance (Pries et al., 
1995a); therefore, acute control of arteriolar diameter must coordinate with topology in 
order to effectively regulate microvascular blood flow and red blood cell (RBC) 
distribution.  
Past and recent investigators of α-adrenoreceptor (i.e., α1R and α2R) arteriolar control of 
the rat cremaster (Faber, 1988; Ohyanagi et al., 1991) and mouse gluteus maximus 
muscle (Moore et al., 2010), concluded that proximal arterioles [i.e., first order (1A) to 
third order (3A)] are dominated by adrenergic control. This is in contrast to both NPY 
(Ekelund & Erlinge, 1997) and ATP (Gitterman & Evans, 2000), where peak responses 
have been reported to act at the distal pre-capillary terminal arterioles. However the scope 
of such studies is limited, as experimental past approaches enabled interrogation of 
partial networks (i.e., 1A to 3A arterioles at best) or discrete vessels. In an effort to reveal 
how the SNS regulates blood flow distribution in skeletal muscle microvasculature, the 
development of a preparation with access to a complete branching arteriolar trees is 
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necessary. To date, no studies have systematically and comprehensively defined the 
relationship between arteriolar order, activation of receptors for sympathetic 
neurotransmitters, and hemodynamics in skeletal muscle networks.  
We recently developed a novel rat gluteus maximus (GM) preparation [Chapter 2, (Al-
Khazraji et al., 2012); adapted from the mouse (Bearden et al., 2004)], which enables the 
investigation of sympathetic control in complete branching arteriolar trees. The aim of 
this study was to characterize topologically-dependent SNS modulation along arteriolar 
trees in the rat GM, and investigate the consequent hemodynamics. Thus, the objectives 
of this study were to: 1) systematically determine the arteriolar responses to specific 
sympathetic receptor activation as a function of branch order (i.e., from 1A to 5A), and 2) 
input these responses into an in-house developed computational blood flow model to 
estimate the functional consequence(s) of order-dependent sympathetic control on total 
blood flow and red blood cell distribution within the arteriolar tree. We predict that 
adrenergic control will be greatest in proximal arterioles, with progressive attenuation 
with increasing arteriolar order. Conversely, we predict that peptidergic and purinergic 
control will be greatest in distal arterioles, with progressive attenuation with decreasing 
arteriolar order. Finally, we anticipate that theoretical estimates of hemodynamic 
consequences will differ based on predicted topologically-dependent SNS control.  
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 Materials and methods 
 Animal care and use 
Experimental protocols were approved by The Council on Animal Care at the University 
of Western Ontario. Experiments were performed using 27 male Sprague–Dawley rats 
(six to seven weeks old; mass: 170 ± 12 g, mean ± SD), purchased from Charles River 
Laboratories (Saint-Constant, Quebec, Canada), and housed on site for at least one week 
prior to the study. Rats were housed in animal care facilities of the University of Western 
Ontario, at 24°C on a 12–12 hour light–dark cycle with access to food and water ad 
libitum. At the end of the experiment, the anesthetized rat was euthanized with an 
overdose of α-chloralose and urethane cocktail mix (intraperitoneal injection), and 
cervical dislocation. 
 Anesthesia and skeletal muscle preparation  
A more detailed description can be found elsewhere (Al-Khazraji et al., 2012). Briefly, 
the rat was anesthetized with a cocktail of α-chloralose (80 mg⁄ kg) and urethane (500 mg⁄ 
kg) using intraperitoneal injection. The fur of the neck and lower back region were 
shaved, and the animal was tracheotomized and cannulated in both the jugular (for 
continuous intravenous drug delivery) and the carotid (for blood pressure recordings). 
Temperature was maintained at 37°C (rectal probe) using a customized temperature 
controlled platform. With the animal shaved and skin prepared, under microscopic 
guidance the GM muscle was cut from its origin along the spine and along its rostral and 
caudal borders. With great care taken to preserve its neurovascular supply, the muscle 
flap was gently reflected away from the rat, spread evenly onto a transparent Sylgard 
(Sylgard 184; Dow Corning, Midland, MI, USA) pedestal to approximate in situ 
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dimensions and pinned to secure edges. The exposed tissue was superfused continuously 
(4–5 ml/min) with bicarbonate-buffered PSS (35°C at tissue, pH 7.4) of the following 
composition: NaCl 137 mM, KCl 4.7 mM, MgSO4 1.2 mM, CaCl2 2 mM, NaHCO3 18 
mM, and equilibrated with 5% CO2 ⁄ 95% N2. 
 Intravital video microscopy (IVVM) 
Upon completion of microsurgical procedures, the preparation was transferred to the 
stage of the intravital microscope (Olympus BX51, Olympus, Tokyo, Japan). The 
preparation was equilibrated for approximately 30 minutes, during which time the 
arteriolar network was observed for experimental sites of observation (vasomotion was 
not observed). Microvessels were imaged under Kohler illumination using a long 
working distance condenser (NA = 0.80) and a long working distance water immersion 
objective (Olympus LUMPLFL: 10× NA = 0.30; depth of field ~9 m) with illumination 
from a 100-Watt halogen light source. The optical image was coupled to an EMCCD 
camera (Qimaging Rolera EMC2, Qimaging, Surrey, BC, Canada), viewed using 
specialized imaging software (MetaMorph 7.6, Molecular Devices Inc., Sunnyvale, CA, 
USA), and stored on a hard drive for offline analysis. Following equilibration, the 
baseline internal vessel lumen diameter was recorded and arterioles were tested for 
oxygen sensitivity by elevating superfusate O2 from 0% to 21% (5% CO2, balance N2) for 
5 minutes, and recording arteriolar diameter (Table 4.1). Equilibration with 5% CO2–95% 
N2 was restored for the duration of experimental procedures. Bright-field video (.tiff) 
images were collected (17 fps) under Kohler bright-field illumination for off-line analysis 
of internal vessel lumen diameters using ImageJ software (Schneider et al., 2012). 
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 Experimental protocols 
All working solutions of drugs were prepared fresh daily and dissolved in the gassed and 
warmed PSS solution. The highest dose of drug was initially prepared, followed by 
preparation of the other concentrations of drug using a dilution series with logarithmic 
increments (dissolved in gassed PSS). Each concentration level was independently stored 
in its own tightly-sealed storage bottle, and placed in a heated water bath to maintain 
solution temperature of 37°C. Two water jacketed reservoir units (Radnoti LLC, CA, 
USA) were set up: 1) one provided warmed and gassed PSS that was gravity fed from a 
larger reservoir bottle, and 2) the other was used only for drug delivery. Each solution 
was then poured into the heated reservoir unit, and was topically applied to the 
preparation via gravity feed. Once the arteriolar responses for a given drug concentration 
were recorded, the solution in the reservoir was replaced with the next higher dose of 
drug solution. This procedure was repeated throughout concentration–response 
determinations. All solutions were pre-gassed prior to mixture, and received continuous 
bubbling of gas within the chamber to ensure continuous and homogenous gassing of the 
solution. For treatment with antagonists, the desired concentration was similarly prepared 
as a combined solution of agonist and antagonist.  
Protocol 1: Regional activation of α1R, α2R, Y1R, and P2X1R 
Five groups of animals were used to evaluate arteriolar responses to phenylephrine (PE; 
α1R specific agonist; Sigma Aldrich, MO, USA), UK 14,304 (α2R specific agonist; 
Tocris Biosciences, MO, USA), neuropeptide Y (NPY; Tocris Biosciences, MO, USA), 
and ATP (Sigma Aldrich, MO, USA). ATP has been shown to exhibit both 
vasoconstrictor [via P2X1R activation; (Hopwood & Burnstock, 1987)] and vasodilator 
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(Hellsten et al., 1998) effects; therefore, in an effort to isolate ATP-mediated 
vasoconstriction (Buckwalter et al., 2004), we conducted a separate set of experiments 
with a fifth group of animals receiving α,β-methylene ATP (αβ-meATP; potent P2X1 
receptor agonist; Sigma Aldrich, MO, USA), a stable non-degradable ATP analogue. All 
experiments were conducted in the rat GM arteriolar network, with one agonist evaluated 
per animal. Arteriolar responses were recorded at log increments (PE: 10-9 to 10-4 M; UK 
14,304: 10-9 to 10-5 M; NPY: 10-13 to 10-8 M; ATP: 10-9 to 10-4 M; αβ-meATP: 10-9 to 10-
5 M), and were evaluated when diameter responses stabilized and remained static for a 
minimum of 5 to 10 minutes. 
 Selection of agonist concentrations 
In all cases, the concentrations selected for each agonist application ranged from 
physiological resting levels to supra-physiological levels in an attempt to maximize 
constriction responses. The ranges selected for PE and UK 14,304 were based off of 
resting plasma levels of norepinephrine [1 to 4 nM (Mortensen et al., 2012)], and high 
intensity exercise [~50 nM (Stratton & Halter, 1985)]. The range selected for NPY 
concentrations were from resting conditions (~1 pM), to high physiological stress such as 
high intensity exercise (10 pM), or vaginal birth delivery (~10 nM) (Hirsch & Zukowska, 
2012).  
In an effort to characterize ATP’s baseline activity as a vasoconstrictor (Galligan et al., 
2001; Gitterman & Evans, 2001; Erlinge & Burnstock, 2008), as well as its role in 
vasodilation as seen in exercise concentrations [2 M (Hellsten et al., 1998)], we selected 
ATP concentrations which represented interstitial skeletal muscle levels ranging from 
resting conditions [~100 nM (Mortensen et al., 2011)] to those noted during heavy 
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exercise (Hellsten et al., 1998). The range selected for αβ-meATP encompassed the 
above ATP range, and is similar with the range used in a previous study (Buckwalter et 
al., 2004).  
 Experimental data collection 
Arteriolar responses at varying branch orders (from 1A to 5A) were recorded at each log 
increment of agonist concentration. The tissue was then superfused with PSS and 
arteriolar diameters were restored to that of baseline. Finally, maximal diameter 
responses to superfused sodium nitroprusside (SNP, 10-5 M) were recorded (Table 4.1). 
At baseline and during all drug interventions, continuously branching sets of arteriolar 
trees were scanned and imaged from 1A to 5A. Next, the same arteriolar tree was scanned 
and imaged from 5A to 1A to confirm that vessel responses were stable and there were no 
temporally-dependent alterations in responses during image scans. The total 
scanning/imaging time (1A to 5A, then from 5A to 1A) was under 30 seconds. In all 
cases, the responses at the beginning and end of imaging did not differ, indicating that 
there were no changes in responses over the scanning period.  
Protocol 2: Selectivity of α1R, α2R, Y1R, and P2X1R agonist 
To confirm specific functional responses to agonists, agonist data were also collected in 
the face of specific receptor antagonist delivery (α1R antagonist: prazosin at 2x10-8 M; 
α2R antagonist: yohimbine at 10-6 M; Y1R antagonist: BIBP3226 at 2x10-8 M; and 
P2X1R antagonist: NF023 at 10-6 M). Concentrations of antagonists were selected based 
on pilot work conducted in our laboratory that showed successful blockade at EC50 
values of agonist. 
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 Tissue viability and inclusion criteria 
Preparations were evaluated for oxygen sensitivity as a means to test for vascular 
responsiveness. As well, responses to oxygen (before beginning agonist delivery 
protocol) and SNP (after completion of experimental protocol) were used as a metric 
(independent of the tested variables) to determine repeatability between preparations. 
Preparations that did not respond to either oxygen or SNP were discarded from data 
inclusion. All 27 animals used in this study responded physiologically to both O2 and 
SNP (Table 4.1). 
 Arteriolar order classification 
The arteriolar network was classified using the centrifugal arteriolar classification method 
(Ellsworth et al., 1987), as follows: the first order (1A) was set as the first bifurcation 
coming off the feed vessel that entered the proximal end of the tissue. Each large 
bifurcation following thereafter was classified as the next generation of arterioles; e.g., 
second order (2A) daughter vessels bifurcated off a 1A vessel, etc. (Wiedemann, 1962; 
Boegehold & Johnson, 1988; Moore et al., 2010).  
To normalize arteriolar order classification across experiments and to avoid bias, we used 
the following criteria to define changes in branch order: 1) branch angle between two 
arterioles at a bifurcation must be less than 90° and greater than 15, 2) bifurcations 
coming off of 1A to 3A must not bifurcate directly into a capillary bed, but rather give 
rise to another bifurcation (i.e., a bifurcation coming off a 3A is labeled a 4A arteriole and 
should give rise to 5A vessels, instead of a capillary bed), and 3) the diameters of the two 
arterioles at a bifurcation must be less than 80% of parent vessel diameter. As reported in 
other preparations (Murrant & Sarelius, 2000), the larger bifurcations (1A to 3A) of the 
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GM preparation were observed to be paired with the venular tree, while the smaller 
orders (4A to 5A) did not run alongside the venular tree. 
In an effort to ensure only continuously branching arteriolar trees were analyzed, we 
outlined the arteriolar tree considered for observation and subsequent analysis was 
outlined using the following criteria: 1) each order must give rise to a subsequent 
interconnected series of bifurcations (i.e., a tree was outlined by selecting a 1A that is 
followed by 2A, etc. until 5A), and 2) similarly, each order, with the exception of 1A, 
must have bifurcated in line with a parent vessel that was within the same connected 
series of arterioles. For example, 4A vessel data were only accepted if that 4A bifurcation 
originated from a 3A vessel included in the original chosen arteriolar tree path.  
 Computational modelling 
Computational modelling is useful in integrating measurements of diameter changes at 
various levels in the arteriolar tree to determine the resulting changes in overall network 
resistance and blood flow (Pries et al., 1994). This is particularly important when seeking 
to compare the overall effects of SNS receptor activation between proximal and distal 
arterioles. Modelling is also useful in determining how measured diameter changes 
coordinate to alter flow distribution within the arteriolar tree, which requires having an 
accurate representation of in vivo network geometry. Thus, in an effort to estimate the 
hemodynamic consequences arising from SNS receptor activation along the branching 
arteriolar tree network, we incorporated our experimental findings into an in-house 
developed computational flow model.  
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We consistently observed high network homology across all rat GM preparations; thus, 
our model was developed from a single rat GM preparation that represented the 
topological mean of all experimental animals observed at baseline. Certainly, network 
homology has been reported in the mouse GM preparation (Bearden et al., 2004). For 
blood flow simulations, arteriolar tree geometry was determined from vascular 
reconstructions using IVVM image montages of the rat GM and consisted of 27 
unbranched (outlet) vessels. The arteriolar tree was discretized into 111 segments with a 
mean length of 33 μm and blood flow was calculated assuming a fixed pressure drop (7 
mmHg) between the inlet segment (1A arteriole) and all the outlet segments (4A and 5A 
arterioles). At the inlet segment the discharge hematocrit was set to 0.42 (the normal 
value for blood sample hematocrit in these animals). Arteriolar orders were 
mathematically determined to best represent the ordering scheme used in the 
experimental analysis (order increasing at bifurcations when a vessel had a diameter 
<80% of parent, or a bifurcation angle > 15). 
A previously described two-phase (RBCs, and plasma) continuum blood flow model was 
used (Goldman & Popel, 2000, 2001). Based on the in vivo rheological model of Pries et 
al. (1994, 1990) the two-phase continuum flow model was used to calculate the steady-
state distribution of total blood flow (Q) and discharge hematocrit (HD) throughout the 
arteriolar tree. The flow model uses conservation equations for blood and RBC volume 
flow into each node j: 
∑ 𝑄𝑖𝑗𝑖 = 0, 
∑ 𝐻𝐷𝑖𝑗𝑄𝑖𝑗𝑖 = 0, 
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where each vessel segment ij is labeled by its end nodes and the sums are over all nodes i 
connected to node j. The flow in segment ij is given by the pressure difference (Δpij) 
along the segment divided by the hydrodynamic resistance of the segment. The pressure-
flow relationship is described by 
𝑄𝑖𝑗 =
𝜋𝑅4∆𝑝𝑖𝑗
8𝜇𝑝𝑙𝜇𝑟𝑒𝑙𝐿
 
where L and R are the length and radius of the vessel segment being considered, μpl is the 
viscosity of plasma, and μrel is the relative viscosity of blood which depends on both 
radius and hematocrit [Fahraeus-Lindqvist effect; (Pries et al., 1990)]. The nonlinear 
relationship between RBC flow distribution at vessel bifurcations and overall blood flow 
distribution [plasma skimming effect; (Pries et al., 1994; Goldman & Popel, 2000)] is 
also included in the model. The nonlinear rheological effects included in the model make 
it necessary to solve the steady-state equations using an iterative method (Pries et al., 
1994; Goldman & Popel, 2000). For the arteriolar geometries considered, the Matlab 
flow simulation code typically required ~30 steps and <10 seconds to converge to a fixed 
solution for all node pressures, segment flows and hematocrits. 
For baseline blood flow calculations, the arteriolar diameters used in the model were 
those measured under control conditions (i.e., in the absence of any SNS agonists or 
antagonists in the superfusion solution). In a separate set of experiments (n = 39 vessels), 
the computational model was validated against in vivo blood flow measurements, using 
the “streak length” method (Al-Khazraji et al., 2012), in continuously branching 
arteriolar trees from the rat GM preparation under baseline control conditions. 
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To computationally determine hemodynamic consequences from experimental data, 
constriction levels for the various cases were input into the model as a function of both 
vessel order and drug concentration (evaluated from in vivo changes in constriction at PE, 
UK 14,304, ATP at 10-9 to 10-6 M, and NPY at 10-13 to 10-10 M). These data were used to 
alter diameters throughout the model arteriolar tree, based on a vessel ordering consistent 
with the experimental approach, and then the flow model described above was used to 
calculate the resulting hemodynamics. Total network flow, resistance, and RBC flow 
heterogeneity (coefficient of variation of RBC volume flow, i.e., standard deviation 
divided by mean) at each order were calculated for the given reconstructed network. 
 Data presentation and statistical analyses 
Experimental data are presented as mean ± SEM, except where otherwise stated. 
Summary data for baseline diameters, responses to O2 (O2 Response = DO2 - DBaseline; in 
µm) and SNP (SNP Response = DSNP - DBaseline; in µm) are summarized in Table 4.1. For 
constriction responses, values were calculated as changes from baseline diameter [% 
constriction = (DBaseline – DResponse) / DBaseline x 100%]. Reactivity between orders was 
determined as percent change differences [((% constrictionA - % constrictionB) / % 
constrictionA) x 100%, where A and B correspond to two different arteriolar orders]. At 
each concentration of agonist, a one-way ANOVA was conducted, to observe the effect of 
arteriolar order on level of arteriolar constriction, with alpha level of 0.05 for statistical 
significance. For each agonist-antagonist plot, individual t-tests were conducted at each 
concentration of drug to evaluate the effect of the antagonist on constriction for each 
order. In the event of unequal variance, a Welsh correction was applied to the t-test. 
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Data for each agonist treatment were fit to a variable-slope sigmoid and, where sigmoidal 
convergence was possible, compared. Due to dichotomous (vasodilatory and 
vasoconstrictor) responses to ATP application and variable responses among arteriolar 
orders to αβ-meATP application, data did not converge and sigmoidal (LogEC50) 
analyses were not possible. 
To compare concentration-response curves (LogEC50) with differing absolute maximum 
constriction responses (EMax), data for PE, UK 14,304, and NPY were transformed using 
Graphpad Prism. Responses were normalized to their respective EMax, where the 
minimum and maximum (y-axis) values were set to 0 and 100% respectively and the x-
axis was converted to a logarithmic scale. LogEC50 values were then compared across all 
orders using a one-way ANOVA with alpha level of 0.05 for statistical significance, 
followed by Tukey’s HSD post-hoc test. 
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Table 4.1: Summary values for 5 arteriolar orders. 
Responses are reported as change (O2 Response = DO2 - DBaseline; SNP Response = DSNP - 
DBaseline) from baseline values. Data reported as mean ± S.E.M. 
Arteriolar Order Baseline Diameter 
(m) 
O2 Response  
(m) 
SNP Response 
(m) 
1A 93  2 -11  1 24  3 
2A 70  2 -9  1 22  3 
3A 55  1 -8  1 22  2 
4A 42  1 -7  1 12  1 
5A 35  1 -5  1 11  1 
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 Results 
Protocols 1 & 2: Activation and selectivity of α1R, α2R, Y1R, and P2X1R agonist 
To confirm the receptor-mediated effects of the sympathetic agonists used in this study, 
we conducted a subset of experiments in the face of antagonist delivery. In all cases, 
antagonism of receptors for sympathetic neurotransmitters abolished vasoconstriction to 
respective sympathetic agonists.  
 Phenylephrine data 
There was an order-dependent effect of PE on arteriolar constriction (Fig. 4.1, Top panel; 
N=8 rats). Arteriolar constriction at maximum PE concentration (10-4 M) was greatest at 
1A which progressively decreased with increasing arteriolar order, such that 1A were 
85% more reactive than 5A. Constriction to maximum PE concentration (10-4 M) was 
blocked by prazosin (P<0.05), confirming that responses were due to 1R activation. 
Phenylephrine LogEC50 values were different across arteriolar orders (Fig. 4.1, Bottom 
panel; P<0.05), where the LogEC50 values (M) were: 1A, -6.23; 2A, -6.42; 3A, -6.43; 
4A, -6.00; 5A, -5.86. Specifically, LogEC50 for 2A was greater than 4A and 5A, and 
LogEC50 for 3A was greater than 4A and 5A (P<0.05).  
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Figure 4.1: Arteriolar responses to α1R activation at 5 arteriolar orders. 
Top: Percent change in arteriolar constriction (from baseline) for 5 arteriolar orders (1A 
through 5A, n = 8-17 arterioles) at increasing concentrations (M) of phenylephrine (PE). 
Data presented as mean  S.E.M. * indicate different from 1A, # indicate different from 
2A, † indicate different from 3A and § indicate different from 4A (P<0.05). Constriction 
responses to peak concentrations of PE were blocked by prazosin (% indicates difference 
between responses with and without antagonist at PE 10-4 M, P<0.05) for all orders. 
Bottom: Normalized constriction responses fit to sigmoids. LogEC50 values reported in 
legend for each arteriolar order. LogEC50 values for 2A and 3A were greater than 4A 
and 5A (P<0.05). 
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 UK 14,304 data 
There was an order-dependent effect of UK 14,304 on arteriolar constriction (Fig. 4.2, 
N=5 rats). Arteriolar constriction at maximum UK 14,304 (10-5 M) was greatest at 1A, 
2A, and 3A, such that these arteriolar orders were up to 85% more reactive than 5A. 
Constriction to UK 14,304 at 10-7 to 10-6 M was blocked by yohimbine at all orders, and 
UK 14,304 at 10-5 M was blocked by yohimbine at 3A to 5A (P<0.05), confirming that 
responses to were due to 2R activation. 
UK 14,304 LogEC50 values were similar across arteriolar orders (Fig. 4.2, Bottom 
panel), where the LogEC50 values (M) were: 1A, -7.07; 2A, -7.02; 3A, -7.26; 4A -7.19; 
5A, -6.68. 
 Neuropeptide Y data  
There was an order-dependent effect of NPY on arteriolar constriction (Fig. 4.3, Top 
panel; N=8 rats). Arteriolar constriction at maximum NPY concentration (10-8 M) was 
greatest at 5A, which progressively decreased with decreasing arteriolar order, such that 
5A were 121% more reactive than 1A. Constriction to NPY at maximum concentration 
(10-8 M) was blocked by BIBP3226 (P<0.05), confirming that responses were due to Y1R 
activation. 
NPY LogEC50 values were similar across arteriolar orders (Fig. 4.3, Bottom panel), 
where the LogEC50 (M) values were: 1A, -10.04; 2A, -10.28; 3A, -10.02; 4A -10.23; 5A, 
-10.59. 
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Figure 4.2: Arteriolar responses to α2R activation at 5 arteriolar orders. 
Top: Percent change in arteriolar constriction (from baseline) for 5 arteriolar orders (1A 
through 5A, n = 6-22 arterioles) at increasing logarithmic concentrations (M) of UK 
14,304. Data presented as mean  S.E.M. # indicate different from 2A, and † indicate 
different from 3A (P<0.05). Constriction responses to peak concentrations of UK 14,304 
were blocked by yohimbine (% indicate difference between responses with and without 
antagonist at UK 14,304 10-5 M, P<0.05) for all orders. Bottom: Normalized constriction 
responses fit to sigmoids. LogEC50 values are reported in legend, and were similar 
across arteriolar orders. 
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Figure 4.3: Arteriolar responses to Y1R activation at 5 arteriolar orders. 
Top: Percent change in arteriolar constriction (from baseline) for 5 arteriolar orders (1A 
through 5A, n = 8-17 arterioles) at increasing logarithmic concentrations (M) of 
neuropeptide Y (NPY). Data presented as mean  S.E.M. * indicate difference from 1A, 
# indicate difference from 2A, and † indicate difference from 3A (P<0.05). Constriction 
responses to peak concentrations of NPY were blocked by BIBP3226 (% indicate 
difference between responses both with and without antagonist, P<0.05) for all orders. 
Bottom: Normalized constriction responses fit to sigmoids. LogEC50 values are reported 
in legend, and were similar across arteriolar orders. 
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 ATP data 
ATP produced concentration-dependent dichotomous arteriolar responses (Fig. 4.4). 
Lower ATP concentrations (10-9 M to 10-7 M) evoked arteriolar constriction, with the 
following branch orders having the greatest level of constriction at each concentration: 
10-9 M of ATP, 4A>1A and 3A; 10-8 M, 4A>1A; and 10-7 M, 4A>1A and 2A (P<0.05). 
ATP evoked maximum arteriolar constriction at 10-8 M, with the following constrictor 
responses: 1A, 3.5%; 2A, 8%; 3A, 9%; 4A, 15%; 5A, 11%. These data indicate that 4A 
are the most responsive to ATP’s constrictor effects. 
At concentrations >10-6 M, all orders dilated, with peak responses to maximal 
concentration of ATP 10-4 M as indicated: 1A, 18%; 2A, 22%; 3A, 24%; 4A, 17%; 5A, 
21% (Fig. 4A). 
Constriction to ATP at 10-9 to 10-7 M was blocked by NF023 (Fig. 4.5, P<0.05) indicating 
that responses to ATP were due to P2X1R activation. 
 α,β-methylene ATP data 
All arteriolar orders constricted for the full concentration range of αβ-meATP (Fig. 4.6). 
Since αβ-meATP is P2X1R specific, these data support that the dilation effects of ATP 
(shown in Fig. 4.4) were not P2X1R mediated. Furthermore, constriction effects of -
meATP were blocked by NF023 (10-6 M) (P<0.05, Fig. 4.6).  
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Figure 4.4: Arteriolar responses to ATP application at 5 arteriolar orders. 
Percent change in arteriolar constriction (from baseline) for 5 arteriolar orders (1A 
through 5A, n = 6-22 arterioles) at increasing logarithmic concentrations (M) of 
adenosine triphosphate (ATP). Data presented as mean  S.E.M. A negative constriction 
is determined as a dilatory response. * indicate difference from 1A, # indicate difference 
from 2A, and † indicate difference from 3A (P<0.05).  
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Figure 4.5: Arteriolar responses to ATP application with P2X1R blockade at 5 
arteriolar orders. 
Percent change in arteriolar constriction (from baseline) for 5 arteriolar orders (1A 
through 5A, n = 5-20 arterioles) at increasing logarithmic concentrations (M) of 
adenosine triphosphate (ATP) in the face of NF023 (P2X1R antagonist). Data presented 
as mean  S.E.M. A negative constriction is determined as a dilatory response. Data 
presented as mean  S.E.M. Constriction responses to ATP were blocked by NF023 for 
ATP concentrations of 10-9 M (* indicate difference in constriction responses for 2A-5A 
with and without antagonist, P<0.05), 10-8 M (# indicate difference in constriction 
responses for 3A-5A with and without antagonist, P<0.05), and 10-7 M († indicate 
difference in constriction responses for 4A-5A with and without antagonist, P<0.05). 
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Figure 4.6: Arteriolar responses to αβ-meATP application at 5 arteriolar orders. 
Percent change in arteriolar constriction (from baseline) for 5 arteriolar orders (1A 
through 5A, n = 5-15 arterioles) at increasing logarithmic concentrations (M) of alpha-
beta-methylene-ATP (-meATP). Data presented as mean  S.E.M. Constriction 
responses to -meATP were blocked by NF023 for -meATP concentrations of 10-6 
M (*indicates difference in constriction responses for 2A, 4A-5A with and without 
antagonist, P<0.05), and 10-5 M (#indicates difference in constriction responses for 4A 
with and without antagonist, P<0.05). 
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 Computational analysis: Calculating hemodynamic 
consequences from spatially-dependent SNS receptor 
activation 
An arteriolar tree was modeled from in vivo network geometry, with centrifugal branch 
orders mathematically determined in the same way and represented using the same 
nomenclature (1A-5A) as in our experimental data analysis (Fig. 4.7). Comparison 
between computational calculations for baseline blood flow did not differ from 
experimental blood flow calculations, as slopes and intercepts between the two regression 
lines were similar (Fig. 4.8). 
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Figure 4.7: Computational network reconstruction schematic. 
Numbers indicate arteriolar diameters (µm) on photomontage, and branch order on 
reconstructed network. The large vessel (inlet) is 1st order (1) and the smallest vessels 
(outlets) are 5th orders (5). Network is color-coded based on baseline (control) blood 
flow through vessel segments (from red being high flow to blue being low flow values). 
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Figure 4.8: Validation of computational flow data with experimental flow data. 
Comparison of blood flow values calculated from the computational model versus blood 
flow values calculated from experimental protocol. There was no significant difference 
between the slopes or the intercepts for both linear regressions. Experimental Flow: 
𝐿𝑜𝑔(𝐶𝑎𝑙𝑐𝑢𝑙𝑎𝑡𝑒𝑑 𝐵𝑙𝑜𝑜𝑑 𝐹𝑙𝑜𝑤) = (2.64 × 𝐿𝑜𝑔(𝐷𝑖𝑎𝑚𝑒𝑡𝑒𝑟)) − 3.44; r2 = 0.96, P<0.05. 
Computational Flow: 𝐿𝑜𝑔(𝐶𝑎𝑙𝑐𝑢𝑙𝑎𝑡𝑒𝑑 𝐵𝑙𝑜𝑜𝑑 𝐹𝑙𝑜𝑤) = (2.79 × 𝐿𝑜𝑔(𝐷𝑖𝑎𝑚𝑒𝑡𝑒𝑟)) −
3.65; r2 = 0.76, P<0.05. 
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This reconstructed arteriolar tree was used in our hemodynamic calculations to obtain 
network flow (Fig. 4.9), total resistance (Fig. 4.10), and RBC flow heterogeneity at 2A-
5A (Fig. 4.11). There was a progressive decrease in total flow within the simulated 
network with increasing concentrations of PE, UK and NPY (Fig. 4.9). Correspondingly, 
there was a progressive increase in total network resistance within the simulated network 
with increasing concentrations of PE, UK and NPY (Fig. 4.10). In parallel with the 
constriction data, ATP exhibited an effect on total flow and network resistance which was 
opposite to that of the other ligands; that is, ATP increased total flow with increasing 
concentration, and decreased network resistance with increasing concentration. Our 
group as well as our collaborators have previously shown that these results are attributed 
to ATP acting as a dilator at higher concentrations (Hellsten et al., 1998; Nyberg et al., 
2013).  
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Figure 4.9: Calculated total network flow during baseline, and sympathetic receptor 
activation. 
Calculated total network flow for baseline; PE, UK 14,304 (UK), and ATP from 10-9 to 
10-6 M; NPY from 10-13 to 10-10 M. There was a progressive decrease in calculated total 
network flow with increasing concentration of agonist, with the exception of ATP as 
dilation occurs at higher concentrations. 
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Figure 4.10: Calculated total network resistance during baseline, and sympathetic 
receptor activation. 
Calculated total network resistance (PRU, peripheral resistance units) for baseline; PE, 
UK 14,304 (UK), and ATP from 10-9 to 10-6 M; NPY from 10-13 to 10-10 M. There was a 
progressive increase in calculated total network resistance with increasing concentration 
of agonist, with the exception of ATP as dilation occurs at higher concentrations. 
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To calculate changes in RBC flow heterogeneity, baseline heterogeneity was used as the 
reference value, and any changes from baseline heterogeneity were reflected as positive 
(increase in heterogeneity) or negative (decrease in heterogeneity) changes from baseline. 
This fractional change was calculated for each order (1A-5A) of the reconstructed 
network (Fig. 4.11). For 2A vessels, there was minimal change in RBC flow 
heterogeneity for all concentrations of the four ligands, with a maximum of 5% increase 
in heterogeneity exhibited by addition of 10-6 M UK 14,304. For 3A vessels, there was a 
10-24% increase in RBC flow heterogeneity exhibited by PE and UK 14,304 at all 
concentrations, with smaller (~1-12%) effect of ATP and especially NPY. For 4A vessels, 
there was a progressive increase in RBC flow heterogeneity with increasing 
concentrations of PE and UK 14,304, and the greatest effect on heterogeneity (~50% 
increase) with 10-6 M concentration of UK 14,304. The changes in heterogeneity for 5A 
vessels do not follow a distinct pattern for each of the concentrations of UK 14,304 and 
ATP; however Fig. 4.11 serves to highlight two important outcomes: 1) PE and NPY have 
opposing effects on heterogeneity at 5A (increasing PE decreases heterogeneity while 
increasing NPY increases heterogeneity), and 2) while PE has a large impact on blood 
flow heterogeneity in the larger vessels (2A-4A), it decreases heterogeneity at 5A vessels. 
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Figure 4.11: Change in RBC flow heterogeneity at 2A to 5A during sympathetic 
receptor activation. 
The coefficient of variation of RBC flow heterogeneity as a function of agonist is 
normalized to baseline RBC flow heterogeneity. Heterogeneity is calculated for the 
following agonist concentrations: PE, UK 14,304 (UK), and ATP from 10-9 – 10-6 M; 
NPY from 10-13 – 10-10 M. Increase in heterogeneity is shown as a positive value, whereas 
decrease in heterogeneity is shown as a negative value. 
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 Discussion 
Herein we provide a comprehensive topological evaluation of sympathetic modulation in 
branching skeletal muscle arteriolar networks. This work provides much needed new data 
describing concentration- and order-dependent vasoconstrictor effects of adrenergic (α1R 
and α2R), peptidergic (Y1R), and purinergic (P2X1R) receptor activation in complex 
skeletal muscle arteriolar trees. Furthermore, we have applied these experimental data to 
our computational blood flow model and described the hemodynamic consequences of 
heterogeneous modulation of receptors for sympathetic neurotransmitters across a 
skeletal muscle network. Our data support and build on the classic “adreno-centric” view 
of sympathetic vascular control, but most importantly illustrate equipotent roles for 
peptidergic and purinergic sympathetic components in skeletal muscle arteriolar 
hemodynamics. 
 Experimental findings: Topologically-dependent 
sympathetic control along arteriolar trees 
 Visualization and imaging of arteriolar networks 
One of the prominent features of the rat GM muscle is its 2-dimensional planar geometry 
(Al-Khazraji et al., 2012), whereby complete arteriolar networks can be quickly scanned 
and imaged with minimal changes in focal depth. For the present study, this enabled 
simultaneous and systematic evaluation of the topologically-dependent effects of 
sympathetic receptor activating receptors for sympathetic neurotransmitters along 
branching arteriolar trees (from 1A to 5A). 
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 Topologically-dependent vasoconstrictor responses to 
adrenergic control 
Prior studies describing differential α-adrenergic control in branching arterioles were 
limited to selected small groupings of arterioles in non-locomotive muscle (i.e., rat 
cremaster) (Faber, 1988; Ohyanagi et al., 1991) or locomotive skeletal muscle arteriolar 
networks of limited branch orders (Moore et al., 2010). In the rat cremaster, Faber (1988) 
binned groups of arterioles (based on luminal diameter) as either large or small. Where 
large arterioles were comprised of 1A and 2A (mean diameter of 100 µm) and small 
arterioles were comprised of 3A vessels (mean diameter of 25 µm). Ohyanagi et al. 
(1991) also used binning, but categorized large arterioles (mean diameter of 120 µm) as 
1A, and terminal arterioles (mean diameter of 13 µm) as 3A vessels. Although their 
approach provided meaningful data, their binning approaches limited spatial resolution, 
which precludes topologically based analyses.  
In the current study, arteriolar responses to PE were order-dependent, where 1A and 2A 
were 27% to 317% more reactive than 4A and 5A for the entire range of PE 
concentrations. As well, arteriolar constriction elicited by the highest PE concentration 
(10-4 M) was completely blocked by prazosin (α1R antagonist; 2x10-8 M) (Fig. 4.1, Top 
panel). Although our data support many of the findings of Moore et al. (2010) on mice, 
we observed that 1A were most responsive to PE application, where they reported that 3A 
were most responsive to PE application. Although we cannot preclude species differences 
(i.e., rat versus mouse), such discrepancies are likely attributed to fundamental 
differences in experimental protocol. Specifically, Moore et al. applied a narrow PE 
concentration range (10-9 to 10-6 M) that did not elicit plateaus in arteriolar response 
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curves, suggesting that responses did not reach maximum constriction. In contrast, we 
employed a broader PE concentration range (10-9 to 10-4 M), resulting in maximum 
arteriolar constriction (i.e., plateau responses). Applying higher PE concentrations (10-5 
and 10-4 M), we demonstrated that 1A and 2A constrict greater than 3A (Fig. 4.1, Top 
panel).  
Since EC50 represents the potency of ligands on arteriolar responses and since efficacy 
(EMax) differed among arteriolar orders, then arteriolar responses were normalized and 
plotted as concentration-response curves. In response to PE, LogEC50 differed among 
orders (Fig. 4.1, Bottom panel; P<0.05), where LogEC50 of 2A and 3A were greater than 
4A and 5A. Our data show that PE has greater potency (i.e., LogEC50) and efficacy 
(EMax; Fig. 4.1, Top panel) in proximal versus distal arterioles. These data suggest that 
proximal arterioles may have either greater receptor density and/or binding affinity; 
however, conclusions describing receptor density and/or binding affinity are beyond the 
scope of this study.  
Arteriolar responses to UK 14,304 (α2R activation, Fig. 4.2, Top panel) were order 
dependent, where (at 10-8 to 10-5 M) 2A was 87% to 261% and 3A was 78% to 289% 
more reactive than 5A vessels (P<0.05). EMax values in 2A and 3A were 87% and 78% 
greater, respectively, than EMax in 5A (Fig. 4.2, Top panel). Since all arteriolar orders 
received the same range of agonist concentrations and reached plateaus in response, these 
EMax data illustrate the profound efficacy of UK 14,304 in proximal versus distal 
arterioles. In contrast, there were no differences in LogEC50 values across arteriolar 
orders in response to UK 14,304 (Fig. 4.2, Bottom panel), illustrating its similar potency 
among all arteriolar orders.  
128 
 
As previously discussed, Faber (1988) and Ohyanagi et al. (1991) binned arterioles 
(based on luminal diameter), which is fundamentally different than the ordering scheme 
used in the current study. Despite differences in arteriolar nomenclature, strictly 
comparing based on diameters instead of orders, our data are in alignment with Faber and 
with Ohyanagi et al., in that we too found that “larger” arterioles (~100 µm) responded 
more to α2R activation than “smaller” arterioles (~25 µm). However, strictly comparing 
based on arteriolar orders, we were not able to resolve differences among 1A-3A for α2R 
activation.  
Recently, Moore et al. (2010) reported that 1A (versus 2A and 3A) were most responsive 
to α2R activation (via UK 14,304) in the GM of the C57BL/6 mouse. This is in contrast 
to our current data where we observed the greatest responses to UK 14,304 in 2A and 3A 
vessels in the GM of the rat. Albeit, our findings are in direct alignment with work 
completed in the cremaster of the C57BL/6 mouse by Moore et al. (2010). These findings 
highlight the complexity in arteriolar control among different species and experimental 
preparations. Notably, topological differences in microvascular networks between 
different species may contribute to such discrepancies in comparison and interpretation. 
To illustrate, our laboratory has recently published that there are at least 4 orders of 
arterioles (from 1A to terminal arterioles) in the same C57BL/6 mouse (Novielli & 
Jackson, 2014). In contrast, we reported up to 6 orders of arterioles (from 1A to terminal 
arterioles) in the Sprague-Dawley rat GM (Al-Khazraji et al., 2012). The 
microvasculature is designed to provide adequate O2 delivery to the muscle tissue, yet the 
geometry is constrained by the dimensions of the capillary bed (as capillary size does not 
scale with species (West et al., 1997)); therefore, the pre-capillary arterioles should 
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behave the same despite the difference in species. Based on noted differences in network 
complexity, it could be argued that a 4A arteriole in the mouse should be similar 
hemodynamically to a 5A or 6A arterioles in the rat; however this remains to be tested. If 
SNS control of arteriolar networks is order-dependent, then we would expect subtle 
differences in control among species and preparations with differing arteriolar network 
complexities.   
 Topologically-dependent vasoconstrictor response to 
peptidergic control 
In the current study, arteriolar responses to NPY were order-dependent, where 5A was 
70% to 151% more reactive than 1A and 2A (Fig. 4.3, Top panel; P<0.05). As well, 
arteriolar constriction elicited by the highest NPY concentration (EMax; 10-8 M) was 
completely blocked by BIBP3226 (Y1R antagonist; 2x10-8 M) (Fig. 4.3, Top panel; 
P<0.05). EMax values in 4A and 5A were 124 and 71% greater than EMax in 1A and 2A 
respectively (Fig. 4.3, Top panel). Since all arteriolar orders received the same range of 
agonist concentrations and reached plateaus in responses, these EMax data illustrate the 
profound efficacy of NPY in distal versus proximal arterioles. However, there were no 
differences in LogEC50 values across arteriolar orders in response to NPY (Fig. 4.3, 
Bottom panel), illustrating its similar potency among all arteriolar orders.  
Our data are the first to show differential responses to Y1R activation as a function of 
arteriolar order. To date, there have been few studies that have directly investigated the 
effects of NPY on branching skeletal muscle arteriolar trees (from 1A to pre-terminal 
arterioles). Although we believe we are the first to describe NPY effects in locomotive 
skeletal muscle arteriolar networks, Joshua (1991) was the first to examine NPY-induced 
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arteriolar tree vasoconstriction in the rat cremaster studied by IVVM (Joshua, 1991). 
Despite fundamental differences in approach, and that their data were limited to only 3 
generations of arterioles, their findings are in close agreement with those in the current 
study.  
To test the effect of NPY on vascular resistance in the cat gastrocnemius muscle, Ekelund 
& Erlinge (1997) used arterially infused NPY and indirect estimations of resistance 
changes from pressure/bulk flow relationships. Although their data lacked spatial 
resolution (i.e., detailed topology) and simply indicated that NPY provided preferential 
vasoconstriction in small-bore (<25 m) compared to large-bore (>25 m) arterioles, our 
findings are in general agreement.  
Our data further corroborate previous work which showed NPY’s prominent role in 
regulating distal microvasculature (Joshua, 1991; Jackson et al., 2004; Evanson et al., 
2012). However, these past studies were limited in scope and did not provide any 
information on network topology or order dependency. For example, Evanson et al. 
(2012) limited their investigation to isolated 1A vessels from rat gastrocnemius muscle, 
Jackson et al. (2004) made generalized inferences from bulk blood flow profiles 
measured at the femoral artery of rats, and Joshua (1991) limited findings to 3 arteriolar 
orders in non-locomotive skeletal muscle (cremaster).  
 Topologically-dependent vasoconstrictor response to 
purinergic control: Dichotomous effects of ATP  
In the current study, arteriolar responses to ATP were order-dependent, where 4A was up 
to 333% more reactive than 1A (for 10-9  to 10-7 M), 285% more reactive than 2A (at 10-7 
M) and 189% more reactive than 3A (at 10-9 M). ATP exhibited vasoconstriction (at low 
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concentrations) and vasodilation (at high concentrations) (Fig. 4.4). ATP-mediated 
vasoconstriction was primarily a result of P2X1R activation (Fig. 4.5), as vasoconstrictor 
effects were completely blocked by application of NF023 (a specific P2X1R antagonist; 
10-6 M) (Fig. 4.5, P<0.05). While ATP has been more commonly described as a 
vasodilator (Hellsten et al., 1998; Clifford & Hellsten, 2004; Mortensen et al., 2009), the 
vasoconstriction elicited by ATP in this study is in agreement with work reported from 
experiments in the rat tail and hindlimb (Johnson et al., 2001), and the rat heart 
(Hopwood & Burnstock, 1987).  
ATP acts on P2X receptors, located on the abluminal smooth muscle of the vessel (Hirst 
& Jobling, 1989), as well as P2Y receptors (responsible for dilation), located on the 
intraluminal endothelium (Burnstock, 1996). In the current study, ATP promoted 
vasoconstriction in all arteriolar orders at 10-9 and 10-8 M, (Fig. 4.4, P<0.05). However, 
with progressive increases in ATP concentration (10-6 and 10-5 M), we observed 
vasodilation in all arteriolar orders (P<0.05). Interestingly, similar ATP concentrations in 
exercising human skeletal muscle have been reported, where interstitial ATP levels 
(measured from intramuscular microdialysate) ranged between 2 to 5 x 10-6 M, 
depending on exercise intensity (Hellsten et al., 1998).  
During micropipette application of ATP to arterioles in the hamster cheek pouch 
preparation, the vasodilator effect of interstitial ATP was suggested to be mediated (in 
part) by the formation of adenosine (from ATP degradation) via 5’-ectonucleotidase 
activity (Duza & Sarelius, 2003). This mechanism of ATP-mediated dilation (via 
breakdown to adenosine) would then differ from intravascular ATP-mediated dilation 
which is solely based on ATP binding onto P2Y receptors residing on the endothelium 
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(and is independent of adenosine’s vasodilatory effects). While Duza and Sarelius applied 
ATP at concentrations of 10-7 M to10-3 M, we used lower concentrations of ATP (10-9 to 
10-7 M), which elicited vasoconstriction. Our conditions correspond to interstitial ATP 
concentrations measured with intramuscular microdialysis at baseline in humans 
(Mortensen et al., 2011). The results from the current and past experiments suggest that 
5’ectonucleotidase is either not active at low concentrations of ATP, or that the 
breakdown of ATP to adenosine does not override the vasoconstrictor effects of ATP for 
these concentrations.  
We recently reported that vasodilation, and ensuing blood flow changes, in response to 
high ATP concentrations (10-6 and 10-5 M) can be abolished by L-NA and indomethacin 
in the rat GM. Thus, the vasodilator effects of high abluminal ATP concentrations are best 
explained by NO and prostanoid formation, respectively (Nyberg et al., 2013). Certainly, 
ATP can diffuse from the interstitial space into the vessel lumen and to invoke P2Y-
mediated vasodilation; however a 50-fold difference in ATP concentration difference 
across the vessel wall is required for this cross over to occur (Mo & Ballard, 2001). 
Notably, the whole blood concentration of ATP in the Sprague Dawley rat is 3 to 510-6 
M (Jagger et al., 2001), which would lead to no net flux of ATP from the interstitium to 
the blood in the current study. Thus, vasodilation induced by 10-6 to 10-5 M [ATP] in our 
study cannot be due to diffusion and subsequent P2Y activation.  
When applying ATP in the face of P2X1R blockade, ATP acted as a vasodilator at all 
concentrations (Fig. 4.5, P<0.05). These data suggest that ATP-induced vasodilation 
buffers its vasoconstrictor effects at all (physiologically relevant) concentrations. This 
was further corroborated by the pure vasoconstrictor effect of -meATP (Fig. 4.6) (also 
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blocked by NF023, highlighting vasoconstriction was specific to P2X1R activation), an 
ATP analogue that does not degrade at the same rate as ATP with high affinity for P2X1R 
receptors.  
Based on our findings and that of previous work, we conclude that ATP acts as a 
vasoconstrictor in skeletal muscle so long as it 1) is not degraded to adenosine, 2) cannot 
cross over into the lumen to act on P2Y receptors, and/or 3) is available at low 
concentrations, as high concentrations of ATP induce NO and prostacyclin formation 
(Nyberg et al., 2013) which masks ATP’s capacity to vasoconstrict (Fig. 4.5). The 
dichotomous roles of ATP may serve to optimize resistance and perfusion pressure in 
contracting muscle (in areas of lower concentration) and, in areas of high concentration, 
participate in localized exercise-induced functional sympatholysis (Kirby et al., 2011). 
 Computational findings: Total network resistance and flow 
changes as a result of a differential distribution of 
receptors for sympathetic neurotransmitters 
The inlet, or 1A, vessel to the arteriolar network provides the bulk flow to the outlets (or 
all the 5A vessels); therefore, having access to tree geometry allows for calculation of 
“upstream” and “downstream” effects on hemodynamics as a result of topologically-
dependent differential responses of arterioles to activation of receptors for sympathetic 
neurotransmitters. The ability to assess the “up/downstream” effects is unique to network 
analysis, and underscores the benefit of analyzing networks of interconnected 
bifurcations, as opposed to acquiring data from single sites of observation (Pries et al., 
1995c).  
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In our previous work, we speculated that Y1R blockade (via BIBP3226) modulated 
downstream systemic vascular resistance, as shown by changes in diastolic conductance 
of the rat hindlimb (Jackson et al., 2004). A remarkable outcome of our present 
hemodynamic calculations was that NPY greatly contributed to total network resistance. 
NPY decreased calculated network flow to the same degree as PE (Fig. 4.9); however, 
NPY operated in a range of concentrations that were 1000x lower than PE. Per mole of 
concentration, it can be stated that NPY is a more potent vasoconstrictor, and therefore 
greatly contributes to resistance, when compared to either PE or UK 14,304 alone. As 
previously stated, this highlights the importance of understanding the consequent 
implications of neurotransmitter contribution, despite its concentration in the interstitial 
milieu. Microvascular surface area increases with progressively increasing arteriolar 
order, with the greatest level of surface area exhibited by the capillaries (Poole et al., 
2013).  
 Order and diameter-dependent changes in RBC 
heterogeneity as a result of a differential distribution of 
receptors for sympathetic neurotransmitters 
Progressing down the arteriolar network, there is an increase in the number of arteriolar 
bifurcations, and a progressive decrease in hematocrit of single vessels for a given order 
(compared to parent orders) (Pries et al., 1986). This assists in providing a baseline level 
of heterogeneous RBC delivery to capillary beds, where RBC flow preference is given to 
the daughter with the greater diameter (or path of lower resistance). It follows that small 
changes in resistance at the smaller (distal) arterioles, will result in robust changes in 
hematocrit (Pries et al., 1990).  
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Traditionally, dilatory mechanisms have been put forth as the primary means for RBC 
distribution within the microvasculature (Clifford & Hellsten, 2004). From our 
experimental data, we illustrate that sympathetic ligands can promote differential and 
topologically-dependent changes in resistance for a wide range of ligand concentrations. 
We postulate that this is carried out through differential SNS control across the 
microcirculation. A topologically-dependent arrangement of sympathetic control would 
enable the SNS to coordinate with intrinsic dilatory mechanisms to precisely titrate RBC 
delivery throughout the network. With regards to the concept of phase separation, where 
blood flow fraction delivery is more sensitive to changes in resistance of smaller 
compared to larger arterioles (Pries et al., 1990), topologically-dependent SNS receptor 
activation warrants large hemodynamic consequences in terminal arterioles feeding into 
capillary beds. 
 Conclusion 
To conclude, we have comprehensively and systematically determined network responses 
to cumulative concentrations of specific sympathetic agonists among 5 arteriolar orders, 
and used these responses to mathematically determine the functional consequence(s) of 
heterogeneous sympathetic receptor distribution on network hemodynamics. We have 
shown differential responses to sympathetic ligands along the arteriolar tree, such that 
proximal arterioles are largely under adrenergic control, while distal arterioles are largely 
under peptidergic and purinergic control. Using computational modelling, we calculated 
that the adrenergic component of blood flow regulation is mainly responsible for 
maintaining total flow to the tissue, while the peptidergic and/or purinergic component(s) 
contribute both to total network resistance/flow and to RBC flow distribution within the 
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network. Finally, we have indicated that alongside the adrenergic system, the peptidergic 
and purinergic components of the SNS carry out integral roles in sympathetically-
mediated microvascular control.  
Our theoretical model illustrates that, due to topologically-dependent modulation, the 
SNS affects RBC heterogeneity differentially at each arteriolar order (Fig. 4.11). Under 
baseline healthy conditions, such control would contribute to setting baseline resistance 
and RBC distribution. At the onset of both healthy aging (Narkiewicz et al., 2005) and 
cardiovascular diseases (Malpas, 2010), there exist concomitant increases in SNA, which 
may then act to exaggerate blood flow heterogeneity (Jackson et al., 2010) and further 
exacerbate microvascular dysfunction, perhaps via upregulation of any or all of the 
receptors for sympathetic neurotransmitters. Certainly, in high stress conditions, Y1R is 
upregulated in microvessels of injured carotid arteries (Li et al., 2005); as well, 
hypertensive patients have shown increased P2X1R activation (Steinmetz et al., 2000; 
Hollah et al., 2001). Our model flow calculations showed that (compared to PE and UK) 
NPY and ATP produced higher RBC flow heterogeneity (relative to baseline) in distal 
(5A) vessels (Fig. 4.11), indicating that heightened SNS receptor activation, as in disease 
conditions, would elicit detrimental consequences to RBC delivery.  
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 Development of the gluteus maximus skeletal muscle 
preparation 
The investigation of in vivo skeletal muscle hemodynamics is greatly limited by 
inaccessibility to vascular networks of interest, and a lack of effective methods for 
acquiring in vivo hemodynamic parameters. In the thesis herein, we introduced a novel 
rat gluteus maximus (GM) skeletal muscle preparation which allows the greatest level of 
access to a microvascular network compared to any other published skeletal muscle 
preparation (i.e., widest range of reported vessel diameters, and orders). This high level 
of accessibility comes as a result of 3 characteristics intrinsic to the preparation: 1) there 
is an inherently large microvascular network (compared to mouse GM) due to a large 
mass of skeletal muscle which requires a greater blood supply, 2) the GM muscle is a 
highly active locomotive muscle which requires dense vasculature for maintaining 
adequate tissue metabolic integrity (Bearden et al., 2004), and 3) the GM tissue is a thin 
muscle which allows for easy tissue transillumination, where its microvasculature is 
optimally positioned such that the entire network (arteriolar/venular trees, capillaries) is 
in a single focal plane (with minimal adjustment in fine focusing). 
Through use of this GM preparation, we were able to nearly simultaneously scan multiple 
orders of arterioles for characterizing red blood cell velocity profiles as a function of 
vessel diameter, and evaluate vasoconstrictor responses from sub- to supra-physiological 
concentrations of 4 different sympathetic nervous system receptor agonists in multiple 
sequentially connected arteriolar orders. We took advantage of the planar layout of the 
vasculature and collected overlapping microscopic images of the arteriolar network such 
that we were able to computationally reconstruct an arteriolar network while preserving 
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its native in vivo geometry. This reconstructed network served as the basis for calculating 
hemodynamic parameters (e.g., blood flow, resistance, and red blood cell flow 
heterogeneity) as a consequence of topologically-dependent activation of sympathetic 
nervous system receptors for neurotransmission. 
The utility of the GM preparation has begun to receive recognition, as it has been recently 
used alongside cellular and human data to show that interstitial ATP-mediated dilation in 
the microvasculature is dependent on prostanoid and nitric oxide formation in the rat GM 
muscle (Nyberg et al., 2013). Additionally, the GM preparation was adapted for use in 
the hamster, where its data were compared to those from the rat cremaster which showed 
prostaglandins were involved in contraction-induced vasodilation in microvascular 
networks that were not secondary to the presence of extraluminal adenosine (Murrant et 
al., 2014). As the GM preparation is one of the few true locomotive skeletal muscle 
microvascular preparations, it is foreseeable that it will continue to serve as a standalone 
microvascular preparation, or at least, accompany data collected from other in vivo 
preparations as a form of data validation or correlation.  
 Development of a method for calculating blood flow in 
fast-flowing arterioles 
While blood flow techniques have been greatly improved upon, pushing past some of the 
previous limitations, the acquisition of centerline velocity via dual sensor technique, and 
assuming the Baker Wayland ratio of 1.6 (Baker & Wayland, 1974) for blood flow 
calculations remains to be the most utilized method for calculating in vivo blood flows in 
skeletal muscle microvascular networks (Duling et al., 1982; Segal & Duling, 1987; 
Hester & Duling, 1988; VanTeeffelen & Segal, 2006; Jackson et al., 2010).  
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The wide use of the Baker Wayland ratio of 1.6 is a direct consequence of limited data 
characterizing in vivo skeletal muscle velocity RBC profile shapes, as use of this ratio has 
been criticized for introducing errors in velocity, and therefore blood flow calculations 
(Pittman & Ellsworth, 1986; Tangelder et al., 1986). These limitations arise as a result of 
both utilizing skeletal muscle preparations which provide access to a narrow range of 
vessel diameters, and the lack of a blood flow measurement technique which can be used 
to acquire in vivo velocity profile shapes for a large range of diameters.  
Following the development and refinement of the GM preparation, we employed use of 
fluorescently-labeled red blood cells to act as tracers within the microvascular network in 
the GM muscle. As these labeled red blood cells maintained their intrinsic characteristics 
(e.g., biconcavity, and deformability), and the fraction of injected labeled red blood cells 
(1% of total blood volume) did not affect total hematocrit within the system, these 
fluorescent red blood cells acted as flow tracers which were representative of the native 
red blood cell flow patterns found within the microvasculature. Limiting the in vivo 
labeled fraction of red blood cells to 1% allowed for high contrast imaging between the 
labeled and unlabeled red blood cells. We then took advantage of our dual bright-
field/epi-fluorescent microscopy system by optimizing camera exposure time during data 
acquisition. This allowed for these labeled red blood cells to form “streaks” of light along 
the vessel, displaying distance traveled in the time that the camera shutter was opened 
and closed, thus providing a way to measure in vivo red blood cell velocities. With the 
increase in network visibility provided by the GM preparation, we were able to measure 
these velocities across the vascular lumen, for an entire arteriolar tree spanning multiple 
branch orders. These data are the first of their kind for providing much needed 
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information on velocity profile shapes in skeletal muscle microvasculature that can be 
immediately implemented in blood flow calculations. 
For true parabolic velocity profiles, the fixed velocity ratio (VMax/VMean) would be 2, as 
the centerline velocity would be twice that of the mean velocity through the vessel. Baker 
and Wayland (Baker & Wayland, 1974) discovered that the average velocity profile 
through glass tubes had a blunted velocity profile shape where the centerline velocity was 
1.6 times greater than the mean velocity averaged over the lumen. While Baker and 
Wayland assumed a parabolic velocity profile, the resulting velocity ratio factor of 1.6 
comes as a consequence of spatial averaging that is inherent to the dual sensor red blood 
cell velocity measurement technique. Certainly, in vivo findings collected from the rabbit 
mesentery preparation have contradicted a constant velocity ratio for all diameters, as 
these velocity ratios were determined to be diameter-dependent (Tangelder et al., 1986).  
The consequences of assuming a fixed velocity ratio are striking, as subsequent blood 
flow calculations would thereby over- or under-estimate blood flow values compared to 
using a diameter-dependent velocity ratio value. Specifically, our data show that using a 
velocity ratio of 1.6 for calculating blood flow in arterioles with diameters less than or 
greater than ~65 μm would result in under- and over-estimation of blood flow by up to 
20%, respectively. Similar to Tangelder et al, in the thesis herein, we also developed a 
diameter-dependent velocity ratio equation; however, the equation we provide, to our 
knowledge, is the first to describe diameter-dependent velocity ratios for skeletal muscle 
arterioles for a wide range of arteriolar diameters encompassing feed to pre-terminal 
arterioles (compared to a range of 17-32 µm in the rabbit mesentery (Tangelder et al., 
1986)). As well, the velocity ratio equation provided in this thesis (Chapter 2) 
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encompasses a large range of diameters, allowing it to be accessible for use in other 
microvascular preparations. As previously mentioned, data acquisition via use of the dual 
sensor technique is widely accepted, with many fundamental advancements in the field of 
microcirculatory hemodynamics made through its use. Certainly, we do not suggest that 
the dual sensor technique (or other red blood cell velocity measurement techniques) be 
replaced by use of our fluorescently-labeled red blood cell velocity measurement 
technique. We do recommend that our diameter-dependent velocity ratio equation be 
used, in conjunction with these measurement techniques, to determine an appropriate 
velocity ratio for use in blood flow calculations, as opposed to utilizing a constant 
velocity ratio such as the Baker Wayland ratio of 1.6. It should be noted that we 
recommend that the experimentally-derived velocity ratio equation be constrained for use 
in arteriolar diameters within the appropriate diameter range (21-115 µm). 
Indeed, there are other groups who have identified a velocity ratio equation that varies 
with hemodynamic parameters. For instance, in the seminal work carried out by Pittman 
and Ellsworth (1986) in the arterioles and venules of the hamster retractor muscle, a 
velocity profile bluntness parameter (“B”) was estimated as a function of both diameter 
and the centerline dual sensor velocity. This parameter has been beneficial in determining 
velocity ratios for use in mathematical modelling of the rat mesentery (Pries et al., 1989); 
however, as highlighted in their conclusions (Pittman & Ellsworth, 1986) their study was 
not based on absolute in vivo velocity calibrations such that any estimates made using 
their bluntness factor are subject to confounding variables that are inherent in the use of 
the dual sensor technique. Despite the fact that their bluntness parameter was not based 
on in vivo velocity calibrations, use of this parameter in calculation of velocity ratios is 
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far more advantageous than assuming a fixed velocity ratio. Our velocity ratio equation, 
described in the thesis herein, was derived from in vivo red blood cell velocity 
calibrations and only requires diameter as an input variable which can easily be collected 
from intravital experiments.  
Moreover, the diameter-blood flow relationships acquired using our “streak length” 
velocity measurement technique was in accordance with diameter-blood flow 
relationships for both the rat cremaster muscle (Mayrovitz & Roy, 1983; House & 
Lipowsky, 1987), and the theoretical “cubic law” first described by Murray (Murray, 
1926). Therefore, we prescribe use of our velocity ratio equation over others as it is 
derived from in vivo red blood cell velocity measurements, and the diameter-blood flow 
relationship derived in our study is in agreement with that found by other groups.  
 Use of in vivo red blood cell velocity profiles for 
estimating wall shear stress 
Shear rate, or as commonly referred to pseudoshear rate, estimates the average shear rate 
across a vessel lumen, and requires input of mean velocity across lumen and lumenal 
diameter. At low shear or pseudoshear rates, red blood cell aggregation increases and 
effective viscosity increases, attributing to the shear-thinning non-Newtonian behavior of 
blood (Chien et al., 1967). Similar to blood flow calculations, the Baker Wayland ratio is 
used to convert centerline red blood cell velocity to acquire mean velocity values for use 
in calculating wall shear rate and stress and pseudoshear rate in microvascular 
preparations. In the thesis herein, we showed that using a constant velocity ratio, such as 
the Baker Wayland ratio of 1.6, would result in up to 25% difference in calculated values 
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compared to using our diameter-dependent velocity ratio function (Al-Khazraji et al., 
2012). 
The widely accepted method for calculating wall shear rate, and wall shear stress, is 
dependent upon the assumption that the fluid flowing through a vessel segment is 
Newtonian (shear rate independent), follows a parabolic velocity profile as predicted by 
Poiseuille’s law flow behaviour, and that this velocity profile shape is constant across the 
entire vascular network (Hester & Duling, 1988). It has been shown that the acceptance 
of these assumptions causes errors in wall shear stress calculations (Reneman et al., 
2006; Katritsis et al., 2007); however, these assumptions are required due to the difficulty 
in acquiring in vivo velocity profile data. The techniques developed in the thesis herein 
allowed for computation of wall shear rates from in vivo velocity profiles for a range of 
arteriolar diameters (21-115 µm). These wall shear rates were 2-3× greater than those 
calculated from conventional approaches (Chapter 3, Fig. 3.8), and we were able to 
resolve differences between the various calculation methodologies.  
It may be argued that any error resulting from conventional wall shear rate calculations is 
carried through; therefore, the absolute values of shear stress are not as important as the 
relative changes in shear rate between groups or for a given treatment. However, it is 
imperative to recognize that the discrepancy between calculated values is dependent upon 
the strong assumption that velocity profile shape is independent of diameter, and profile 
blunting can be incorporated into hemodynamic calculations by using a velocity ratio of 
1.6. In fact, the calculation error is not linearly carried through for all diameters, as there 
is an under- and over-estimation of shear rate calculations depending on the arteriole of 
investigation (when comparing values calculated using a constant velocity ratio against 
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values calculated from use of diameter-dependent velocity ratios). Moreover, despite 
modifying the conventional wall shear rate equation to include velocity ratios as a 
function of diameter, the computation of wall shear rates under Poiseuille parabolic 
assumptions greatly underestimates wall shear rates compared to those derived from in 
vivo velocity profiles. With these reasons in mind, the discrepancy in values become 
more meaningful as they are grounded by assumptions which are deemed invalid by both 
theoretical (Sriram et al., 2014) and experimental evidence (Reneman et al., 2006; 
Reneman & Hoeks, 2008). Overall, the wall shear rate values calculated using our 
velocity profiles were significantly greater than the values calculated using conventional 
methods.  
Certainly, the acquisition of velocity profiles required for the evaluation of in vivo wall 
shear rate and stress is challenging. With the “streak length” velocity measurement 
technique, we were able to acquire in vivo velocity profile data across numerous arteriolar 
orders; however, the most salient finding from this analysis was the development of a 
straightforward function for use alongside other velocity measurement techniques. 
Similar to the practical function we provided earlier, describing the relationship between 
arteriolar order and the velocity ratio required for in vivo blood flow calculations 
(Chapter 2, Equation 2.5), we described an equation which relates arteriolar diameter and 
centerline velocity to wall shear rate (Chapter 3, Equation 3.12). The utility of this 
equation can be extended to numerous aforementioned velocity and diameter 
measurement techniques that have been regularly used in in vivo experiments 
investigating control of skeletal muscle microcirculation. As well, due to the derivation of 
the equation (i.e., confined to the red blood cell free layer located between the edge of the 
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red cell column and the inner lumenal wall), plasma viscosity is required for calculating 
wall shear stress. Plasma viscosity is mostly dependent on protein content (Kesmarky et 
al., 2008), rather than vessel diameter, therefore it is acceptable to use a constant plasma 
viscosity value for calculating wall shear stress from wall shear rate values (Namgung et 
al., 2011).  
 Recent use of “streak length” method in skeletal muscle 
microvascular studies 
As previously mentioned, from the time of its development, the rat GM preparation has 
since been put to use by groups investigating skeletal muscle microvascular control 
mechanisms in both the rat (Nyberg et al., 2013) and hamster GM muscles (Murrant et 
al., 2014). In our collaborative study with Nyberg et al., we also implemented the “streak 
length” red blood cell velocity measurement technique and were able to calculate changes 
in blood flow responses as a result of superfusion of ATP corresponding to interstitial 
ATP concentrations found during exercise. We were then able to recover these responses 
by blocking endothelial-mediated prostanoid and nitric oxide formation via superfusion 
of indomethacin and L-NA, respectively.  
The results from this study demonstrate, for the first time, that increasing ATP 
concentration of skeletal muscle interstitial fluid, to concentrations measured in human 
and animal skeletal muscle interstitium during muscle contractions, results in both 
vasodilation and ensuing increases in blood flow within the skeletal muscle. This study 
was greatly strengthened by use of the GM and the “streak length” method for reasons 
described by: 1) experimental data were collected from a locomotive muscle resembling 
that of human muscle, 2) infusion of ATP via dialysis probes into human skeletal muscle 
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only results in local hemodynamic changes; therefore blood flow responses are 
undetectable, whereas the GM preparation coupled with the use of the “streak length” 
technique was able to provide detectable changes in blood flow responses, and 3) the GM 
preparation allowed for direct observation of vasodilation and blood flow responses, 
thereby confirming that ATP’s actions are located within the microvasculature. These 
findings greatly contribute to and corroborate findings in the human and rat 
microvascular endothelial cell data, and provide insight to the mechanisms associated 
with the interstitial ATP vasodilation response. 
More recently, our laboratory has for the first time described the blood flow responses 
associated with the attenuation of vasodilation found in the skeletal muscle of pre-
diabetic mice under electric field stimulation. Under both single tetanic and rhythmic 
muscle contraction paradigms, blood flow responses in branching arterioles of the pre-
diabetic mouse GM muscle were attenuated by 50 to 80%, respectively, compared to that 
of control (Novielli & Jackson, 2014).  
The use of fluorescently-labeled red blood cells in these experiments provides 
noteworthy advantages over the traditional method of solely collecting diameter data, 
followed by inferences made on changes in blood flow. Previously, the assumption was 
that the velocity profile shape (and therefore the velocity ratio) is not only diameter 
independent for baseline values, but is also independent of diameter changes that 
accompany vasodilation responses to muscle contraction. As previously stated, we found 
a strong linear relationship between arteriolar diameter and velocity ratio (a surrogate for 
velocity profile shape), therefore assuming a fixed velocity ratio of 1.6 would result in 
over- and/or under-estimation of hemodynamic responses to contraction both within and 
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between control and pre-diabetic groups; and 2) use of the “streak length” velocity 
measurement technique provided instantaneous hemodynamic data collection alongside 
the collection of geometrical data both during and after muscle contraction. This novel 
advancement in data collection provides insight on the time-course associated with blood 
flow responses to contraction. With our intravital video microscopy setup, we are able to 
acquire high frame rates, which allowed for minimal time spent on acquiring fluorescent 
red blood cell data, in between tracking arteriolar diameter changes throughout both 
contraction paradigms.  
 Use of “streak length” method for the validation of an in-
house computational flow model 
Finally, in vivo blood flow calculations determined by using the “streak length” technique 
have been used to validate our in-house computational flow model blood flow 
calculations. The planar geometry of the rat GM allowed for direct mapping and 
reconstruction of network geometry, which was used for network flow analysis by 
incorporating our computational flow model. The computational flow model assumed a 
fixed pressure drop across the reconstructed arteriolar network, and calculated blood flow 
based on resistance values calculated with input of arteriolar diameter measurements. 
When compared as functions of diameter, the slope and y-intercept values for the 
computational versus experimental blood flow calculations were similar, thereby 
validating the calculated outputs of our computational model. As this validation using 
data collected under baseline conditions, we were able to estimate hemodynamic changes 
that accompany changes in arteriolar diameters under the activation of sympathetic 
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nervous system receptors by incorporating the calculated levels of resistance from 
vasoconstrictor experimental data (Chapter 4). 
Moreover, the benefit of validating our computational flow model is that we can now 
compute hemodynamic parameters that are otherwise difficult to acquire experimentally. 
For instance, while mapping the network geometry under bright-field microscopy is 
straight-forward (under stable hemodynamic conditions), acquiring “streak” velocity data 
for the entire network may prove to be challenging as there is a finite amount of 
fluorescent exposure the muscle can endure prior to being subject to fluorescent leakage 
from the labeled red blood cells. Fluorescent leakage is problematic as it results in a 
drastic decrease in contrast between the labeled red blood cells and the background. As 
we have collected experimental blood flow values for a large range of arteriolar 
diameters, the validation of the computational model implies that the model can 
interpolate blood flow values, for a greater number of vessel segments than what would 
be experimentally feasible. 
The computational flow model can also be used to estimate flow changes during 
application of superfused agonists. The model relies on the input of diameter values at 
each node (i.e., one end of a finite vessel segment) of the reconstructed network, inlet 
hematocrit, and both inlet and outlet pressure values. Arteriolar diameters are acquired 
from in vivo data collection, inlet hematocrit is approximated to be near systemic values, 
with an assumed fixed pressure drop across the network. From these hemodynamic 
parameters, resistance is measured for each vascular segment, followed by calculation of 
theoretical blood flow values. In the thesis herein, we evaluated vasoconstrictor responses 
to several sympathetic nervous system receptor agonists across multiple consecutively 
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branching arteriolar orders. Our computational flow model was able to estimate changes 
in total resistance and blood flow throughout the entire reconstructed network, as well as 
red blood cell flow heterogeneity at each order in response to each receptor agonist. 
 Use of the rat GM for investigating SNS receptor 
functionality in branching arteriolar trees 
The findings from this thesis include topologically-dependent responses to the activation 
of 4 SNS receptors in 5 consecutively branching arteriolar orders of the rat GM muscle. 
The collected data highlighted in this thesis represent the most comprehensive evaluation 
of SNS receptor activation in skeletal muscle arteriolar networks to date. Indeed, our 
work builds upon and is in agreement with other studies (Faber, 1988; Joshua, 1991; 
Ohyanagi et al., 1991; Ekelund & Erlinge, 1997; Gitterman & Evans, 2000; Moore et al., 
2010) whose findings are summarized by Fig. 1.1 (Chapter 1); however, the work herein 
is the first of its kind to assess the topological dependence of adrenergic, purinergic, and 
peptidergic receptor activation in branching arteriolar segments of skeletal muscle 
microvasculature. Moreover, we are the first to estimate the ensuing changes in 
hemodynamic parameters as a result of topologically-dependent responses to SNS 
receptor activation.  
Classically, the role of the SNS on skeletal muscle microvascular regulation has been 
understood to be primarily carried out through adrenergic control. This view has evolved 
from several experimental designs; namely: 1) upon either sympathetic neuronal 
stimulation (Marshall, 1982), or activation of adrenergic receptors via sympathetic 
agonist delivery (Faber, 1988; Ohyanagi et al., 1991; Moore et al., 2010), the sites of 
observation used in other studies for assessing vasoconstrictor responses were acquired 
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from proximal arterioles (1A to 3A) and did not include data from distal (4A to terminal) 
arterioles, and 2) while activation of purinergic P2X1 receptor (Buckwalter et al., 2003) 
or NPY Y1R (Jackson et al., 2004), via infusion of specific SNS receptor agonists, 
resulted in substantial increases in downstream resistance, activation of both Y1R and 
P2X1R have not been investigated using IVVM experiments; thus, it was unclear 
whether increases in resistance were due to vasoconstrictor responses at the feed artery, 
or downstream within the distal microcirculation. 
The first experimental limitation was due to either a deliberate design in experimental 
protocol such that data were collected up until 3A vessels, or a significant increase in 
difficulty acquiring data beyond 3A vessels. In the case that the experimental protocol 
had been designed to limit data collection to 3A vessels, then importance was not placed 
on data collection beyond 3A. However, if data collection did not go beyond 3A vessels 
due to a lack of adequate visibility, then it is necessary to develop a preparation which 
allows for appropriate visibility of all vessels. 
The second experimental limitation is also due to the lack of an appropriate skeletal 
muscle model for investigating the purinergic and peptidergic responses. However, 
similar to previous adrenergic data, the observation of purinergic and peptidergic 
vasoconstrictor responses were nevertheless possible at 1A-3A vessels. To our 
knowledge, there is a finite number of studies evaluating purinergic and peptidergic 
(Joshua, 1991) vasoconstrictor responses in skeletal muscle microvasculature; thus, 
limited purinergic and peptidergic responses may have been limited due to a lack of 
investigation.  
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 Topologically-dependent SNS receptor activation and 
ligand contribution 
We showed that proximal (1A to 3A) arterioles are more responsive to α1R and α2R 
activation than distal arterioles. Interestingly, the LogEC50 among the 5 arteriolar orders 
was different during α1R activation (with phenylephrine, specific α1R agonist, being 
least potent in 5A arterioles). There was no difference in LogEC50 among the 5 arteriolar 
orders during UK 14,304 delivery (specific α2R agonist). The maximal efficacy to each 
of phenylephrine and UK 14,304 was significantly greater for proximal versus distal 
arterioles.  
We showed that for a wide range of concentrations, ATP elicited a dichotomous response 
in arterioles: constriction at low concentrations (10-9 to 10-8 M), and dilation at higher 
concentrations (>10-6 M) of ATP. Finally, we showed that distal arterioles are more 
responsive to Y1R activation than proximal arterioles. The LogEC50 among the 5 
arteriolar orders was not different during Y1R activation; however, the maximal efficacy 
to NPY was significantly greater for distal versus proximal arterioles.  
By strict comparison of agonist concentration, NPY is approximately 1000x more potent 
than the other SNS receptor agonists. Certainly, norepinephrine would cause a maximal 
efficacy much greater than that of phenylephrine and UK 14,304 (Moore et al., 2010); 
however, despite the lack of norepinephrine data, we predict NPY would remain more 
potent even if these key data had been collected. The potency of NPY is evident even at 
physiological resting concentrations, where it is available at a 1000× lower concentration 
than that of norepinephrine (Abd-Allah et al., 2004; Hirsch & Zukowska, 2012). In terms 
of equivalent concentrations, the baseline levels of norepinephrine (10-9 to 10-8 M) would 
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correspond to the concentration of NPY during high stress conditions such as during 
hemorrhaging shock in the rat (Hirsch & Zukowska, 2012). While the current dogma 
upholds adrenergic control as the primary determinant of microvascular regulation, our 
data strongly support considering a shift in this paradigm. Explicitly, although the 
absolute baseline concentration of norepinephrine is higher than that of NPY, the 
potential contribution of NPY is greater than that of norepinephrine; thus, it is necessary 
to revisit the classic “adreno-centric” model of SNS-mediated regulation of skeletal 
muscle microvasculature.  
 Importance of collecting data from microvascular 
networks 
Using the rat gluteus maximus muscle, we were successful in evaluating adrenergic, 
purinergic, and peptidergic receptor activation for arteriolar orders beyond 3A. This is 
due to the aforementioned clear visibility provided by the preparation itself, coupled with 
intravital video microscopy and adequate care of the muscle during experimentation (e.g., 
constant superfusion of physiological salt solution with maintained temperature) in order 
to uphold tissue integrity. Vasoconstrictor responses due to adrenergic receptor activation 
have been evaluated in the mouse GM preparation (Moore et al., 2010), although this 
study did not consider responses beyond 3A arterioles.  
Our laboratory has recently investigated the effects of pre-diabetes in response to muscle 
contraction on branching arterioles in the mouse GM muscle. Data from this study were 
from branching arteriolar tree segments that included 4A arterioles, where the 4A 
arterioles were represented as terminal or pre-capillary arterioles which immediately 
preceded capillary networks (Novielli & Jackson, 2014). In fact, one of the key findings 
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of this study was that reactivity of these 4A vessels was most affected in pre-diabetic 
conditions, thereby having the greatest impact on red blood cell distribution to capillaries 
(Pries et al., 1989). Similarly, in the thesis herein, the vasoconstrictor responses to SNS 
receptor activation is an integrated response to change in resistance throughout the 
network. These findings underscore the importance of evaluating complete arteriolar 
trees, as fundamental data predicting red blood cell distribution can be understood from 
analyzing hemodynamic data at arteriolar orders beyond 3A. 
 Future Studies 
 Experimental values of hematocrit 
By fluorescently labeling red blood cells, we are able to single out a red blood cell as it 
travels through the vessel segment of interest. Theoretically, use of flow cytometry 
should allow us to calculate how many red blood cells are represented by a single 
fluorescently-labeled red blood cell (i.e., what fraction of total red blood cells does a 
single fluorescent cell represent?). Thereafter, quantifying the number of fluorescent cells 
across a vessel segment is straightforward, as the fraction of labeled cells is low, allowing 
for high contrast between labeled and unlabeled portions. Once a finite number of labeled 
cells are quantified, the data from flow cytometry can be used to determine the total 
number of red blood cells present in the vessel segment of interest.  
While this approach is simple to follow in theory, it is difficult to put into practice. A 
vessel segment is assumed to be modeled by a cylindrical geometry, where the wall 
buckling phenomenon (Davis, 2005) is considered negligible in classical blood flow 
calculations. Using intravital video microscopy, we observe a single plane through a 
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blood vessel, where the longitudinal height of that plane is limited to the focal depth. 
While it may seem simple to count the number of fluorescent red cells in a given plane, 
the fundamental limitation with calculating experimental hematocrit using the described 
method would be the potential leakage of fluorescent signal from red blood cells outside 
of the plane of interest. The issue of fluorescent signal leakage would raise concern 
because it would result in inaccuracies (i.e., an over-estimation) in hematocrit 
calculations.  
Future in vivo studies involving use of the “streak length” method should include data 
that scans through the entire depth of the vessel segment, in addition to focusing on the 
center plane where the most accurate measure of diameter can be made. By scanning 
through the depth of the entire vessel lumen, one can approach hematocrit counts by two 
proposed methods: 1) Acquire finite number of video segments at each incremental step 
through each of the planes of the vessel segment (plane width can be user-defined), 
followed by off-line analysis of fluorescent red blood cell incidence in each of the frames 
for each plane. The total number of labeled cells can be used to determine total number of 
red blood cells via use of flow cytometry. 2) Acquire a single video spanning the entire 
depth of the vessel segment, and recreate this video using z-stacking software. Thereafter, 
the labeled red cells would be quantified and through use of flow cytometry the total red 
cell fraction through that segment can be calculated.  
From these two proposed approaches to calculating experimental hematocrit, the first 
approach, although more methodical, is predicted to be more experimentally feasible to 
carry through compared to the second approach. The second approach assumes that the 
final z-stacked vessel segment would be temporally equivalent throughout the segment; 
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however, each frame throughout the volume reconstruction of the segment would in fact 
be temporally out of sync with the subsequent collected frame. This assumption is not 
necessary nor is it implied in the first approach, whereas the individual video segments 
from the first approach would resolve any temporal issues as data are averaged 
throughout the video segment, and does not rely on a single frame to be representative of 
the flow behavior throughout the segment. 
With hematocrit values, it would then be possible to calculate viscosity and develop an 
experimentally-derived tube hematocrit to discharge hematocrit relationship (originally 
theoretically derived by Pries et al.) that would be specific to skeletal muscle arterioles. 
As well, the Fahraeus effect, describing how hematocrit changes with diameter, can be 
derived experimentally and be purposeful for validation of computational flow analysis. 
As well, with the collection of experimental hematocrit values, it would be beneficial to 
assess the plasma skimming effect across the vascular network, primarily focusing on 
blood flow from pre-terminal arterioles to capillaries. In vivo hematocrit data would 
introduce the opportunity to assess numerous other hemodynamic questions, such as (but 
not limited to): What is the effect of arteriolar diameter on shear rate variability? How 
does the activation of SNS receptors affect RBC distribution?  
 Sympathetic nervous system co-transmission of 
neurotransmitters 
Our analysis evaluated vasoconstrictor responses due to activation of one SNS receptor at 
a time. While these findings highlight essential information regarding the topologically-
dependent nature of SNS receptor functionality, the experimental design does not model 
the physiological case of co-transmitter release. To build upon our findings, future 
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experiments should entail the evaluation of vasoconstrictor responses to co-delivery of 
norepinephrine and/or ATP, and/or neuropeptide Y, as well as the combined delivery of 
all three agonists. 
 Other topics of interest 
Future studies should aim to answer the following: 1) characterizing homology in 
vascular topology and geometry in rat GM preparations [as previously shown in the 
mouse GM (Bearden et al., 2004)], 2) acquisition of outlet data at numerous terminal 
arteriolar segments for input in the computational flow model, 3) the shear rate values in 
arteriolar diameters under SNS-mediated vasoconstriction and the resolution between 
shear-mediated dilation and imposing SNS constriction, 4) characterizing purinergic 
mediation of vasoregulation (constriction and dilation) by delivering combinations of 
adenosine, ATP, ADP, as well as the appropriate blockade experiments, and 5) 
conducting SNS neuronal stimulation studies, in the face of antagonist delivery, 
alongside conducting in situ molecular characterization of receptor density at each level 
of the tree (i.e., immunohistochemistry and/or Western blotting on vessel sections from 
varying branch orders). Finally, it would be of great interest to estimate the effect(s) of 
the glycocalyx (a glycoprotein-polysaccharide that is tethered to the luminal surface of 
the endothelium and extends into the vessel lumen) on the velocity profile shape within 
the red blood cell free layer, and how the presence of the glycocalyx adjusts wall shear 
rate calculations. With the resolution used in the thesis herein, the dimensions of the 
glycocalyx are not resolvable; however, its dimensions can be approximated from 
literature and incorporated into wall shear rate calculations. 
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Appendix C: An automated cell-counting algorithm for 
fluorescently-stained cells in migration assays 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A form of this manuscript has been published: 
Al-Khazraji BK, Medeiros PJ, Novielli NM & Jackson DN. (2011). An automated cell-
counting algorithm for fluorescently-stained cells in migration assays. Biol Proced 
Online 13, 9. 
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Background  
Traditionally, in vitro cell-counting methodologies consist of manual counts through use 
of a hemacytometer (Kukulski et al., 2007; Ricardo & Phelan, 2008). Generally, cell 
migration experiments are conducted using modified Boyden chambers, whereby the 
cells of interest migrate through a porous membrane and are stained for counting. Such 
migratory cells are commonly labelled on the membrane with a crystal violet stain (Chien 
et al., 2011; Jones et al., 2012), Trypan Blue dye (Kuo et al., 2010), or hematoxylin (Jee 
et al., 2007; Zhu et al., 2007; Wedel et al., 2011), and quantified manually. Although it 
remains the gold standard, manual cell counting is very time-consuming and may 
introduce experimenter bias, thus increasing the potential for measurement errors (Piuri 
& Scotti, 2004).  
In an effort to increase efficiency and mitigate potential sources of bias/error associated 
with manual cell counting, a number of commercially available software suites provide 
automated cell counting from microscopic images. These software packages enable users 
to collect cell counts from random fields of view within specimens of interest. 
Unfortunately, these software suites contain proprietary algorithms (making them 
inadaptable), are generally expensive, and often require powerful computers, making 
them an unfeasible option for many research laboratories. 
Whole membrane quantification has been accomplished through spectrophotometric 
methods using absorbance microplate readers (Denholm & Stankus, 1995; Mu et al., 
2006; He et al., 2010). These microplate readers are able to detect total stained (if using 
dyes/stains) or fluorescence signal, where output values are a direct indication of total 
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migrated cells. Although absorbance microplate readers allow for an expeditious analysis 
of migration assays, they are costly and do not provide a record of membrane images 
should manual confirmation or further analysis be required. 
In the current study, we sought to develop a feasible, valid, and reliable algorithm 
designed to automate cell counting using stored images from cell migration experiments. 
In an effort to validate our algorithm we: 1) compared automated cell counts with manual 
counts from a blinded experimenter; and 2) determined the effect of objective power 
(2.5, 5, and 10) and increasing the number of cells in images on our algorithm’s 
ability to accurately resolve and quantify cells. 
Results  
Cell-Counting Algorithm 
Matlab software was used to create an algorithm (Appendix A) for counting 4',6-
diamidino-2-phenylindole (DAPI)-stained 4T1 (murine breast cancer) cells from cell 
migration assays. DAPI nucleic stain provided images with high contrast between nuclei 
and background (Figure 1, Panel A). Our algorithm consisted of three main components 
(in order) for automated counting: 
1) Image thresholding: Original images (Figure 1A) were read into the algorithm, and 
through use of the Matlab command graythresh, Otsu’s method for global 
thresholding (Otsu, 1979) was applied for selection of a threshold level used to 
convert the original image into a binary image. Briefly, Otsu’s method segments an 
image by maximizing the separability of the two populations in a histogram. Three 
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conditions must be met in order to maximize use of Otsu’s method: a) minimum 
variability in grey levels of foreground objects, b) minimum variability in background 
grey levels, c) maximum variability between background and foreground objects grey 
levels. These conditions are met by the DAPI-nucleic stained images used in this 
study.  
2) Pixel intensity values greater than threshold level were assigned a value of 1 (white; 
Figure 1, Panel B), and values lower than threshold level were assigned a value of 0 
(black). 
3) Calculating average cell nucleus area: The command regionprops (measures properties 
for image regions) was then used to sequentially (from left to right of image) label each 
object at its centroid (Figure 1, Panel C), and to measure area (pixel2) of each object in 
the binary image. The trimmed mean (command trimmean) of the constructed area array 
was calculated with a chosen percent value of 10%. As such, for a given image, 5% of the 
highest and lowest values from the area cell array were not included in calculation of the 
mean cell nucleus area. Average cell area (mean  S.E.M.) at 2.5, 5, and 10 power 
was 20.9  0.6 pixels2, 62.4  1.1 pixels2, and 256.1  18.9 pixels2, respectively, and was 
independent of total number of seeded cells.  
4) Determining final cell count: Each value in the area cell array was divided by the average 
cell nucleus area and rounded to the nearest integer (using command round). The sum of 
the integers then provided the total number of cells for a given image. Final counts were 
saved as a text file and exported into Microsoft® Excel® software (Version 12.2.8) for 
column statistics and data organization. 
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Figure 1: Flow Chart of Algorithm Processes.  
Panel A: original image (2.5×) read by algorithm; B: post-thresholding using Otsu's 
method for selection of threshold level. C: thresholded image with each object 
numerically labeled. 
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Algorithm Outputs Compared to Manual Counts 
A blinded experimenter conducted manual cell counts using ImageJ software (ImageJ 
1.43u, National Institute of Health, Bethesda, Maryland, USA), which required them to 
manually place a marker on each cell. A total of 47 images from varying fields of view 
within each membrane (for 10,000 and 100,000 total seeded cells) were read in as a series 
of images (.tif series) based on sequential file name order. Using our algorithm, total 
computing time for 47 images was 14.5 seconds, which was 596 times faster than manual 
counting [total manual counting time for 47 images = 8640 seconds (2.4 hours)]. Linear 
correlation between manual and automated cell counts from 47 images images taken 
using 2.5×, 5×, and 10× objectives illustrated near perfect correlation and congruency (r2 
= 0.99, P < 0.0001, Slope = 1.02, Y intercept = 2.2; Figure 2). 
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Figure 2: Manual versus Automated Cell Counts. Linear regression of manual versus 
automated cell counts for 47 images, with a correlation of r2 = 0.99, P < 0.0001. Dotted 
lines represent 95% confidence interval for slope and y-intercept. 
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Algorithm Outputs Compared to Manual Cell Counts Based on Objective Power and 
Total Seeded Cells 
To determine the effect of objective power on the software’s ability to resolve migrated 
cells, a single 2.5 image (centered on the membrane) was captured for experiments that 
used 10,000 and 100,000 seeded cells, followed by images of the same membrane area at 
5, and then 10. Multiple 5 and 10 images were assembled into a photomontage (all 
image resolutions were collected and maintained at 150 dpi) to reconstruct exact 
membrane area covered by the single 2.5 image. At each number of total seeded cells 
(10,000 and 100,000 cells), manual counts (in triplicate) were performed on the single 
2.5 image, 5 photomontage, and the 10 photomontage (Figure 3). It is important to 
note that during cell migration experiments not all seeded cells migrate through the 
membrane, thus cell counts are lower than the total number of seeded cells. 
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Figure 3: Manual versus Automated Cell Counts Based on Objective Power. 
Comparison of manual versus automated cell counts for varying objective power (2.5 ×, 5 
× montages, and 10 × montages) and total seeded cells (10,000 and 100,000 cells). 
Within each group of total seeded cells, RM ANOVA confirmed no significant difference 
between manual and automated counts at all objective powers. 
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Discussion  
In the current study, an automated cell counting algorithm was created to quantify 
resultant migratory 4T1 breast cancer cells in cell migration assays that used 10,000 and 
100,000 total seeded cells. The algorithm was only tested in migration assays conducted 
in modified Boyden chambers using DAPI-stained 4T1 breast cancer cells. For a total of 
47 images, automated cell counts had strong correlation with manual counts (r2 = 0.99, P 
< 0.0001; Figure 2). To highlight the congruency between methods, the y-intercept for 
the linear regression line (Fig. 2) indicated that our automated method overestimated an 
average of only 2 cells under all experimental and imaging conditions. Furthermore, there 
were no differences in cell counts between methods regardless of experimental conditions 
(number of cells seeded) or objective power (Fig. 3).      
Our results support the notion that manual cell counting is time consuming (47 images; 
manual counting time = 2.4 hours versus automated computing time = 14.5 seconds) and 
subject to operator bias (hence our experimenter was blinded). Further, it is difficult to 
reproduce exact measurements using manual methods (hence variability in our manual 
cell counts, Fig. 3), which is likely due to disparate criteria under which manual cell 
counting is performed from image to image. Our automated method processes and counts 
all images using set criteria making it immune to the aforementioned sources of error. 
Upon multiple independent screening of the same 47 images, zero variability was still 
obtained. 
Quantification of migrated cells from cell migration experiments are generally limited to 
objective powers ranging from 5 to 200 (Alge-Priglinger et al., 2009) and thus require 
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3 (Du et al., 2010) to 10 (Kusuma et al., 2012) fields of view in an effort to capture a 
representative sample of the membrane. The consistency in computed cell counts among 
different objective magnifications highlights our algorithm’s ability to accurately resolve 
and count cells even under low magnification; thus enabling the user to analyze larger 
proportions of total membrane surface area in one field of view. This is due to the 
thresholding portion of our algorithm, which optimizes contrast between cell nuclei and 
the image background (Fig. 1).  
Conclusions  
We have successfully developed a feasible algorithm for automated cell counting within 
cell migration assays. Automated cell counts agreed favorably with manual counts for all 
objective powers and for different levels of total seeded cells. As well, in contrast to 
manual counting, our automated algorithm counted cells quickly and independent of bias, 
and presented zero variability for counting cells multiple times within single images. 
Materials and methods 
Cell Culture 
4T1 cells, a gift from Dr. Fred Miller (Wayne State University, Michigan USA), were 
cultivated in high glucose Dulbecco’s Minimal Essential Medium (DMEM) 
supplemented with 10% sterile FBS. Cells were incubated at 37ºC and 5% carbon 
dioxide. At approximately 80% confluency, cells were washed with HBSS and passaged 
using 0.25% trypsin-EDTA treatment for dissociation. 
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Migration Assays 
Migration assays were conducted using a modified Boyden chamber apparatus with a 12-
well plate and cell culture inserts with polyethylene terephthalate membranes (8 μm 
pores, BD Biosciences). 4T1 cells were plated in the upper chamber in serum-free media 
(10,000 and 100,000 cells). Serum-containing media (10% fetal bovine serum) was added 
to the bottom chamber as a chemoattractant. After 24 hours of incubation, non-migrated 
cells were scraped from the top of the membrane with a cotton swab; migrated cells (on 
the bottom of the membrane) were then fixed in methanol and stained with DAPI. The 
mounted on slides, and imaged using fluorescence microscopy at 2.5, 5 and 10 
magnification (Zeiss Axiovert 200, Zeiss Axiocam HRc camera). Image exposure time 
was consistent at each magnification (2.5: 581 ms; 5: 206 ms, 10: 49 ms). 
Image Assembly 
To reproduce single 2.5 fields of view at higher objective powers, photomontages (.tif) 
of overlapping fields of view taken at the 5 and 10 power objectives were assembled in 
Adobe Photoshop CS3 [(version 10.0.1), no changes were made to the original image 
files].  
Statistical Analysis and Data Presentation 
All data are presented as mean  S.D., unless stated otherwise. Statistical analysis was 
performed using Prism Software (version 4, GraphPad Software Inc, La Jolla, CA, USA) 
and differences were accepted as statistically significant when P < 0.05. Manual versus 
automated cell counts for all 47 images (Fig. 2) were plotted using linear regression 
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analysis. To analyze the effects of objective power and manual versus automated counts 
within a given level of seeded cells, a repeated measures analysis of variance (RM 
ANOVA) was conducted (Fig. 3). 
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Appendix D: Cell counting algorithm 
%%Automated Cell Counting Algorithm.  
    %%Created by Baraa Al-Khazraji,  
    %%The Jackson Laboratory, Department of Medical Biophysics, 
Schulich School of Medicine & Dentistry, The University of Western 
Ontario. PROPERTY OF Dr. DWAYNE N. JACKSON, FREE FOR ACADEMIC USE ONLY 
 
close all 
clear all 
clc 
% p = ('/Users/dwaynejackson/Jackson Lab Exp Files renamed for 
matlab/SNAP-0001.tif'); 
% filelist = dir([fileparts(p) filesep 'SNAP-00*.tif']); 
% fileNames = {filelist.name}'; 
%  
% % file = '/Users/dwaynejackson/Desktop/Jackson Lab Exp Files renamed 
for 
% % matlab/SNAP-00*.tif'; 
% I = imread(fileNames{1}); 
% [mrows,ncols] = size(I); 
% totalimages = length(fileNames); 
FoldertoRead = '/Users/dwaynejackson/Desktop/now reading'; 
Pattern_of_files = fullfile(FoldertoRead, '*.tif'); 
tif_Files = dir(Pattern_of_files); 
 
for i = 1:length(tif_Files) 
    baseFileName = tif_Files(i).name; 
    fullFileName = fullfile(FoldertoRead, baseFileName); 
    fprintf(1, 'Now Reading %s\n', fullFileName); 
     
  %%Open individual .tif file for analysis 
    I = imread(fullFileName); 
     
  %%Show current .tif file that is being analyzed 
    figure 
    imshow(I) 
  %%Turn image into a binary image, with a variable threshold value 
    B = im2bw(I,0.32); 
    figure 
    imshow(B) 
  %%Label each object in the binary image 
    bw = bwlabel(B); 
  %%Quantify each labeled object; choosing 'all' means that all 
parameters 
  %%(majoraxislength, perimeter, centroid, etc.) are analyzed 
    measures = regionprops(B, 'all'); 
    numberOfitems = size(measures, 1); 
  %%Label each object in the binary image at its centroid, in the order 
that it is analyzed, and make the font pink, and size 12   
        for k = 1 : numberOfitems % Loop through all items. 
            itemCentroid = measures(k).Centroid; % Get centroid. 
                     % Write item number over item at its centroid. 
            text(itemCentroid(1), itemCentroid(2), num2str(k), 'Color', 
[1 0.3 0.5], 'fontsize',12); 
        end 
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  %%Convert each measurement from regionprops output into cells     
    convertstruct2cell = struct2cell(measures); 
   
  %%Take fluorescent area of each object and convert it to a matrix, 
then 
  %%take the sum of total fluorescent area for each image 
    Area = convertstruct2cell(1,:); 
    Area_array = cell2mat(Area); 
    TotalArea = sum(Area_array(1,:)); 
   
  %%Take the mean of fluorescent area in each image 
    normalmean = mean(Area_array); 
     
  %%Take the mean of fluorescent area in each image, then cleave off 
outliers within 10% of the mean   
    trimmedmean = trimmean(Area_array,10); 
 
  %%Take the Area matrix and divide each value by by the mean 
fluorescent 
  %%area, then round to the nearest integer. Done using normal mean, 
and 
  %%the "trimmedmean" (outliers removed) 
    WholeCells = round(Area_array/normalmean); 
    WholeCellstrimmed = round(Area_array/trimmedmean); 
     
  %%Add up all the integers to calculate total cells in each image   
    TotalWholeCells(i) = sum(WholeCells); 
    TotalWholecellstrimmed(i) = sum(WholeCellstrimmed); 
 
    % NumberofCells_highrange = TotalArea/17; 
    % NumberofCells_lowrange = TotalArea/20; 
    % Averagenumber_fromhighandlowrange(i) = (NumberofCells_highrange + 
NumberofCells_lowrange)/2; 
     
  %%Convert the row to a column (transpose it)   
    Totalwholecells_usingtrimmedmean = TotalWholecellstrimmed'; 
    Totalwholecells_usingnormalmean = TotalWholeCells'; 
        
    % ConvertFileName = char(baseFileName); 
    % FileName = ConvertFileName'; 
    trimmean_mean = trimmedmean'; 
    normal_mean = normalmean'; 
    % Averagenumber_from_highandlowrange = 
Averagenumber_fromhighandlowrange'; 
     
     
  %%Create a dataset of results 
    T1_25000cells_5x = dataset(Totalwholecells_usingtrimmedmean, 
Totalwholecells_usingnormalmean,normal_mean,trimmean_mean); 
     
  %%Export dataset to a text file, and name the text file 
    export(T1_25000cells_5x) 
end 
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 UWO Graduate Thesis Awards Fund Winner, 2010-2011 
 UWO University Student Council Teaching Honor Roll, 2009-2010 
 UWO Western Mustang Band Most Dedicated Band Member Award Winner, 
2007-2008 
SCHOLARSHIPS 
 Western University Faculty of Health Sciences Postdoctoral Fellowship (2015-
2016) 
 CIHR Banting Postdoctoral Fellowship Nominee, September 2014 
 Alexander Graham Bell Canada Graduate Scholarship (NSERC CGS D; 
September 2012 – August 2014) 
 Nominated by UWO for Vanier Canada Graduate Scholarship (September 2011), 
rank: top 35% in Canada 
 Ontario Graduate Scholarship (September 2012 – August 2013) - Declined 
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 Ontario Graduate Scholarship (September 2011 – August 2012) 
 Alexander Graham Bell Canada Graduate Scholarship (NSERC CGS M; 
September 2010 – August 2011) 
 CIHR Strategic Training Program in Vascular Research (September 2009 – 
August 2011) 
 Ontario Graduate Scholarship (September 2009 – August 2010) 
 SSMD Graduate Tuition Scholarship (full tuition scholarship; September 2009 – 
August 2014) 
 Western Entrance Scholarship (September 2005 – April 2009) 
 
RELEVANT WORK EXPERIENCE 
Teaching 
 Guest Lecturer for 3rd year Medical Biophysics course (MBP 3501F) 2011-2014 
 Guest Lecturer for 4th year Medical Biophysics course (MBP 4535) 2012-2014 
 Teaching Assistant/ Lab Instructor, Assisted in course development (General 
Biophysics Laboratory (course code 3970Z)). UWO USC Teaching Honor Roll 
(2009 – 2010) 2009 -2011 
 Teaching Assistant for 3rd year Medical Biophysics course (MBP 3501F) 2012-
2013 
Mentoring 
 Research Mentor for Mohammad Al-Tarhuni (1st year MSc student, May 2014 – 
current) 
 Research Mentor for Partners in Education High School Student: Nicole 
Omoruwa (February 2010  – Current) 
 Research Mentor for Elton Law (4th year Physiology student, Thesis project, 
September 2013-April 2014) 
 Research Mentor for David Yeung (3rd year MBP student, 6 week project, 
September 2013-April 2014) 
 Research Mentor for Jenna Kara (3rd year MBP student, 6 week project, 
September 2013-April 2014) 
 Assistant Research Mentor for UWO Scholar’s Elective Student: Ryann Kwan 
(May – June 2012) 
 Research Mentor for 4th year Medical Biophysics Thesis student: Samantha 
Coleman (September 2011 – April 2012) 
 Research Mentor (3rd Year General Biophysics Laboratory (course code 3970Z) 
Research Project): Joanne Wong, Department of Medical Biophysics (January  – 
April 2011) 
 Research Mentor (undergraduate summer student researcher): Kelley Bronson, 
Department of Medical Biophysics (May – August 2009) 
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PUBLICATIONS 
Published Peer Reviewed Articles 
Shoemaker J.K., Badrov M., Al-Khazraji B.K., Jackson D.N. Neural control 
of vascular function (invited review). Comprehensive Physiology. 2015. (in 2nd 
review; submission #: CPHY-15-0004; May 2015) 
 
       Al-Khazraji B.K., Saleem A., Goldman D., Jackson D.N. From one 
generation to the next: A comprehensive account of sympathetic receptor control in 
branching arteriolar trees. Journal of Physiology. 2015 (in press; April 2015). 
 
Yeung T.P., Kurdi M., Wang Y., Al-Khazraji B., Morrison L., Hoffman L., 
Jackson D., Crukley C., Lee T.Y., Bauman G, Yartsev S. CT perfusion imaging as 
an early biomarker of differential response to stereotactic radiosurgery in C6 rat 
gliomas. PLoS One. 2014.  
 
Nyberg M., Al-Khazraji B.K., Mortensen S.P., Jackson D.N., Ellis C.G., 
Hellsten Y. Effect of extraluminal ATP application on vascular tone and blood flow 
in skeletal muscle: implications for exercise hyperemia. The American Journal of 
Physiology - Regulatory, Integrative and Comparative Physiology. 2013.  
 
Novielli N.M., Al-Khazraji B.K., Medeiros P.J., Jackson D.N. Pre-diabetes 
augments neuropeptide Y1- and 1-receptor control of basal hindlimb vascular tone 
in young ZDF rats. PLoS ONE. 2012. 
 
Al-Khazraji B.K., Novielli N.M., Goldman D., Medeiros P.J., Jackson D.N. 
A simple “streak method” for quantifying and characterizing red blood cell velocity 
profiles and blood flow in rat skeletal muscle arteriolar networks. Microcirculation. 
2011.  
 
Al-Khazraji B.K., Medeiros P.J., Novielli N.M., Jackson D.N. Method: An 
automated cell-counting algorithm for fluorescent-stained cells in migration assays. 
Biological Procedures Online. 2011. 
Medeiros P.J., Al-Khazraji B.K., Novielli N.M., Postovit L.M., Chambers 
A.F., Jackson D.N. Neuropeptide Y stimulates proliferation and migration in the 4T1 
breast cancer cell line. International Journal of Cancer. 2011. 
 
Peer Reviewed Abstracts 
Al Tarhuni M., Al-Khazraji B.K., Omoruwa N, Jackson D.N. Level of 
Sympathetically Mediated Arteriolar Control is Inversely Dependent on Arteriolar 
Segment Length in Rat Gluteus Maximus Microvascular Networks. Experimental 
Biology. The FASEB Journal March 2015 
 
Al-Khazraji B.K., Saleem A., Goldman D., Jackson D.N. Hemodynamic 
consequences of spatially-dependent sympathetic regulation in skeletal muscle 
arteriolar trees. (678.14) The FASEB Journal April 2014 28:678.14 
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Yeung T.P.C., Al-Khazraji B., Morrison L., Hoffman L., Jackson D., Lee 
T.Y., Bauman G., and Yartsev S.. Monitoring vascular response to stereotactic 
radiosurgery in a brain tumor model using CT perfusion. Radiotherapy and 
Oncology. 2013;108(supplement 1):S25. 
 
Yeung T.P.C., Al-Khazraji B., Morrison L., Hoffman L., Jackson D., Lee 
T.Y., Yartsev S., and Bauman G. Assessing the acute anti-angiogenic effect of 
Bevacizumab on glioma with CT perfusion. The 11th Imaging Network Ontario 
Symposium. (04/02/13 – 05/02/13).Book of abstract: page 55 
 
Yeung T.P.C., Al-Khazraji B., Morrison L., Hoffman L., Jackson D., Lee 
T.Y., Bauman G., Yartsev S. Monitoring the vascular response of brain tumor to 
stereotactic radiosurgery with CT perfusion. The 11th Imaging Network Ontario 
Symposium. (04/02/13 – 05/02/13). Book of abstract: page 56. 
 
Al-Khazraji B.K., and Jackson D.N. (2012) Heterogeneous Arteriolar 
Constriction And Blood Flow Responses To Sympathetic Co-Transmitters In Skeletal 
Muscle Microvascular Networks. Presented at the Joint Meeting of the British and 
American Microcirculation Societies. Oxford University, Oxford, United Kingdom. 
 
Novielli, N.M., Al-Khazraji B.K., Jackson D.N. (2012). Pre-diabetes and 
microvascular dysfunction in contracting skeletal muscle. The Canadian Student 
Health Research Forum 2012 Book. Winnipeg, Manitoba, Canada. 
 
Al-Khazraji B.K., Novielli, N.M., Goldman D., Ellis C.G., Jackson D.N. 
(2011). Novel Video Method for Acquiring and Modeling In Vivo Hemodynamic 
Data From Arteriolar Networks of Rat Gluteus Maximus Skeletal Muscle. 2011 
CIHR National Student Research Poster Competition (National). Abstract #255. The 
Canadian Student Health Research Forum 2011 Book. Winnipeg, Manitoba, Canada. 
(Recipient of Silver Award) 
 
Al-Khazraji B.K., Novielli N.M., Goldman D., Ellis C.G., Jackson D.N. 
(2011). Novel Video Method for Acquiring and Modeling In Vivo Hemodynamic 
Data From Arteriolar Networks of Rat Gluteus Maximus Skeletal Muscle. 
Experimental Biology 2011 (International); Abstract # 7005 (Poster). The FASEB 
Journal April 2011. Washington, District of Columbia, United States  
 
Novielli, N.M., Al-Khazraji B.K., Jackson D.N. (2011). Impaired 
microvascular control in contracting skeletal muscle in a murine model of 
prediabetes. Experimental Biology 2011 (International). The FASEB Journal April 
2011. Washington, District of Columbia, United States  
 
Novielli, N.M., Al-Khazraji B.K., Ellis C.G., Jackson D.N. (2010). 
Sympathetic modulation of baseline hindlimb blood flow and vascular conductance 
in a model of prediabetes using young Zucker Diabetic Fatty rats. Experimental 
Biology 2010. The FASEB Journal April 2010.  
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Lizardo M.M., Al-Khazraji B., Percy D.B., Wirtzfeld L.A., MacDonald I., 
Fenster A., Lacefield J.C., and Chambers A.F. (2008) Optical Fluorescence and 
High Frequency (40mHz) Ultrasound Imaging of Spontaneous Lymph Node 
Metastases in a Xenograft Model of Breast Cancer. (Poster) Canadian Breast 
Cancer Research Alliance (CBCRA) Reasons for Hope Conference. 
 
Lizardo M.M., Strike D.R.G., Al-Khazraji B., Wirtzfeld L.A., MacDonald I., 
Fenster A., Lacefield J., and Chambers A.F. (2007) Development of a High 
Frequency Ultrasound (40mHz) Imaging Technique to Study the Progression of 
Lymph Node Metastasis in a Mouse Model of Breast Cancer. (Poster) National 
Cancer Institute of Canada (NCIC) 60th Anniversary Canadian Cancer Research 
Conference. 
 
INVITED PRESENTATIONS 
Annual Alan C. Burton Day, Graduate Student speaker, Department of Medical 
Biophysics, April 2015 
 
Canadian Student Research Health Forum (held by CIHR) Doctoral Student National 
Poster Competition Winnipeg, MB, Canada. June 2011 (2nd place winner) 
 
London Health Research Day Platform Competition. London Convention Centre, March 
2012 and 2013 (2013 1st Place Award Winner), London, Ontario, Canada. 
